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Abstract
Lipoproteins are lipid modified proteins attached to the cytoplasmic membrane of 
both Gram-negative and Gram-positive bacteria.  In Gram-negative bacteria, 
lipoproteins are produced in a four stage process.  Firstly the protein is translocated 
across the cytoplasmic membrane, primarily  by the Sec general secretory  pathway, 
then lipidated at a conserved cysteine by  the enzyme Lipoprotein diacylglyceryl 
transferase (Lgt).  The signal peptide is cleaved by  Lipoprotein signal peptidase II 
(Lsp), to leave the lipid modified cysteine at the N-terminus.  Finally  the lipoprotein 
is N-acylated by Lipoprotein N-acyl transferase (Lnt).  This pathway  is essential and 
occurs in the order listed.  However the pathway in all Gram-positive bacteria 
tested to date is non-essential, and in low GC Gram-positive bacteria the Lnt 
enzyme is absent.  This work concentrates on the lipoprotein biosynthetic pathway 
of Streptomyces coelicolor, the model organism for the high GC branch of Gram-
positive bacteria and Streptomyces scabies, a pathogen of potatoes.  Each of the 
genes encoding the enzymes listed above were disrupted to assess their 
importance to the bacteria.  Strong evidence is shown in both species that the Lsp 
(and probably the Lgt) enzyme is essential, not seen in other Gram-positive 
bacteria.  Evidence from the S. scabies work suggests the pathway occurs in a 
strict, regimented order.  Both results indicate the lipoprotein biosynthetic pathway 
of Streptomyces is closer to that of the Gram-negative bacteria, than that of the 
other Gram-positives tested to date.  This work also provides the first insights into 
the role of the lipoprotein biosynthetic pathway in plant pathogenesis.  Studies in 
animal pathogens have shown that disrupting the pathway  can have a variety  of 
effects, ranging from avirulence to hypervirulence.  This work shows that disrupting 
the lipoprotein processing enzymes has a moderate effect of the virulence of S. 
scabies on both potato tubers and radish seedlings.
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Chapter 1 - Introduction
1.1 Introduction
Bacteria live in a variety  of different environments.  As such, they are subjected 
to a multitude of stresses to which they must sense and respond in order to 
survive. Both branches of bacteria, Gram-positive and Gram-negative, contain 
proteins localised within their membranes which can interact with the 
surrounding environment.  This thesis will summarise work carried out on a 
specialised class of membrane proteins known as lipoproteins in the Gram-
positive bacteria Streptomyces coelicolor and Streptomyces scabies.
1.2 Protein Translocation
The translocation of proteins across the cell membrane is essential for all 
cellular life.  Although all proteins are synthesised cytoplasmically, many have 
extra-cellular functions, be they metabolic or structural, and their transport from 
the inside to the outside of the cell must be tightly regulated.  There are two 
main translocation routes for proteins across the cytoplasmic membrane, i) The 
Sec (General Secretory) pathway and ii) The Tat (Twin Arginine Translocation) 
pathway.
1.2.1 The Sec Pathway
The Sec pathway has been studied for several decades, and is relatively  well 
understood.  This translocation pathway is involved in the secretion of unfolded 
proteins, as well as the insertion of proteins into the cell membrane [1].  The 
Sec pathway is found in all organisms, including the Endoplasmic Reticulum of 
eukaryotic cells and the thylakoid membranes of plant chloroplasts.  Proteins 
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are targeted to the Sec machinery by a Sec signal sequence which is also 
conserved in all domains of life.  The sequence is usually about twenty amino 
acids in length and does not contain any conserved sequence motifs. Instead 
there are three distinct regions: i) the n-region which consists of positively 
charged amino acids ii) the h-region consisting of hydrophobic amino acids, iii) 
the c-region or cleavage region (fig. 1.2), which is necessary for the action of 
signal peptidases.
The Sec machinery consists of several proteins: SecY, SecE and SecG form 
the hydrophilic protein conducting channel (PCC) and are associated with 
SecA, the motor protein which contains an ATPase domain.  SecD and SecF 
are required for efficient translocation.  Of these proteins, SecYEA are essential. 
There are two methods of Sec mediated translocation, co-translational and 
post-translational.  Co-translational protein translocation in bacteria is used by 
only a few secretory proteins [1], and is mainly used to insert integral membrane 
proteins into the membrane.  In this method the Sec signal sequence of the 
protein to be translocated is recognised by the Signal Recognition Particle 
(SRP) whilst it is emerging from the ribosome.  This entire complex is then 
transferred to the Sec machinery with the aid of the SRP receptor (fig. 1.1).  The 
post-translational translocation in Gram-negative bacteria requires an additional 
chaperone protein, which in E. coli is named SecB.  SecB is a secretion-specific 
chaperone which binds to aromatic and basic regions of the preprotein as it is 
emerging from the ribosome, stabilising it, and preventing folding.  SecB 
interacts with SecA in the SecYEGA complex and passes the unfolded protein 
to SecA to allow for translocation.  SecB is not essential for Sec translocation.  It 
18
appears that in its absence, the Sec signal peptide is enough to target the 
unfolded protein to the Sec machinery [1].  As SecB is only found in 
proteobacteria, it seems likely that bacteria lacking in this protein either rely on 
the signal peptide, or utilise other chaperones.  
Figure 1.1 An overview of Sec and Tat dependent translocation. Sec dependent 
translocation can be co-translational (a), or post-translational (b) and involves 
unfolded proteins, whilst Tat dependent translocation (c) involves full folded 
proteins.  From [1].
1.2.2 The Tat Pathway
The Tat pathway is used to transfer fully folded proteins across the cell 
membrane.  Whilst the Sec system is ubiquitous, it appears that the Tat system 
is only  encoded in about half of the currently sequenced bacterial genomes [2], 
although it must be stressed that there is a bias in the number of bacterial 
species sequenced towards the Gram-negatives, so this figure may not 
represent the true number of species containing the Tat system.  Proteins which 
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are translocated by Tat can be identified by their signal sequence, which is 
larger than the Sec sequence, but still contains the tripartite structure described 
above.  Unlike the Sec signal peptide however, the Tat signal peptide contains a 
very  specific sequence which gives the system its name. A comparison of the 
two signal peptides can be seen in figure 1.2.  The amino acid sequence 
spanning the division between n and h region contains the motif Ser/Thr-Arg-
Arg-X-Φ-Φ (where X can be any amino acid and Φ is a hydrophobic residue) [3]. 
This sequence is essential for translocation, and the twin arginine residues are 
almost always conserved.  To date only two Tat substrates have been found that 
lack the Arg-Arg motif [4].  The Tat system is able to translocate proteins that 
contain cofactors, which need to be folded before translocation.  A molybdenum 
cofactor containing subunit of DMSO Reductase in Shewanella oneidensis, 
DmsA, has been shown to contain a twin arginine motif in its leader sequence 
[5], as has the HysB subunit of [NiFeSe]  hydrogenase from Desulfovibrio 
vulgaris [6].
In E. coli, the Tat system consists of three proteins: TatA, TatB and TatC.  A 
homologue of TatA, TatE, also exists but is encoded elsewhere in the genome. 
The transmembrane pore in the Tat complex is formed by the TatA protein. 
TatA is 89 amino acids in length and its functional domain is a single N-terminal 
transmembrane helix [4].  TatA is only approximately  9kDa in size, but individual 
TatA monomers are able to interact via their transmembrane domains to form 
complexes estimated to be up to 750kDa in size [7].
The TatC protein is 258 amino acids in length and contains six transmembrane 
helices.  Both the N and C termini are located in the cytoplasm.  This protein is 
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the most conserved Tat subunit throughout the bacterial kingdom [8].  TatC is 
essential for the formation of the Tat complex and is able to bind both the signal 
peptide of the protein to be transported and TatB.  The structure of TatB is 
similar to that of TatA but its function is somewhat of a mystery.  Many Gram-
Positive bacteria, such as B. subtilis, lack TatB and are still able to export 
proteins via the Tat pathway.  In E. coli however, the loss of TatB leads to a 
disruption of the translocation of some proteins, but not others [4, 7].
It is currently thought that in E. coli, when at rest, TatB and C from a complex 
which is ready to accept the Tat signal sequence.  Once the TatBC-substrate 
complex is formed, TatA monomers are recruited, and the protein is 
translocated.  Once this occurs the TatABC complex rapidly dissociates back to 
its resting state [7].  What is not known currently is whether a ready sized TatA 
pore is selected depending on the size of the substrate, or whether the TatA 
monomers form a pore when required.  The exact role of TatB is yet to be 
elucidated.  It is possible that this protein acts as a bridge between the TatC 
bound substrate and the TatA pore [3, 7].
n-region h-region c-region
Z-R-R-x-ϕ-ϕ
Tat
Sec
C+1
Figure 1.2 Comparison of the Tat and Sec secretion N-terminal signal sequences.  The 
characteristic Twin arginine motif of a Tat substrate is shown.  The cysteine at position 
+1 represents the first amino acid of a mature lipoprotein.  Based upon [1].
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1.3 Lipoproteins 
In bacteria the addition of a lipid molecule to a protein to form a lipoprotein is 
tightly controlled as part of a multi-step  reaction which occurs after translocation 
across the cytoplasmic membrane.  This pathway  appears to be unique to the 
Bacteria even though lipid modified proteins are also found in Archaea and 
Eukaryotes [9].  Most of the work on bacterial lipoproteins has been carried out 
in the Gram-negative bacterium Escherichia coli.  The first lipoprotein 
discovered was the murein lipoprotein from E. coli also known as Braunʼs 
lipoprotein in 1969 [10].
The leader sequences of lipoproteins closely resemble those of other Sec 
transported proteins with the exception of an extra motif known as the lipobox. 
As before, the signal sequence contain three distinct regions: i) The n-region ii) 
The h-region iii) The c-region.  The c, or cleavage, region contains the lipobox 
motif.  This motif is essential for correct lipoprotein processing and contains a 
four amino acid sequence as follows: L-3-[A/S/T]-2-[G/A]-1-C+1 [11].
The only  invariant here is the cysteine residue at +1.  The other three amino 
acids are occasionally different, but the frequency at which others occur is much 
lower [12].  The cysteine is invariant as it contains the sulphydryl group  to which 
the diacylglyceride (lipid) moiety is covalently attached.  It is labelled +1 as it will 
become the first amino acid (the N-terminus) of the mature lipoprotein.  It has 
been noted that the lipoprotein signal sequence appears to be shorter than that 
of exported proteins that are not lipidated [13].
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The production of a mature lipoprotein in Gram-negative bacteria is a four-stage 
process.  The first stage involves export of the protein to be lipidated via the 
Sec (or Tat) pathway.  The next three steps are processing steps which occur 
on the extracytoplasmic face of the membrane, each requiring a separate 
enzyme: i) Lipoprotein diacylglyceryl transferase (Lgt) ii) Lipoprotein signal 
peptidase II (Lsp) iii) Lipoprotein N-acyl transferase (Lnt).  The pathway is tightly 
controlled and occurs strictly in the order listed  [14] (figs. 1.3, 1.4).  In Gram-
positive bacteria, the pathway is different, due to the lack of an outer 
membrane.
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1.3.1 Lipoprotein diacylglyceryl transferase
The first enzyme in the pathway, Lgt, is responsible for adding the diacylglyceryl 
molecule to the cysteine  in the lipobox via a thioether linkage.  In E. coli it has 
been shown that this lipid moiety is transferred from phosphatidyl glycerol (PG) 
to the sulphhydrl group of the unmodified immature liprotein [12].  Lgt is a 
membrane bound enzyme which is highly conserved throughout the bacterial 
kingdom, with the structure containing large sections of hydrophobic amino 
acids separated by  short hydrophilic sections.  The large amounts of arginine 
and lysine lead to a net basic charge for the enzyme [15], estimated to have a 
pKa value ~10 [16].  It is thought that the basic charge is important for 
interaction with acidic membrane phospholipids [14].  In E. coli a histidine 
residue at position 103 has been shown to be essential for enzyme activity and 
two other amino acids, His-196 and Tyr-235, important for function [17].  The 
generally  accepted theory is that Lgt lipidates an immature lipoprotein that is 
anchored in the cytoplasmic membrane by its signal peptide.  This would 
explain the presence of the hydrophobic region in the signal peptide. 
Confusingly  however, a recent paper has suggested that the h-regions of some 
signal peptides may be more hydrophilic than previously thought and that the 
Lgt enzyme may be located on the inner face of the cytoplasmic membrane 
[16].
Lgt catalysed lipidation of the immature lipoproteins has been shown in various 
bacteria, including L. monocytogenes, S. aureus, and S. equi.  ∆lgt mutants 
grown in the presence of [14C]-palmitic acid had no detectable lipoproteins in 
their membrane fractions, whereas they were detectable in the wild type 
controls [15, 18, 19]. 
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1.3.2!  Lipoprotein signal peptidase II
Lsp, also known as signal peptidase II, is the second enzyme in the pathway, 
and is a transmembrane protein responsible for removing the signal sequence 
from exported immature lipoproteins [19].  In eubacteria such as B. subtilis there 
is only a single copy of the lsp gene, whereas there are multiple signal 
peptidase I genes [20], which cleave the signal sequences from all non-
lipoproteins translocated via Tat or Sec.   This appears to be the case in the 
majority of bacterial species, although there do appear to be some examples of 
an organism having more than one lsp paralogue, such as in Myxococcus 
xanthus [21].  In E. coli the lsp gene is encoded in an operon with four other 
genes and is cotranscribed with ileS, which encodes the isoleucyl-tRNA 
synthetase [22], although there seems to be no obvious physiological 
connection.  This cotranscription is conserved in a number of Gram-negative 
bacteria as are the other downstream open reading frames (ORF) [19].  In 
Gram-positive bacteria lsp and ileS are not found in the same operon [21].  To 
date an Lsp  homologue has not been identified in eukaryotes or archaea but it 
has been shown that signal cleavage of lipoproteins in archaea is inhibited by 
globomycin, a potent inhibitor of Lsp  [20, 23].  It has been shown that in the 
majority of bacteria, both Gram-positive and Gram-negative, a lipoprotein must 
be lipidated by Lgt before Lsp can recognise its substrate [20].  However, there 
are exceptions to this rule and L. monocytogenes Lsp can act on non-lipidated 
lipoproteins leading to their mass release into the growth medium [24].  This 
enzyme cleaves the signal sequence just prior to the +1 cysteine, which then 
becomes the N-terminal residue of the mature protein.
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The sizes of the lsp genes sequenced so far encode Lsp  enzymes ranging from 
154 amino acids in B. subtilis to 181 amino acids M. genitalium [25].  Computer 
analysis of the protein suggests it contains four membrane spanning domains 
[19], consistent with the idea that this is a membrane-bound protein.  The 
enzyme also contains several conserved amino acids that are necessary for 
function, including two aspartic acid residues which may form a catalytic dyad in 
the active site of the enzyme [19].  These residues are all predicted to be 
located on the external face of the cytoplasmic membrane in B. subtilis [26]. 
Indeed Lsp lacks the amino acids or associated metal ions required by several 
classes of proteases and is inhibited by  Pepstatin, an inhibitor of aspartate 
peptidases, indicating that the enzyme belongs to this group, although it does 
not share the active sites found in plant or viral aspartate petidases, suggesting 
that Lsp may represent a novel class of these enzymes [26].
Many of the studies carried out on Lsp  have been made possible by the action 
of the cyclic peptide antibiotic, globomycin.  This antibiotic acts as a non-
competitive analogue inhibitor of Lsp [27], and is lethal to Gram-negative 
bacteria as it leads to the accumulation of incorrectly processed lipoproteins in 
the inner membrane.  Globomycin is lethal to E. coli at a concentration of 20-40 
μg ml-1 [28].  Overexpression of Lsp leads to increased resistance to 
globomycin, and this has been used to determine whether lsp genes from other 
bacteria expressed in E. coli can raise the level of globomycin resistance and 
therefore be shown to be active Lsp homologues as has been demonstrated in 
a variety of different species [19, 21, 25, 28].
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1.3.3 Lipoprotein N-acyl transferase
The final enzyme involved in the maturation of a lipoprotein is Lnt.  The function 
of this protein is to N-acylate the amino group found in the C+1 cysteine of the 
lipoprotein.  Lnt was initially thought to be unique to Gram-negative bacteria as 
it had not been found in most Gram-positive bacteria, including B. subtilis, the 
model low GC Gram-positive bacterium [29].  However, recent genome 
sequence analysis has revealed that some members of the actinomycetes, the 
high-GC branch of Gram-positive bacteria, contain homologues of Lnt [30].  It is 
believed to be a member of the nitrilase superfamily of enzymes, which 
hydrolyse carbon-hydrogen bonds [30, 31].
Before Lnt can act on a lipoprotein it must first have its signal sequence 
removed by Lsp  giving the strict sequence Lgt->Lsp->Lnt [14].  Once the signal 
peptide has been removed, Lnt catalyses the addition of an acyl group  to the +1 
cysteine residue in the lipoprotein [12].  In E. coli this acyl group is typically 
donated by phosphatidylglycerol, although phosphatidylethanolamine and 
cardiolipin can also be used [32].
Using sequence alignments and site-directed mutagenesis, in E. coli seven 
conserved amino acid residues have been discovered, three of which form a 
potential catalytic triad (E267, K335 and C387), and four which are found within 
the periplasm (W237, E343, Y388 and E389) [30].  Lnt is thought to be one of 
the few examples of a protein that exists in its reaction intermediary  form in vivo 
[33].  The reason for this seems to be that due to the large number of 
lipoproteins found in a typical E. coli cell (~106  of the murein lipoprotein at any 
one time) there needs to be a rapid turn over of fatty acids, which has been 
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estimated at >2 x 104 min-1 [33].
As mentioned above, Lnt homologues have been identified in a number of 
Gram-positive bacteria.  Intriguingly, indirect evidence of N-acylated lipoproteins 
has been discovered in B. subtilis [34], and in S. aureus the lipoprotein SitC has 
been shown to be triacylated, whereas others have been shown to only  be 
diacylated [35, 36].  Both of these low GC species lack any homologues of E. 
coli Lnt, indicating that there may be other types of N-acetyltransferases 
currently unknown.
To date, only two confirmed Gram-positive Lnt proteins exist, found in M. 
smegmatis and M. tuberculosis.  Homologues of this protein are found in 
several members of the Mycobacteriaceae.  The Lnt from M. tuberculosis is 
interesting, as it has fused with a separate protein to become a two domain 
enzyme, known as Ppm1, a polyprenol monophosphomannose synthase.  The 
Ppm1 domain is found at the c-terminus, and in M. smegmatis and M. leprae 
the two enzymes Lnt and Ppm are encoded by separate genes [37].  As well as 
acting as N-acyl transferase, Ppm1 is involved with the biosynthesis of 
lipomannan (LM) and lipoarabinomannan (LAM), cell envelope glycolipids 
involved in the infection process [37].  The confirmation of triacylation of 
lipoproteins in both species was carried out using the confirmed M. tuberculosis 
lipoprotein LppX expressed in M. smegmatis.  Mass spectrometry of a trypsin 
digested LppX from a wild-type strain showed a much larger mass at the N-
terminal cysteine than the predicted mass of the peptide, confirming there was 
an N-terminal modification. A Δlnt strain showed a mass smaller than the wild-
type by a size corresponding to a C16 fatty acid.  LppX run on an SDS-Page gel 
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was 0.3 kDa larger in a wild-type strain than in a Δlnt stain [38].  The Δlnt strain 
of M. smegmatis could be rescued by M. tuberculosis Ppm1, suggesting that 
part of it has the same function.  Neither M. smegmatis lnt nor ppm1 were able 
to rescue a Δlnt strain of E. coli  [38].  The same can be said for the putative lnt 
genes from Streptomyces coelicolor and Corynebacterium glutamicum [30].  All 
of these homologues are missing the essential W237 and Y388 found in E. coli 
although the rest of the active site residues are conserved, and it is speculated 
that these differences are due to an altered substrate for each of the enzymes, 
given their difference in membrane fatty acids [30, 33].
1.3.4 The Lol System 
In Gram-negative bacteria, following the action of Lnt, mature lipoproteins either 
remain anchored to the cytoplasmic membrane or, for the majority, are 
transported through the hydrophilic periplasm to the outer membrane via the 
lipoprotein localisation (Lol) transport system. The Lol system is comprised of 
five genes, ordered in the operon lolABCDE.  The lolCDE genes encode an 
ATP-Binding Cassette (ABC) transporter consisting of two LolD, one LolC  and 
one LolE proteins, whilst the two remaining genes encode the proteins LolA and 
LolB, responsible for transporting a lipoprotein across the periplasm and 
anchoring it into the outer membrane, respectively.  The system is essential in 
E. coli, and is highly conserved in Gram-negative bacteria, although LolB does 
appear to be absent from several species [39].  The Lol system is absent in all 
Gram-positive bacteria checked to date [40], although a potential homologue of 
LolD has been found in S. coelicolor.
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Figure 1.5 The Lol system from E. coli  [13], the inner membrane retention +2 
Aspartate (D) can be seen.
The LolCDE complex differs from other ABC transporters as it is not involved in 
the transmembrane transfer of a substrate and contains fewer membrane 
spanning domains (8) than ABC transporters usually  have (≥10).  It is one of 
only two essential ABC transporters found in E. coli [39].  To transport a 
lipoprotein across the periplasm, it is first accepted by the LolCDE complex, 
with LolD acting as the ATPase, releasing it from the cytoplasmic membrane. 
Since lipoproteins are hydrophobic, a chaperone is needed to move it across 
the periplasm.  The LolA protein acts as the chaperone.  This protein is 20 kDa 
and works as a monomer, consisting of an incomplete β-barrel with an α-helical 
lid, forming an internal hydrophobic cavity, which opens and closes to allow 
entrance and exit of the lipoprotein [41].  The LolA-lipoprotein complex is water 
soluble, presumably as the N-terminal lipid is shielded from the aqueous 
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environment by LolA [39].  The complex crosses the periplasm and passes the 
lipoprotein to LolB, a 23 kDa novel outer membrane lipoprotein.  LolB transfers 
the lipoprotein to the inner leaflet of the outer membrane where it becomes 
firmly  attached [39].  LolB has a similar structure to LolA and it contains the 
same hydrophobic pocket.  It has a higher affinity for lipoproteins than LolA and 
it is believed that an arginine residue at +43 in LolA  is important for the transfer 
of lipoproteins from LolA to LolB [41].  Direct mouth-to-mouth transfer of 
lipoproteins from LolA to LolB has been speculated, given that the opening of 
the hydrophobic pocket of LolA contains many negatively charged residues, 
whilst the opening of LolB has many positively charged residues, suggesting a 
direct interaction [42].  Currently  it is not known how LolA accepts the 
lipoproteins from the LolCDE complex.  The roles of LolC and LolE are unclear. 
Despite sharing ~26% identity they are both essential [39],  and  have ~19% 
identity to LolB, so it is possible that the same mouth-to-mouth transfer occurs 
between LolC/LolE-LolA as with LolA-LolB [42].  What is clear however, is that 
the transport across the periplasm is rapid and efficient.  There is an estimated 
106 molecules of the murein lipoprotein in the outer membrane in an E. coli 
bacterium, yet there are only a few hundred LolA and LolB enzymes [42].  Thus 
far no LolA-lipoprotein intermediates have been detected in periplasmic 
fractions of E. coli [41].  Triacylation by Lnt is a prerequisite for a lipoprotein 
being accepted by the Lol system, but the inner membrane retention signal has 
been shown to have no effect on the activity of Lnt [43].
E. coli has over 90 predicted lipoproteins with the vast majority expected to be 
found on the periplasmic face of the outer membrane [13].  It is vitally important 
that these outer membrane proteins are correctly  localised as an accumulation 
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in the inner membrane leads to instability and, ultimately, cell death [44, 45].  In 
E. coli the location that lipoproteins ultimately end up in is determined by the 
amino acid residue found at position +2.  Generally, a lipoprotein with an 
aspartate (Asp) residue at +2 will be retained in the cytoplasmic membrane, 
whilst the presence of another amino acid will lead to the lipoprotein becoming 
a substrate for the Lol machinery and transported to the outer membrane [13, 
45]. However this +2 rule is not absolute, and it appears that the amino acid at 
position +3 has a bearing on the destination of the lipoprotein.  An acidic or 
amide amino acid seems to enhance the effectiveness of Asp+2 whilst a histidine 
or lysine at +3 leads to the lipoprotein being localised to the outer membrane, 
regardless of the presence of Asp+2 [39].  Also, a number of synthetic inner 
membrane retention signals have been identified at +2, including phenylalanine, 
tryptophan, tyrosine, glycine and proline, although these do not occur naturally 
in E. coli lipoproteins [39].  The current hypothesis as to how the +2 rule works 
is that the Lol complex does not directly recognise the presence or absence of 
Asp at +2, but that the negative charge of the R group  (carboxylic acid) is the 
correct distance away from its backbone carbon (Cα) to lead to a 
conformational change of the lipoprotein and Lol avoidance [13].  Also, Lol 
avoidance appears to involve an interaction between the Asp+2 and 
phosphatidylethanolamine found in the cytoplasmic membrane [46].
Other species of Gram-negative bacteria have been shown to possess a 
different set of retention signals, Psuedomonas aeruginosa uses the amino 
acids at +3 and +4, as well as the +2 Asp  to determine whether a lipoprotein is 
retained or not [44].  Borrelia burgdorferi, the causative agent of Lyme disease, 
has no Lol avoidance system with all lipoproteins being targeted to the outer 
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membrane by default [47].  Interestingly, despite the lack of an outer membrane 
and the fact that all lipoproteins remain in the ʻ innerʼ membrane, there has yet to 
be a Gram-positive lipoprotein found with an Asp at residue +2 [45].
1.3.5! The essentiality of the lipoprotein pathway
The lipoprotein pathway is essential for viability  in all the Gram-negative 
bacteria tested to date [48].  Mutants lacking the lipoprotein biosynthetic 
enzymes are likely  to aggregate improperly processed lipoproteins in the 
cytoplasmic membrane or periplasm which ultimately leads to cell death [14].  A 
number of essential lipoproteins have been identified in E. coli such as LolB and 
Murein, as mentioned previously.  The same is true of the Lol system [44]. 
Conversely it appears that Gram-positive bacteria are able to survive without 
this pathway, and in contrast to the rigid Gram-negative pathway, there is some 
flexibility as to the order of lipoprotein processing.  As described above, the first 
enzyme in the pathway, Lgt, is a prerequisite for the action of the second 
enzyme Lsp  in Gram-negative bacteria.  A number of viable Δlgt Gram-positive 
mutants have been described, including B. subtilis [49], L. monocytogenes [24] 
and S. agalactiae [50], with the latter two examples having detectable, 
unlipidated, immature lipoproteins in their supernatant, showing that the action 
of Lsp is independent of Lgt.  Examples of Δlsp Gram-positive bacteria can also 
be found, such as in B. subtilis [20], L. monocytogenes [51] and M. tuberculosis 
[18].  Confusingly, despite the non-essentiality of this pathway in Gram-
positives, a number of essential lipoproteins do exist.  In Lactococcus lactis two 
lipoproteins, PrtM and OppA, are essential for growth in milk but a Δlsp mutant 
is still viable and able to grow [52].  The proteins are lipidated, and remain 
active in their pro form, in the absence of Lsp.  The same can be said of the B. 
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subtilis lipoprotein PrsA, involved in extracytoplasmic folding of secreted 
proteins [49].  In an Δlgt mutant the protein is unlipidated and remains attached 
to the cell membrane by its signal peptide unprocessed by Lsp, whereas in a 
Δlsp mutant the protein is found in both in its immature form, with an intact 
signal peptide and in its ʻmatureʼ form, suggesting that some alternative 
processing may be occurring in the absence of Lsp  [49].  Examples of 
alternative processing of lipoproteins have been discovered in other Gram-
positive bacteria, such as the Eep protein from Streptococcus uberis [53].  The 
reason for these alternative processing pathways is unclear, potentially they 
prevent the buildup of unprocessed lipoproteins in the cell membrane.
The final enzyme in the Gram-negative pathway Lnt is, as discussed, absent 
from the majority of Gram-positive bacteria.  The reasons for its presence in the 
actinomycetes is unclear, especially given that it is not essential in M. 
smegmatis [38].  Recently  however, it has been postulated that the outer most 
cell wall lipid in various mycobacteria forms a symmetrical bilayer that could be 
thought of as an outer membrane [54].  This, coupled with the fact that Cryo-
Electron Microscopy has revealed a periplasm between the cell membrane and 
the cell wall in S. aureus [55] and in B. subtilis [56], leads to the tempting 
thought that the Lnt proteins found in Gram-positives thus far may be involved 
in the transport of lipoproteins to the outer cell wall.  If this were true however, 
then the transport system is unknown, given the absence of the Lol system.
1.3.6! Functions of lipoproteins
Bacteria use lipoproteins to interact with their extracellular environment and 
they perform a variety of functions.  The first identified lipoprotein, the murein 
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lipoprotein, was found to be anchored to the outer membrane of E. coli and is 
vital for its integrity.  The C-terminal end is bound to the periplasmic 
peptidoglycan layer and stabilises the outer membrane [10].  A substantial 
number of Gram-positive lipoproteins are solute-binding proteins, a well studied 
example of which is the high affinity maltodextrin binding protein MalX of 
Streptococcus pneumoniae [12].  Solute-binding proteins in Gram-negative 
bacteria are located in the periplasm, and their function is to bind reversibly with 
their specific substrate, and pass it to their partner ABC transporters for uptake 
into the cytoplasm [57].  There have been many other identified lipoprotein 
functions including antibiotic resistance, sporulation and bacterial conjugation 
[58], but the most well studied is the pathogen-host interaction.  Given that 
lipoproteins are non-essential in Gram-positive bacteria, the lgt or lsp genes 
have been disrupted in a number of pathogens with differing results.  The loss 
of Lgt during in vitro experiments in L. monocytogenes, S. aureus and S. 
agalactiae lead to impaired growth in cell cultures, whilst in vivo tests in mice 
showed the two latter species to be hypervirulent [24, 50, 59].  In mice, a S. 
equi Δlgt mutant was attenuated, whilst in its natural host, ponies, the bacteria 
showed no change in virulence [60].  The loss of Lsp leads to both in vitro and 
in vivo attenuation of L. monocytogenes [51].  An M. tuberculosis Δlsp mutant, 
shows no growth impairment in vitro but is attenuated in vivo [61].  Other Δlsp 
mutants also show different phenotypes.
Aside from the species to species variation, the most striking thing about the 
results above is the hypervirulence of some of the Δlgt mutants.  At first glance 
this seems counterintuitive.  If, as described above, the loss of Lgt can lead to 
the loss of lipoproteins into a culture supernatant, one might assume that their 
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loss would lead to the reduced fitness of a bacterium and therefore a reduction 
in its ability  to cause infection.  However what seems to be happening is that the 
hypervirulent bacteria are evading the hostʼs innate immune response.  Bacteria 
can be recognised in their hosts by their lipoproteins.  In vertebrates, 
lipoproteins are recognised by  Toll-like receptor 2 (TLR2), which can recognise 
whether a lipoprotein is di- or triacylated and form heterodimers with TLR6 or 
TLR1 respectively, as can be seen in figure 1.6 [62]. For a TLR2-TLR1 
heterodimer to be formed, an N-acyl fatty acid of at least eight carbons in length 
is needed to interact with a hydrophobic channel found in TLR1.  This channel 
is not present in TLR6 and so it can only form the TLR2-TLR6 heterodimer in 
the presence of a diacylated lipoprotein.  The immune response induced by 
both heterodimers appear to be the same and it is unknown if there are subtle 
differences in the response to each [62].  Hypervirulence in bacteria is 
presumably due to this pathway not being activated due to the lack of lipid 
molecules anchoring the protein into the membrane. 
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Figure 1.6. A diacylated or triacylated lipoproteins is recognised by  either the TLR2-
TLR6 or TLR2-TLR1 heterodimers respectively.  TLR6 lacks the hydrophobic channel 
necessary to accept the N-acylated lipoprotein.  Modified from [62].
1.3.7!Computational analysis of Lipoproteins
The rapid increase in the number of fully sequenced bacterial genomes has led 
to a huge amount of data available for mining.  Currently more than 2000 
lipoproteins have been identified in silico in a variety of species [63]. 
Lipoproteins are thought to represent between 0.5 and 8% of a bacterial 
genome [64], although the average is around 2.5%.  Computer analysis often 
leads to the identification of false positives as the signal sequence can be highly 
variable. Pattern searches have been used to identify  potential lipoproteins and 
most are based around the signal sequence, which contains the characteristic 
lipobox motif, L-3-[A/S/T]-2-[G/A]-1-C+1 [11].
Studies on the Gram-positive signal sequence have led to the following 
observations.  For a protein to be identified as a lipoprotein it must contain: i) no 
charged amino acids in the h-box ii) a cysteine residue at +1 but only between 
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position 15 and 50 in the leader peptide iii) only one Arg or Lys in the first seven 
amino acids [58].  Gram-negatives should have i) one or more charged amino 
acids in the first five to seven residues ii) the h-region should be 7 to 22 
residues in length iii) the lipobox motif (shown above) should occur in the first 
50 amino acids from the N-terminus [63].
1.4 Streptomyces coelicolor
Streptomyces coelicolor is the model organism for the high GC branch of Gram-
positive bacteria known as the actinomycetes.  It is a soil dwelling bacterium 
and has developed a complex life-cycle to enable it to survive in this nutrient 
scarce ecological niche.
One of the most striking things about S. coelicolor is its complex multistage life-
cycle, which is highly unusual amongst prokaryotes.  This bacterium begins life 
as a uninucleate spore that contains a hydrophobic coating and is resistant to 
desiccation.  These spores germinate and establish a complex network of 
hyphae known as the substrate mycelium.  These are often multinucleate with 
infrequent septa [65] with growth occurring at the hyphal tips.  This method of 
growth initially lead to Streptomyces being mis-categorised as a fungus [66].
Specific environmental signals, including nutrient deprivation, activate the next 
stage of the developmental cycle.  The substrate mycelial growth halts and the 
erection of aerial hyphae is initiated.  The growth of these reproductive 
structures is fuelled by  controlled lysis of the substrate mycelium [67], which 
provides nutrients to the aerial mycelium.  The substrate hyphae are emptied of 
their cellular contents, but retain their cell wall integrity, presumably to prevent 
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collapse of the colony [68].  Emergence of the aerial hyphae is dependent on 
the production, and action, of the secreted lantibiotic (lanthionine-containing 
peptide antibiotics) SapB [69].  This protein reduces the surface tension at the 
water-air interface allowing the aerial hyphae to escape the aqueous 
environment of the colony.  Other proteins known as chaplins act as 
hydrophobic sheaths, enhancing the growth of the hyphal tip [70].
When fully developed, the aerial mycelia undergo cell division by 
compartmentalising their chromosomes and laying down septa.  These septated 
hyphae eventually form spore chains with each compartment a separate spore. 
The spore chains grow in a characteristic spiral shape, and their hydrophobic 
coating aids propagation as they can be carried long distances by water [67].
S. coelicolor is also unusual as it contains one of the largest genomes of any 
currently sequenced bacterium, with 8,667,507 base pairs encoding 7,825 
genes [66], twice as many as the related actinomycete M. tuberculosis.  The 
genome is linear, which is also very unusual amongst bacteria, and consists of 
a central core region flanked by two ʻarmsʼ.  The core region is approximately 
half the genome in size (4.9 Mbp) and contains all the essential genes whilst 
the arms contain genes that are non-essential, only expressed under specific 
conditions and which were probably acquired through horizontal gene transfer 
(HGT).  The left arm and right arm are of different lengths, being 1.5 Mbp and 
2.3 Mbp  respectively.  Indeed, the core region has more in common with other 
actinomycetes such as M. tuberculosis or Corynebacterium diptheriae than the 
arms [66].
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This large genome is certainly  useful given the variability  of the soil environment 
and S. coelicolor secretes a large number of proteins in order to break down a 
variety of potential nutrient sources.  A predicted 10.5% of the encoded proteins 
are hydrolases (proteases, cellulases etc.) with an equally significant proportion 
of the proteome (7.8%) taken up  by various transport systems, probably for 
uptake of the breakdown products [71].
It is generally accepted that the amount of regulatory genes in an organism 
increases proportionally  to the increase in genome size and S. coelicolor 
contains a high proportion of regulatory proteins (12.3%) [66].  S. coelicolor 
encodes multiple two-component regulatory systems and contains 84 sensor 
kinases (SK) and 80 response regulators (RR), (67 paired SK/RRs and 17 
unpaired RRs) comprising 0.86% of its total Open Reading Frames (ORFs). 
This value is 25% higher than the average non-pathogenic bacteria [72].  The 
high number of two-component systems is again almost certainly  due to the 
variety of stresses the bacterium faces in the soil.
Another important set of genes in S. coelicolor are those which encode 
secondary metabolites.  There are predicted to be 220 genes, in 22 clusters 
involved in the biosynthesis of secondary metabolites [71].  Commercially these 
metabolites are very important as approximately  70% of commercial antibiotics 
are derived from Streptomyces species as well as other pharmaceutically 
important compounds such as anti-tumour drugs [73].  These metabolites are 
most likely produced as a defence response to competitors, but may also serve 
other functions such as combating physical, chemical or biological stresses [66].
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1.5 Streptomyces scabies 
Like S. coelicolor, S. scabies is a soil dwelling saprophyte, and shares many 
elements of the multistage lifecycle seen in S. coelicolor.  However, S. scabies 
is unusual in that it is a pathogenic Streptomyces species.  S. scabies is 
predominantly a pathogen of potatoes (Solanum tuberosum), and has been 
identified worldwide [74].  The bacterium causes characteristic lesions on the 
surface of potato tubers, which reduces their market value.  This disease is of 
great economic importance worldwide.  As well as attacking potatoes and other 
tap root crops, S. scabies is also able to infect other monocotyledonous or 
dicotyledonous plants [67] and appears neither host, nor tissue, specific.
The ability to cause disease is due to the presence of a discrete cluster of 
genes, known as a pathogenicity island (PAI).  The genes found in these islands 
can be moved between bacteria either individually or as a group, and as such 
the G+C  content of the PAI can differ from the genome it is found in [75].  S. 
scabies contains a PAI which at 325 kb is currently  the largest known bacterial 
PAI, with a G+C  content substantially lower than the remaining genome [76]. 
The genes on this island encode the two main virulence factors for S. scabies, 
thaxtomin A and Nec1.  Thaxtomin A is a nitrated dipeptide phytotoxin, capable 
of necrosing excised potato tissue and causing scabs on immature potatoes 
[67], whilst Nec1 is a novel virulence factor, and is a necrotic protein of unknown 
target [75].  Both factors are required for full plant virulence.
The mechanisms that S. scabies uses to invade plants is unknown, and being 
soil based offers  some unique challenges that other plant pathogens do not 
face.  Root structures lack the natural openings seen in other plant organs, 
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such as stomata found in leaves [77], and it appears that S. scabies employs 
specialised mechanisms to penetrate the potato tuber.  Specialised hyphae 
have been visualised growing directly into a tuber, although it is not known 
whether enzymatic degradation of the plant cell wall occurs to allow the 
bacterial hyphae to enter the potato [77, 78].
1.6 Aims of this thesis
This work will investigate the lipoprotein biosynthetic pathways in both S. 
coelicolor and S. scabies.  These pathways are unusual amongst bacteria, both 
contain one copy of lsp, whilst S. coelicolor contains two copies of lgt, and both 
contain two copies of lnt. There is also good evidence that Streptomyces 
species send large numbers of lipoproteins out via the Tat pathway which is 
highly unusual amongst bacteria.
Of the two lgt genes found in S. coelicolor, lgt1 (SCO2034) is found in the 
central region of the chromosome, whilst lgt2 (SCO7822) is found on one of the 
arms and has possibly been acquired by HGT.  It is possible, therefore, that the 
gene may have an alternative function or be functionally  redundant.  It will be 
interesting to see which Lgt is able to add the diacylglyceride to an immature 
lipoprotein and, if both are able, whether there are specific proteins lipidated by 
each one.  To test the functions of these enzymes it should be possible to 
examine whether Δlgt1 lgt2 mutants release unlipidated proteins into their 
growth media, as is the case with L. monocytogenes [24].
Why both S. coelicolor and S. scabies would have two homologues of lnt is a 
mystery.  As has been previously  stated, the Lnt protein was only thought to be 
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active in Gram-negative bacteria, until the recent discovery of an active Lnt in 
M. smegmatis [38].  As with the M. smegmatis Lnt, both of the Streptomyces 
proteins share five of the seven residues needed for activity in E. coli.  It is 
currently unknown whether these proteins can act as true Lnts as the M. 
smegmatis Lnt does.
As discussed, S. coelicolor, S. scabies and other members of the 
actinomycetes are unusual in their lipoprotein biosynthesis and they  may 
represent a new paradigm in this field of research.  The S. coelicolor pathway 
will be analysed by a combination of experimental and in silico analysis.  The lgt 
and lsp genes will be deleted from the chromosome of S. coelicolor and the 
mutant strains will be subjected to phenotypic analysis.  Bioinformatic 
identification of lipoproteins and their roles in S. coelicolor will give clues about 
processes affected in strains which cannot synthesise lipoproteins.  The 
macroscopic and microscopic phenotypes of the mutants will also be analysed 
to determine whether this pathway has any effect on development or antibiotic 
production.  The same will be done for S. scabies, with the addition that the 
action of the lipoprotein pathway on the infection of plants will be assessed by 
the disruption of each of the lipoprotein processing genes.  The action of these 
mutants on both living plants, and potato tubers will be tested.  Whilst there 
have been multiple studies on disrupting lipoprotein biosynthesis in animal 
pathogens and the effect therein on virulence, to date there has been no such 
study on plant pathogens.  
It seems likely that lipoproteins and the lipoprotein biosynthetic pathway will be 
of particular importance to Streptomyces species given their saprophytic 
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lifestyle.  Nutrient scavenging in the soil requires a variety  of exported and 
externally facing proteins, including plant cell wall degrading enzymes and 
substrate transport systems.  It is likely that a number of these are lipoproteins, 
especially  given the ability of this subset of proteins to remain anchored in the 
cell membrane in large numbers without mechanical disruption to the cell.
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Chapter 2. Materials and Methods.
2.1 Strains and culture conditions.
The bacterial strains, and plasmids used or constructed in this study are listed 
in table 2.2.  Growth media used are listed in table 2.3.  Liquid cultures of E. coli 
were routinely grown shaking at 250 rpm, in LB broth at 37°C unless stated. 
Liquid cultures of S. coelicolor or S. scabies were grown at 30°C, shaking at 
250 rpm.  Typically  10 ml of liquid culture was grown.  Cultures grown on solid 
media were grown at the same temperatures listed above, unless stated. 
Where necessary, cultures were supplemented with antibiotics at 
concentrations listed in table 2.1.
Antibiotic
Stock Concentration 
(mg/ml)
Working Concentration 
(μg/ml) for media
Working Concentration 
(mg/ml) for overlays
Ampicillin 100 100
Apramycin 50 50 1.25
Chloramphenicol 25 25
Hygromycin 25 12.5 0.625
Kanamycin 50 50
Nalidixic acid 25 25 0.5
Vancomycin 25 25
Table 2.1 Concentrations of antibiotics used during this thesis.
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Media Composition
Weight, %v/v, 
%w/v or mM 
per 1 litre
Lennox Broth (LB) Tryptone 10 g
Yeast Extract 5 g
NaCl 5 g
dH2O 1000 ml
LB Agar Tryptone 10 g
Yeast Extract 5 g
NaCl 5 g
Agar 15 g
dH2O 1000 ml
Soy Flour Media (SFM) Mannitol 20 g
Soy Flour 20 g
Agar 20 g
Tap Water 1000 ml
Tryptone Soya Broth 
(TSB)
TSB powder (Oxoid) 30 g 
dH2O 1000 ml
Yeast extract Malt extract 
medium (YEME)
Yeast Extract 3 g
Peptone 5 g
Malt Extract 3 g
Glucose 10 g
dH2O 1000 ml
Difco Nutrient Broth (DNB) 
Agar
DNB powder (BD) 4 g
Agar 20 g
Minimal Media (pH 7.0) L-asparagine 0.5 g
di-potassium hydrogen orthophosphate 0.5 g
Magnesium Sulpate heptahydrate 0.2 g
Iron (II) sulphate heptahydrate 0.01 g
Agar 10 g
dH2O 1000 ml
Before dispensing, 4 ml 50% glucose added per 200ml
Instant Mash Agar (IMA) SMASH potato powder 20 g
Agar 20 g
Tap Water 1000 ml
Murashige & Skoog (MS) 
Medium
MS powder (Melford) 2.2 g 
Sucrose 2%
MES Sodium Salt pH 5.9 (Sigma Aldrich) 0.5 g
dH2O 1000 ml
Table 2.3 Growth media used during this thesis.
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2.1.1 Preparation of Streptomyces  spores.
Spores from S. coelicolor or S. scabies were plated onto Soya Flour Media 
(SFM), or Instant Mash Agar (IMA) respectively, with the spores streaked out to 
grow a confluent lawn on the plate.  Plates were incubated at 30°C for 5 nights. 
Spores were harvested by  placing 1 ml of sterile 20% glycerol (2G) on the plate, 
and sloughing off the spores with a sterile cotton bud.  A further 1 ml of 2G was 
then added and the spore suspension was removed by pipetting and stored in a 
2 ml centrifuge tube at -20° C.
2.1.2 Glycerol stocks.
Glycerol stocks of E. coli strains were made by centrifuging 1ml of culture in a 
desktop centrifuge for 30 seconds.  Once centrifuged the supernatant was 
poured off, 0.5ml of fresh LB broth and 0.5 ml 40% glycerol were added.  The 
pellet was resuspended and frozen.
2.2 Genetic Manipulations. 
2.2.1 Plasmid preparation.
Qiaprep Spin Miniprep  kits (Qiagen) were used to prepare plasmid DNA from 10 
ml overnight cultures, as per the manufacturers instructions.  Plasmids were 
eluted in autoclaved distilled water and stored at -20°C.  A number of plasmids 
were synthesised by Genscript USA Inc. (section 2.4.1).
2.2.2 Cosmid preparation.
In order to recover cosmid DNA from E. coli, 1.5 ml of overnight culture 
containing the cosmid was transferred to a 1.6 ml microfuge tube and cells were 
recovered by centrifugation at 13,000 rpm for 1 minute.  The cell pellet was 
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immediately resuspended in 100 μl of Solution 1 (table 2.5).  Once 
resuspended, 200 μl Solution 2 (table 2.5) was added and the tube was mixed 
10 times by inversion.  After mixing, 150 μl ice cold Solution 3 (table 2.5) was 
added and mixing was achieved by inverting the tubes five times.  The solution 
was centrifuged for five minutes at 13,000 rpm and the supernatant was 
transferred to a fresh tube.  Immediately after centrifugation 400 μl 1:1 phenol/
chloroform was added to the supernatant and the solution was mixed for 2 
minutes on a vortex mixer. The tube was then centrifuged as above.  The upper 
phase was transferred to a fresh tube and 600 μl ice-cold 2-propanol was 
added.  The tube was left on ice for 10 minutes.  Once cooled the tube was 
centrifuged as above to spin down the precipitated cosmid DNA.  All liquid was 
removed from the tube and the pellet, containing cosmid DNA and total RNA, 
was washed with 200 μl 70% ethanol.  The tube was centrifuged as above, all 
ethanol was removed and the tube was left open on its side for five minutes to 
air dry the pellet and remove any residual ethanol.  The pellet was resuspended 
in 50 μl TE buffer plus 2 μl DNase free RNase (Sigma-Aldrich) and the tube 
was incubated at 37°C for 15 minutes. The cosmid DNA was then stored at 
-20°C.
2.2.3 Polymerase Chain Reaction.
GoTaq polymerase (Promega) was used for colony PCR, with TaqExpand Long 
Template (with buffer 3) (Roche) used for high fidelity PCR and cloning.  A 
typical reaction contained buffer supplied by the manufacturer, 50 μM dNTP mix 
(12.5 μM each dNTP), 5% DMSO, 20 pmoles of each primer (Invitrogen), 2.5 
units polymerase in a 50 μl reaction.  If the template was a plasmid, 1 μl of a 
stock at approximately 50 ng/μl was used.  When genomic DNA was used, a 
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bacterial colony was picked with a sterile wooden toothpick and scraped into a 
PCR tube.  To amplify DNA a BioRad DNA Engine thermocycler was used.  A 
typical PCR program included an initial denaturing step of 94°C/5 minutes 
followed by 25 cycles with a denaturing step  of  94°C/30 seconds, a primer 
annealing step  of 63°C/90 seconds and an extension step  of 72°C/2 minutes, 
and a final single extension of 72°C/5 minutes.  The annealing temperatures 
and extension times were tailored to suit each primer set.
2.2.4 DNA sequencing.
All cloned PCR products were sequenced using the ABI Big Dye 3.1 die-
terminator reaction mix, according to the manufacturers instructions.  When 
sequencing from a plasmid, a 10 μl reaction containing; 1 μl of DNA, 1 μl of 
primer (3.2 pm/μl), 1 μl reaction mix, 1.5 μl reaction buffer, 5.5 μl dH2O was 
used.  The thermo-cycler conditions included an initial denaturing step  of 96°C/1 
minute followed by 25 cycles with a denaturing step of  96°C/10 seconds, a 
primer annealing step  of 50°C/5 seconds and an extension step  of 60°C/4 
minutes, and a final single extension of 60°C/10 seconds.  The sequence 
a n a l y s i s w a s c a r r i e d o u t a t T h e G e n o m e A n a l y s i s C e n t r e 
(www.jicgenomelab.co.uk) using 3730XL sequencers (Life Technologies). 
Sequence trace files were analysed using 4Peaks software (mekentosj.com/
science/4peaks/).
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Solution Composition
Tris/Borate/EDTA buffer (TBE) 90 mM Tris Base
90 mM Boric Acid
2 mM EDTA
TE buffer 10 mM Tris-HCl (pH 7.0)
1 mM EDTA
DNA loading buffer 0.25% (w/v) bromophenol blue
0.25% (w/v) xylene-cyanol blue
40% (w/v) sucrose in water
DNA extraction ʻSolution 1ʼ 50 mM Tris-HCl pH 8.0
10 mM EDTA
DNA extraction ʻSolution 2ʼ 200 mM NaOH
1% (v/v) SDS
DNA extraction ʻSolution 3ʼ 3 M Potassium Acetate pH 5.5
Tris/Glycine/SDS (TGS) Buffer 25 mM Tris
192 mM glycine
0.1% (w/v) SDS
Transfer Buffer 25 mM Tris
192 mM glycine
20% (v/v) ethanol
Tris buffered saline (TBS) buffer 20 mM Tris-HCl (pH 7.6)
137 mM NaCl
TBS Tween buffer TBS + 0.1% (v/v) Tween
Blocking solution TBS + 0.1% (v/v) Tween
5% Skimmed Milk Powder
Enhanced Chemiluminescence (ECL) ʻSolution Aʼ 100 mM Tris-HCl pH 8.5
0.4 mM coumaric acid in DMSO
2.5 mM Luminol
ECL ʻSolution Bʼ 100 mM Tris-HCl pH 8.5
0.02% (v/v) Hydrogen Peroxide
TCB ultracentrifuge buffer 100 mM Tris pH 8.0
50 mM NaCl
Table 2.5 Solutions and reagents used during this thesis.
2.2.5 General restriction digest.
When digesting DNA with a single restriction enzyme typically a 20 μl reaction 
was set up  using; 1 μl of the required enzyme, 2μl of the corresponding buffer 
(Roche), 10μl of DNA and 7 μl sH2O.  A digest was incubated at 37°C for 1 
hour.  When a double digest was required, 1 μl of the second enzyme was 
added at the expense of 1 μl dH2O.
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2.2.6 DNA ligation.
DNA ligation reactions took place in a total volume of 10 μl containing 1x 
ligation buffer and 1 unit of T4 DNA ligase (Roche), tubes were placed in a float 
in a beaker of room temperature water and chilled in a refrigerator to 4°C 
overnight.  Concentrations of both vector and insert DNA were obtained using a 
nanodrop ND2000c (Thermo Scientific), with volumes of vector and insert being 
adjusted so that the molar ratio was approximately 3:1, with total DNA 
concentration being approximately  10 μg/ml.  The following day the ligations 
were PCR purified (Qiagen) as per the manufacturers instructions, and 
electroporated into E. coli strain DH5α.
2.2.7 Preparing and transforming CaCl2 competent cells.
An E. coli overnight culture was diluted 1/50 in 10 ml fresh LB and grown  at 
37°C until the OD600 reached between 0.3-0.6.  The cells were then recovered 
by centrifugation, the media decanted and the cell pellet resuspended in 5ml ice 
cold CaCl2 (glycerol).  The cells were left on ice for a minimum of 30 minutes. 
The cells were then recovered by centrifugation and resuspended in 1 ml ice 
cold CaCl2 (glycerol).  The cells were left on ice for a minimum of 10 minutes 
then aliquoted out into 500 ml aliquots for storage at -80°C.  10 μl of the 
plasmid to be ligated was mixed with 200 μl of CaCl2 and plated onto pre-
warmed plates containing the appropriate antibiotics.
2.2.8 Preparation of electrocompetent cells.
E. coli cells to be electroporated were grown overnight from glycerol stocks with 
the relevant antibiotics in 10 ml of growth medium.  The overnight culture was 
diluted 1/100 into 10 ml of fresh LB and grown shaking for 3-4 hours until they 
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reached an OD600 of approximately 0.4.  The cells were recovered by 
centrifugation at 4000 rpm in a desktop  centrifuge at 4°C.  Once recovered the 
supernatant was poured off and the cell pellet was gently resuspended in 10 ml 
of ice-cold 10% glycerol.  The cells were recovered by centrifugation as above, 
with the pellet resuspended in 5 ml of ice-cold glycerol.  The cells were again 
centrifuged, the supernatant decanted and the cells resuspended in the 
remaining volume of glycerol (~100 μl).  Cells were then divided into 50 μl 
aliquots and stored at -20°C.
2.2.9 Electroporating cells.
Cosmid DNA (2 μg) was used to transform 50 μl of pre-prepared 
electrocompetent cells in an ice cold electroporation cuvette using the BioRad® 
Electroporator set to: 200 Ω, 25 μF and 2.5 kV.  Immediately  following 
electroporation, 1 ml of ice cold LB broth was added to the cuvette.  The entire 
contents of the cuvette was transferred to a 1.5 ml microfuge tube and the cells 
were incubated shaking at 30ºC for 1 hour.  A 0.5 ml sample of these cells were 
plated onto an agar plate containing the relevant antibiotics and incubated 
overnight.
2.2.10 Agarose Gel electrophoresis.
Assessing the sizes of DNA fragments required running them in agarose gels 
containing 1% (w/v) agarose in 1x TBE buffer (table 2.5) and 1 μl ethidium 
bromide.  Samples were mixed with 0.25 volumes of DNA loading buffer (table 
2.5) and the gels were run in 1x TBE buffer at 100v for approximately  1 h.  A 
1Kb  DNA marker ladder (Roche) was co-electrophoresed alongside the 
samples, and the DNA was visualised by exposure to UV light. 
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2.2.11 Extraction of DNA from agarose gels.
DNA fragments of interest were excised from an agarose gel using a scalpel 
and extracted using a Qiaquick Gel Extraction Kit (Qiagen), according to the 
manufacturerʼs instructions.  The DNA was eluted in 50 μl dH2O.
2.2.12 PCR purification.
The Qiaquick PCR purification kit (Qiagen) was used to remove any 
incorporated nucleotides, primers, enzymes etc. from a PCR reaction.  The 
DNA was eluted in 50 μl dH2O.
2.2.13 Precipitating DNA with Ethanol.
To precipitate DNA from a solution, 1/10 volume of 3M Sodium Acetate was 
added to the sample which was then mixed by inversion.  Two volumes of ice 
cold 100% ethanol was then added followed by mixing by inversion.  The 
mixture was centrifuged at 13000 rpm in a bench top centrifuge for 10 minutes. 
Post centrifugation, all ethanol was removed by pipetting and 200 μl of 70% 
ethanol was added to the pellet which was mixed by inversion.  The sample was 
centrifuged at 13000 rpm for 5 minutes, and all ethanol was removed.  The 
microfuge tube was left open for 2 minutes to air dry the DNA pellet which was 
then resuspended in either 30 μl TE buffer (table 2.5) containing 2 μl RNase 
(Sigma-Aldrich), or 30 μl autoclaved distilled water.
2.2.14 Chromosomal DNA preparation from Streptomyces.
An overnight culture of Streptomyces grown in 50% TSB/YEME media at 30 °C 
was centrifuged at 4000 rpm in a desktop centrifuge for 5 minutes.  The 
supernatant was discarded and the cell was resuspended in 500 μl of Solution 
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1 (table 2.5) and transferred to a 1.5 ml microfuge tube.  10 μl of filter sterilised 
lysozyme (30 mg/ml) and 5 μl DNase-free RNase (10 mg/ml) (Roche) were 
added and the mycelial pellet was incubated for 1 hour at 30°C.  After 
incubation, 5 μl of 20% SDS was added and the solution was mixed by 
inversion.  One volume of 1:1 phenol-chloroform (approximately  500 μl) was 
added and the solution was mixed thoroughly by vortexing for 1 minute and 
centrifuged on a bench-top centrifuge at full speed for 5 minutes.  Post-
centrifugation, the solution had separated and the upper-aqueous level 
containing the DNA was carefully removed and transferred to a fresh microfuge 
tube.  The phenol-chloroform steps were repeated until the top aqueous level 
was clear, indicating the all protein had been removed.  The clear aqueous layer 
was transferred to a fresh microfuge tube, and 1 ml of 100% ethanol was 
added.  The tube was mixed by inverting the tube several times followed by 
centrifuging at maximum speed for 5 minutes.  All ethanol was removed and the 
resultant cell pellet was washed in 200 μl 70% ethanol and centrifuged for 2 
minutes at maximum speed.  All ethanol was removed and the pellet was dried 
for one minute at room temperature.  The DNA was resuspended in 50 μl of 
sterile water.  Where necessary the microfuge tube was warmed to 37 °C  for 15 
minutes to dissolve the DNA pellet.
2.3 Constructing gene knockouts.
2.3.1 Generating a knockout PCR product.
The antibiotic resistance cassette of choice, typically apramycin (apr) or 
hygromycin (hyg), containing the origin of transfer oriT was amplified using 
knockout (KO) primers specific for the gene to be disrupted (see table 2.4).  The 
details of the plasmids containing the antibiotic cassettes, as well as instructions 
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regarding the design of the KO cosmids was found at http: / /
streptomyces.org.uk/.  The forward primer contains 39 nucleotides (nt) of the 
upstream coding region ending ATG, the translational start codon of each gene, 
plus a 20 nt P1 sequence corresponding to the 5′ end of the antibiotic 
resistance cassette.  The reverse primer had 39 nt of antisense sequence 
ending TGA, the translational stop  codon of each gene plus a 19 nt sequence 
corresponding to the end of the antibiotic resistance cassette.  The PCR 
amplification included an initial denaturing step  of 94°C/2 minutes followed by 
10 cycles with a denaturing step of 94°C/45 seconds, a primer annealing step  of 
50°C/45 seconds and an extension step of 72°C/90 seconds, followed by 15 
cycles with a denaturing step of 94°C/45 seconds, a primer annealing step of 
55°C/45 seconds and an extension step of 72°C/90 seconds with and a final 
single extension of 72°C/5 minutes. PCR products were checked by agarose 
gel electrophoresis, excised and gel extracted then stored at -20ºC until use.
2.3.2 Introducing cosmids into E. coli.
Cosmids from S. coelicolor or S. scabies were obtained from the Streptomyces 
group at the John Innes Centre (JIC) or Prof Rose Loriaʼs group  at Cornell 
University, respectively.  These cosmids contained the wild-type copy of the 
gene to be targeted for replacement.  To check the S. coelicolor cosmids were 
correct they were digested with SacI (1μl SacI, 2 μl Buffer A, 17 μl cosmid DNA) 
at 37ºC for 1 hour.  The S. scabies cosmids were digested with BamHI (1μl 
BamHI, 2 μl Buffer B, 17 μl cosmid DNA) at 37ºC for 1 hour.  All digests were 
separated on a 1% agarose gel with the results checked either in silico at http://
streptomyces.org.uk/redirect/res_cosmid2.html or, for S. scabies cosmids, via 
information received from Prof Rose Loriaʼs group at Cornell university.
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Cosmid DNA (2 μg) was used to transform 50 μl electrocompetent E. coli 
BW25113/pIJ790 as described in section 2.2.9.  The entire contents of the 
cuvette were transferred to a 1.5ml microfuge tube and the cells were incubated 
shaking at 30ºC for 1 hour.  A 0.5 ml sample of these cells were plated onto LB-
agar containing; ampicillin, kanamycin (to select for the incoming cosmid) and 
chloramphenicol (to select for pIJ790), at concentrations described in table. 
The plates were incubated at 30°C  overnight.  A single colony was picked from 
each plate and inoculated into a 10ml LB broth containing the same antibiotics. 
These cultures were grown shaking overnight at 30°C.
2.3.3 PCR-targeting the S. coelicolor cosmid.
An overnight culture (0.1 ml) of E. coli BW25113/pIJ790 containing the cosmid 
of choice was inoculated into 10 ml LB broth plus antibiotics (as in the previous 
section) and 100 μl 1M L-arabinose, and grown shaking at 30°C for 4 hours. 
The arabinose induces the λ red genes carried on pIJ790 allowing 
transformation with linear DNA [84].
The cells were made electrocompetent and 50μl cells were electroporated with 
2 μl of the antibiotic knockout PCR corresponding to the gene of choice.  The 
cells were incubated shaking at 37°C  for 1 hour and then plated onto LB agar 
containing ampicillin  and kanamycin, to select for the cosmid, and apramycin, 
to select for the gene disruption.  The plates were incubated at 37°C  overnight 
to select for the loss of pIJ790.  Single colonies were selected and grown in 10 
ml LB broth plus antibiotics for 15 hours at 37°C.
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2.3.4 Checking the mutagenised cosmid.
The cosmids were extracted from overnight cultures as in section 2.2.2 and 
were checked for gene disruption using PCR.  Test primers for the disrupted 
genes of choice were used in combination with primers P1 and P2 which anneal 
to the antibiotic resistance cassette (see table 2.4) to ensure the knock-out was 
successful.  The cosmids were also digested with SacI or BamHI to check for 
disruption.
2.3.5 Conjugating the cosmids into Streptomyces.
Both S. coelicolor and S. scabies contain a methyl-sensing restriction system. 
The disrupted cosmid must therefore be passaged through the non-methylating 
E. coli strain ET12567 before introduction into the target Streptomyces species. 
Cosmid DNA (2 μl) was electroporated into 50 μl of electrocompetent ET12567 
cells containing the driver plasmid pUZ8002 (table 2.2). Following 
electroporation the cells were plated onto LB agar containing; ampicillin, 
apramycin and chloramphenicol to select for the incoming cosmid, and to retain 
the dam mutation.  The plates were incubated at 37ºC overnight.  Single 
colonies were selected and grown in 10 ml LB broth plus antibiotics at 37ºC 
overnight.
Overnight culture (300 μl) was diluted into 10 ml fresh LB broth plus antibiotics 
and grown shaking for 4 hours at 37ºC. Cultures were centrifuged for 5 minutes 
at 13,000 rpm to recover the cells.  The pellet was then washed twice with fresh 
LB broth, to remove any antibiotics potentially harmful to S. coelicolor or S. 
scabies.  The cell pellet was then resuspended in 1 ml fresh LB broth.
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Spores (10 μl) of the required strain were added to 500 μl LB broth, and heat 
shocked at 50°C in a water bath for 10 minutes. They were left to cool for 15 
minutes at room temperature.
Washed E. coli cells (500 μl) were mixed with 500 μl of heat shocked spores. 
The mixture was centrifuged briefly, the supernatant was poured off and the 
remaining volume (about 50 μl) was used to resuspend the pellet. The entire 
mixture was then plated out onto SFM agar for S. coelicolor, or IMA agar for S. 
scabies  and incubated at 30°C for 16-20 hours.
The following day the SFM or IMA plates were overlaid with 1 ml of sterile H2O 
containing 0.5 mg naladixic acid (an antibiotic used to selectively kill E. coli) and 
either 1.25 mg apramycin or 0.625 mg hygromycin (to select for recombination 
of the incoming cosmid with the streptomycete chromosome).  A sterile 
spreader was used to gently  distribute the antibiotic solution evenly.  Once 
overlaid the plate was incubated at 30°C for four days or until colonies 
appeared. These colonies were replicated using velvets onto DNA agar plates 
containing nalidixic acid and apramycin (or hygromycin) and DNA plates 
containing nalidixic acid and kanamycin.  These were incubated at 30°C for two 
days.
Any double cross-over exconjugants would be apramycin or hygromycin 
resistant and kanamycin sensitive as the apr or hyg cassette has replaced the 
chromosomal copy of gene in the genome.  These colonies were picked from 
the original conjugation plate and plated onto an SFM or IMA plate containing 
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apramycin or hygromycin and nalidixic acid (as above).  This plate was grown at 
30°C for five days.  This cycle of apramycin/hygromycin selection followed by 
velvet replica plating was done a minimum of three times to ensure loss of all 
kanamycin resistant single crossovers. Spores of these double cross-over 
exconjugants were prepared and stored at -20°C. 
2.3.6 Excising the gene disruption cassette using FLP recombinase.
The antibiotic disruption cassette found in the gene disruption contains FLP 
recognition targets (FRT) sites at the 5′ and 3′ ends.  The enzyme FLP 
recombinase is able to remove the cassette between these FRTs leaving an 
81bp ʻscarʼ. 
E. coli DH5α/BT340 (table 2.2) was grown shaking at 30°C in 10 ml LB broth 
containing chloramphenicol (to retain the BT340 plasmid) overnight.  A fresh 10 
ml LB broth was inoculated using 100 μl of this overnight culture and grown with 
chloramphenicol for 4 hours.  These cells were made electrocompetent and 
electroporated with the apramycin cassette disrupted cosmid.  The 
electroporation was plated out onto LB agar containing apramycin (to select for 
the incoming cosmid) and chloramphenicol (to retain BT340).  The plate was 
incubated at 30°C for 2 days.  A  single colony was selected and restreaked onto 
LB agar containing no antibiotics, which was in turn plated at 42°C  for 15 hours 
to induce expression of FLP recombinase followed by loss of the BT340 
plasmid.  The cosmids were checked using PCR primers against the gene of 
choice.  If the apra cassette had been removed by the FLP recombinase an 
81bp PCR fragment was amplified and could be detected by electrophoresis.
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2.3.7 Introduction of oriT to a FLP cosmid.
The removal of the apramycin cassette by the action of FLP recombinase also 
removes the origin of transfer (oriT) found within it.  In order for the knockout 
FLP cosmid to be introduced into the S. coelicolor chromosome, a new oriT 
must be introduced to the cosmid.  This was done by amplifying the apramycin 
cassette from plasmid pIJ773 (table 2.2) which contains an oriT using the 
apramycin specific primers (known as P1 and P2) with flanking sequence 
against the bla gene in the cosmid backbone (table 2.4).  Once amplified, this 
cassette was transformed into electrocompetent E. coli BW25113/pIJ790 (as 
described above) containing the FLP knockout cosmid of choice.  Following 
electroporation the cells were plated onto LB agar containing ampicillin and 
apramycin to select for the altered cosmid.  The plates were incubated at 37ºC 
overnight.
Once checked by PCR, the FLP cosmids were transformed into 
electrocompetent Et12567/pUZ8002 as before, and stored at -20°C.  This strain 
was conjugated into the required Streptomyces species to create an unmarked 
gene deletion.  Single exconjugants were selected by growing potential 
unmarked deletion mutants on SFM media containing kanamycin to select for 
the incoming FLP cosmid.  Kanamycin resistant colonies were selected and 
streaked for single colonies onto SFM containing no antibiotics.  These plates 
were grown for 4-5 nights then the colonies were replica plated onto DNA agar 
plates containing either apramycin or kanamycin.  Colonies that were sensitive 
to both represented potential double exconjugants and were selected and 
tested by PCR for the FLP scar.
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2.4 Gene Complementations
2.4.1 Complementation with full length and truncated lsp.
The unmarked deletion strain of S. coelicolor lsp, lspFlp  was complemented 
with both full length, and N-terminally truncated versions of the gene.  The 
truncations removed either the first 10, 20, 30 or 40 amino acids of the gene, 
and were designed so that the first codon was in the same position as the 
annotated lsp start codon with an additional 300 bp upstream DNA, containing 
the lsp promoter.  The constructs were synthesised by Genscript USA Inc. and 
cloned into the vector pUC57.  Each allele was excised from the pUC57 by 
digestion with BamHI and EcoRI restriction enzymes and sub-cloned into 
pSET152, to make the plasmids listed in table 2.2.  Each plasmid was 
transformed into ET12567 / pUZ8002 by  electroporation, and transformants 
were selected on LB agar containing apramycin.  The transformed strains were 
conjugated into S. coelicolor M145 ΔlspFLP and plated onto SFM medium. 
Exconjugants were selected using apramycin resistance.
2.4.2 Complementation of lsp::apr with 4A10.
In order to reverse the apramycin disruption of the lsp gene, the wild type gene 
was reintroduced into the strain M145 lsp::apr.  The cosmid 4A10, containing 
the lsp gene, was electroporated into E. coli strain BW25113/pIJ790 and plated 
onto LB-agar containing ampicillin, kanamycin and chloramphenicol.  The plate 
was incubated at 30°C overnight.  A single transformant was picked and grown 
in 10 ml LB broth containing the same antibiotics and grown shaking overnight 
at 30°C. Overnight culture (0.1 ml) was diluted into 10 ml fresh LB broth plus 
antibiotics plus and 100 μl 1M L-arabinose and grown for approximately 4 hours 
at 30°C.  These cells were made electrocompetent, and the ampicillin 
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resistance gene (bla) found on the backbone of the cosmid was replaced by 
electroporating the cells with a hygromycin resistance cassette (containing oriT) 
that was amplified with primers bla replacement For and bla replacement Rev 
(table 2.4). Hygromycin resistant, ampicillin sensitive colonies were selected 
and confirmed by PCR using the bla Test For and bla Test Rev primers (table 
2.4).  The cosmid was extracted and transformed into E. coli ET12567 / 
pUZ8002 by electroporation and conjugated with the strain M145 lspFlp 
Selection for single exconjugants involved picking colonies that were 
hygromycin resistant, kanamycin resistant and apramycin sensitive.  After 
growth on SFM agar in the absence of antibiotics, double exconjugants were 
selected by identifying colonies that were hygromycin sensitive, kanamycin 
sensitive and apramycin sensitive, with genomic DNA tested by PCR, using the 
Lsp  Test For and Lsp  Test Rev primers to ensure the full length gene was 
present.
2.4.3 E. coli complementation.
E.coli lsp was amplified from genomic DNA using primers EcolspA For and 
EcolspA Rev. S. coelicolor lsp and S. coelicolor N40 lsp were amplified using 
pBT100 and pBT105 as templates, respectively.  PCR primers ScoFL LspA For 
and Sco LspA Rev were used for S. coelicolor lspA with ScoN40 LspA For and 
Sco LspA Rev used for S. coelicolor N40 lspA.  Each of the forward primers 
incorporated an NdeI restriction site, and each of the reverse primers 
incorporated a BamHI restriction site.  Once amplified, each PCR product run 
on a 1% agarose gel, extracted and gel purified (sections 2.11, 2.12) was 
cloned into PCR2.1-Topo (Invitrogen).  Following cloning, each plasmid was 
transformed into competent Top10 E. coli cells (Invitrogen) and plated onto LB-
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agar, containing ampicillin, X-Gal and IPTG and incubated at 37°C overnight. 
White colonies were selected from the overnight plates, grown for 15 hours in 
LB-media and ampicillin at 37°C.  Plasmids were extracted from each overnight, 
digested with NdeI and BamHI and ligated into the vector pBAD24-NdeI to 
make vectors pBT106-109 (table 2.2), such that each inserted gene is under 
the control of the arabinose-inducible pBAD promoter.  Each clone was 
confirmed by restriction digest and sequencing and then used to transform E. 
coli strain BW25113 / pIJ790 by  electroporation.  The incoming plasmid was 
selected for by growth on LB-agar containing ampicillin, with kanamycin and 
chloramphenicol, and grown at 30 °C in order to maintain pIJ790.  The 
chromosomal copy of lsp was disrupted by PCR targeting it using an apramycin 
cassette containing lspA flanking DNA amplified using the EcolspA KO For and 
EcolspA KO Rev PCR primers.  Transformants were plated onto LB agar 
containing ampicillin, apramycin, and arabinose, to express the lsp alleles in 
trans.
2.5 Protein Methods
2.5.1 Protein preparation for electrophoresis.
Mycelium from an overnight culture grown shaking at 30°C in 10 ml of 50% 
TSB/YEME media was harvested by centrifuging in a bench-top centrifuge at 
4000 rpm for 5 minutes.  All medium was discarded and the pellets were 
washed in 1 ml of TCB (table 2.5) and transferred to a microfuge tube.  The 
pellet was centrifuged briefly, the TCB removed and was resuspended in a 
volume of fresh TCB ranging from 100μl to 500μl depending on the size of the 
pellet.  The required volume of 50x EDTA free protease inhibitor (Roche) was 
added to the mix.
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The suspensions were sonicated, on ice, at 50 kHz for 5 seconds, followed by 
one minute chilling on ice.  Each sample was sonicated an average of 5 times. 
Following sonication the samples were centrifuged in a bench-top centrifuge at 
15,000 rpm for 1 minute and the supernatant stored at -20°C  as crude protein 
extract.
2.5.2 SDS-PAGE.
15% SDS polyacrylamide gels were cast using a mini Protean 3 system as per 
the manufacturerʼs instructions (BioRad).  In addition to the 15% 
polyacrylamide, the resolving gels contained 0.325M Tris-HCl pH 8.8, 0.1% (w/
v) SDS, 0.01% (v/v) TEMED and 0.1% (v/v) ammonium persulphate (APS). 
The mixture was poured between two glass plates to a distance of 
approximately  2.5 cm from the top of the plates and was layered with 100% 
ethanol.  Once polymerisation had occurred, the ethanol was removed and the 
gel was washed with dH2O.  All water was removed using filter paper, and the 
stacking gel was layered on top.  The stacking gel consists of 4% 
polyacrylamide, 0.125M Tris-HCl pH 6.8, 0.1% (w/v) SDS, 0.01% (v/v) TEMED 
and 0.1% (w/v) APS.  A comb was inserted into the top layer, and once 
polymerisation had occurred, the comb  was removed and the gel was fastened 
into its electrode, and placed into the electrophoresis tank, which was filled with 
TGS buffer (table 2.5).  The concentration of protein in samples was 
ascertained using a BioRad protein concentration assay kit.  Equal 
concentrations of protein were loaded into each well, having first been mixed 
with one volume of Laemmli buffer (BioRad) + 5% 2-mercaptoethanol and 
boiled at 95°C for 2 minutes.  The samples were run at 200 volts for 1.5 hours.  
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2.5.3 Semi-dry immunoblotting.
For immunoblotting, proteins immobilised within the gel were transferred to a 
polyvinylidene difluoride (PDVF) membrane using a Bio-Rad Semi Dry Transfer 
Cell.  Following electroporation, the gel was washed in transfer buffer (table 
2.5), along with 12 pieces of 1 mm filter paper (Whattman) cut slightly larger 
then the gel. Six pieces of filter paper were placed in the Transfer Cell with a 
sheet of PVDF membrane (BioRad), cut to a slightly smaller size and presoaked 
in methanol and then transfer buffer was lain on top.  The gel was then placed 
on top of the membrane, with the final 6 sheets of filter paper rested on top. 
Pressure was placed on this sandwich to remove any air bubbles, and any 
excess transfer buffer was removed.  The Transfer Cell was assembled and run 
at 15 volts for 1 hour.  Following the run, the membrane was blocked overnight, 
shaking, in 50 ml blocking solution (table 2.5).  The following day the blocking 
solution was removed, and 10 ml of fresh blocking solution containing either 8 
μl of CseA primary antibody or 2 μl Anti-His-HRP antibody was added.   The 
membrane was incubated in this solution on a shaker for 1 hour at room 
temperature.  After incubation the membrane was washed twice in 20 ml 1 x 
TBS + 1% Tween.  Each wash was 10 minutes long.  Following these washes, 
the TBS/Tween was removed and 10 ml of fresh blocking solution containing 
2.5 μl of secondary antibody (HRP-linked anti-rabbit IgG) was added to the 
CseA blot.  The Anti-His antibody  is an HRP conjugate and requires no 
secondary antibody.  The membrane was incubated for 1 hour.  Once this 
incubation was complete the membrane was washed twice as above.  2 ml of 
developing solution was mixed immediately  prior to development (table 2.5), 
and then pipetted over the membrane, ensuring the entire surface was covered, 
and then incubated at room temperature for 1 minute.  Once incubated the 
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membrane was placed in an Hypercassette (GE Healthcare), covered with 
clingfilm and overlaid with X-ray film (FujiFilm).  The X-ray  film was exposed for 
1 minute, with fresh exposures taken at increasing/decreasing time points as 
required. Films were developed using a Konica-Minolta SRX-101A development 
machine.
2.5.4 Sub-cellular fractionations.
In order to separate the cell membrane from the cytoplasm, crude cell extracts 
were ultracentrifuged.  Crude extracts were placed in a 1 mm thick walled 
centrifuge tube (Beckman) and were balanced by volume.  The tubes were 
spun for 1 hour at 80,000 rpm at 4°C in a Beckman centrifuge.  Following 
centrifugation the supernatant (cytoplasmic fraction) was removed and stored at 
-20°C.  200 μl of fresh TCB buffer was added and the tubes were respun as 
above.  The supernatant (wash fraction) was removed and discarded, leaving 
the cell membrane pellet.  This was resuspended by gentle pipetting in 50 - 200 
μl of TCB + 1% Sarcosyl depending on the size of the pellet.  This membrane 
fraction was then stored at -20°C.
2.6 Microscopy.
2.6.1 Light Microscopy.
Brightfield images were acquired using a Zeiss M2 Bio Quad SV11 
stereomicroscope. The samples were illuminated with a halogen lamp and 
reflected-light images captured with an AxioCam HRc CCD camera and 
AxioVision software (Carl Zeiss, Welwyn Garden City, UK).
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2.6.2 Scanning Electron Microscopy.
Samples were mounted on an aluminium stub using Tissue TekR (BDH 
Laboratory Supplies, Poole, UK).  The stub  was then immediately  plunged into 
liquid nitrogen slush at approximately -210°C  to cryo-preserve the material.  The 
sample was transferred, onto the cryostage of an ALTO 2500 cryo-transfer 
system (Gatan, Oxford, UK) attached to a Zeiss Supra 55 VP FEG scanning 
electron microscope (Zeiss SMT, Germany).  Sublimation of surface frost was 
performed at -95°C  for three minutes before sputter coating the sample with 
platinum for 3 mins at 10mA, at colder than -110°C.  After sputter-coating, the 
sample was moved onto the cryo-stage in the main chamber of the microscope, 
held at approximately -130°C. The sample was imaged at 3 kV and digital TIFF 
files were stored.
2.7 Phenotype Assays.
2.7.1 Antibiotic sensitivity.
All phenotype assays were conducted in a standard 12 well cell culture plate. 
Each well contained 3 ml minimal media (+1% glucose).  When strains were 
being tested for sensitivity to antibiotics, the required concentration of the 
relevant antibiotic was dissolved into the minimal medium before it was poured 
into the 12 well plate.  The highest concentration was found in well A1, whilst 
the lowest was found in well C3.  A  control well containing no antibiotics was 
found in C4.  100 μl of sterile water containing 1 μl spores was placed onto 
each well and thoroughly spread to cover the entire surface of the growth 
media.  The plates were sealed and incubated at 30°C for 5 days.  Growth was 
assessed as either ʻconfluentʼ, ʻweakʼ where there were sufficient colonies to 
count individually, or ʻnoneʼ where there was an absence of any colonies.
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2.7.2 Lysozyme/SDS sensitivity.
When strains were assessed for sensitivity to lysozyme or SDS, they were they 
were tested in three different ways.  Firstly 100 μl of sterile water containing 1 μl 
spores was placed onto each well of a plate containing 3 ml minimal media. 
The plates were dried in a sterile flow hood, and once fully dried, they were 
overlaid with sterile water containing differing concentrations of lysozyme, or 
percentages of SDS.  The plates were dried as before, sealed and incubated at 
30°C for 5 days.  A variance of this method involved the spores being placed 
onto the plates and dried as above, but grown for 15 hours at 30°C  prior to 
overlay with the lysozyme or SDS.  Once overlayed the plates were reincubated 
for a further 5 days.  The final assay  involved preincubation of the spores in 
sterile water containing differing concentrations of lysozyme or percentages of 
SDS for one hour, prior to plating onto 12 well plates.
2.8 Virulence assays.
2.8.1 Potato disc tuber assay.
A potato tuber of the cultivar Maris Piper, was washed and peeled.  The tuber 
was surface sterilised by immersion in 2% bleach for 5 minutes, with stirring. 
The potato was transferred using sterile forceps into a beaker containing 500 ml 
of sterile water in a laminar flow hood.  The potato was rinsed for 2 minutes, 
and transferred to a second beaker of water where it was washed as before. 
After washing was completed, the potato was lain on some sterile paper towels 
and cores were taken using a sturdy potato peeler (sterilised with ethanol). 
These cores were sliced into discs 0.5 cm thick using a sterile scalpel.  The 
slices were placed onto sterile filter paper, prewetted with 2 ml of sterile water, 
in a petri dish.  Four potato slices were placed in each dish.  Plates of the S. 
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scabies strains were prepared on IM agar.  Spores were plated in order to 
obtain confluent lawns of bacteria.  The plates were incubated for 5 nights, and 
agar plugs (1 cm2) were cut using a sterile scalpel.  A plug was placed on each 
potato piece, spore side down.  Uninoculated IM agar was used as a negative 
control.  The plates were sealed and incubated at 30 °C in the dark for either 2 
nights, or 7 nights.  The agar plugs were then removed and the potato slices 
were viewed under a microscope to investigate signs of necrosis.
2.8.2 Radish seedling root virulence assay.
Radish seeds of the cultivar Scarlet Globe were soaked in 70% ethanol for 10 
minutes, the ethanol removed, then soaked in 13% bleach for a further 10 
minutes.  The bleach was removed, and the seeds were washed copiously in 
sterile H2O.  The seeds were placed onto sterile filter paper in a petri dish, 
prewetted with 2 ml sterile H2O.  The seeds were incubated in the dark at room 
temperature for 24 hours.  Cultures of various S. scabies strains were set up by 
growing 1 x 106 spores in 10 ml of 50% TSB/YEME media, with the relevant 
antibiotics at 30° C for 20 hours.  After this time had elapsed the mycelium was 
collected by  centrifugation and washed twice in TSB.  After the final wash the 
mycelium was resuspended in 1 ml of TSB broth, with 500 μl being spread over 
half a square petri dish containing plant MS medium (table 2.3) (1% agar).  The 
remaining 500 μl of mycelium were placed in a 12 well cell culture plate, into 
which seedlings at the same stage of germination were immersed prior to being 
placed in the petri dish.  These dishes were sealed and stored vertically in a 
incubation chamber at 21° C with a day length of 12 hours.
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Chapter 3 - The lipoprotein biosynthetic pathway of S. coelicolor.
3.1 Introduction
This chapter focuses on the biosynthetic pathway by which S. coelicolor 
processes its lipoproteins, from the cytoplasm to the fully  functional cell surface 
protein.  The lipoprotein biosynthetic pathway in S. coelicolor consists of several 
different steps, starting with translocation of the protein across the cell 
membrane.  This usually occurs via the Sec pathway but S. coelicolor can also 
export fully folded, but unlipidated lipoproteins through the twin arginine 
translocase (Tat) pathway and this appears to be unusual amongst bacteria 
[82].  Following translocation the protein is anchored in the bacterial membrane 
by its signal sequence.  The protein is tethered to the membrane by the addition 
of a diacylglyceryl lipid moiety to the conserved cysteine residue found in all 
lipoprotein signal sequences.  Addition of this lipid is catalysed by the 
membrane bound enzyme Lgt (Lipoprotein diaclyglyceryl transferase).  Once 
lipidated, the Lsp  enzyme (Lipoprotein signal peptidase) cleaves the signal 
peptide from the anchored, lipidated protein to produce the mature lipoprotein. 
As mentioned in Chapter 1 this pathway is strictly ordered in Gram negative 
bacteria [14] and appears, with few exceptions, to be similarly controlled in 
Gram positive bacteria.  There are some unusual aspects to the lipoprotein 
biosynthetic pathway in S. coelicolor which will be examined in detail below. 
Whilst there is only one copy of the lsp gene as in other bacteria, there are two 
putative lgt genes, named in this study as lgt1 (Sco2034) and lgt2 (Sco7822). 
There are also two copies of lnt, lnt1 (Sco1014) and lnt2 (Sco1336).  What role 
these genes have is currently  unknown, however, as discussed in Chapter 1, 
the recent discovery  of a fully functional Lnt protein in M. smegmatis, does 
suggest that one or both may serve their predicted function.
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3.2 Aims.
The aims for this chapter are two-fold.  Firstly, it will focus on the bioinformatic 
analysis of the lipoprotein biosynthetic enzymes from a variety of bacterial 
species and analysis of the functions of the predicted 223 lipoproteins found in 
S. coelicolor.  These functions will be related to any potential developmental 
phenotypes gained from the second aim, which is to obtain and analyse 
mutants in each of the lipoprotein synthesis genes found in S. coelicolor, using 
the REDIRECT system.  These mutants will be examined both macroscopically 
and microscopically, using light and electron microscopy.  Two model 
lipoproteins, CseA (SCO3357) and SCO3484 will be immunoblotted to examine 
their processing in each of the mutants, either natively, or fused to a hexa-
histidine peptide.  Each of the mutants will be subjected to a variety of stresses, 
to gauge the effect the mutations are having on the bacteria.  Any mutants 
which exhibit a drastic phenotype will be complemented to see whether it is 
possible to restore the wild-type phenotype.
3.3 Results.
3.3.1 Identification and comparison of the lipoprotein biosynthetic 
enzymes.
In order to learn more about the lipoprotein biosynthetic enzymes in S. 
coelicolor the sequences were first identified by BLASTP analysis and then 
aligned with the primary sequences of homologous enzymes from other 
bacteria.  In total, eight species were chosen for sequence comparisons. 
Alongside S. coelicolor (Sco), three other streptomycetes were chosen: S. 
scabies (Scab), S. avermitilis (Sav) and S. griseus (Sgr).  Two related 
actinomycetes M. tuberculosis (Mtb) and M. smegmatis (Msm) were also 
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chosen, primarily due to the confirmed Lnt enzyme in M. smegmatis.  B. subtilis 
(Bsu) was used to represent the low GC Gram-positive bacteria.  Finally, the 
model Gram-negative bacterium E. coli (Eco) was chosen, as much of the work 
involved with identifying essential residues in Lgt and Lnt has been carried out 
in E. coli.
3.3.1.1 Lipoprotein diacyglycerol transferase (Lgt).
The two Lgt enzymes from S. coelicolor share 60% identity.  Both are predicted 
to contain seven transmembrane helices (http://www.enzim.hu/hmmtop/, http://
www.cbs.dtu.dk/services/TMHMM-2.0/, http://www.ch.embnet.org/software/
TMPRED_form.html).  Both S. coelicolor enzymes show a high degree of 
identity with the other Streptomyces species (>70%), and both have ≥45% 
similarity  with the MtbLgt enzymes.  Both ScoLgt1 nor ScoLgt2 share a low 
identity with the Lgt enzymes from E. coli and B. subtilis (<30%), however the 
enzymes from these two species are equally dissimilar.
The Histidine residue at position 103 in the E. coli Lgt enzyme has been shown 
to be essential for function [17], but interestingly it is absent from all of the 
actinomycete proteins compared, where it is a tryptophan (fig. 3.1).  Conversely, 
the two other amino acids important for function in E. coli , His-196 and Tyr-235 
[17], are both present in all of the bacteria, with the exception of H196Q in M. 
tuberculosis.
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ScoLgt1 ---MELAFIPSPSRGVLHLGPVPLRGYAFCIIIGVFVAVWLGNKRWVARGG--RPGTVAD 55
ScoLgt2 ---MDLAYLPSPSTGVLHLGPIPLRAYAFCIILGVFAAVWLGNRRWVARGG--KQGVIAD 55
ScabLgt ---MELAYIPSPSHGVYYLGPVPLRGYAFCIIIGVFVAVWLGNKRWVARGG--QAGTIAD 55
SavLgt  ---MELAYIPSPARGVLYLGPIPLRGYAFCIIIGVFVAVWLGNKRWVARGG--RPGTVAD 55
SgrLgt  ---MNLAFIPSPSTGVIELGPIPLRGYAFCIIIGVFVAVWFGNKRWVARGG--KAGTVAD 55
MtbLgt  -MRMLPSYIPSPPRGVWYLGPLPVRAYAVCVITGIIVALLIGDRRLTARGG--ERGMTYD 57
MsmLgt  MTTTVLAYLPSPSQGVWHLGPVPIRAYALCIIVGIVAALVIGDRRWQARGG--EPGVIYD 58
EcoLgt  -MTSSYLHFPEFDPVIFSIGPVALHWYGLMYLVGFIFAMWLATRRANRPGSGWTKNEVEN 59
BsuLgt  ----MNEAIEPLNPIAFQLGPLAVHWYGIIIGLGALLGLWIAMRESEKRGL--QKDTFID 54
                       
ScoLgt1 IAVWAVPFGLIGGRL-YHVITDYQLYFSE-GRDWVDAFKIWEGGLGIWGAIAFGAVGAWI 113
ScoLgt2 VTLWAVPFGLVGGRL-YHVFTSPDAYFGE-RGEPVRALYVWEGGLGIWGAIALGAVGAWI 113
ScabLgt IAVWAVPFGLVGGRL-YHVITDYELYFSE-GRDWVDAFKVWEGGLGIWGAIALGAVGAWI 113
SavLgt  IAVWAVPFGLVGGRL-YHVITDYELYFSE-GRDWVDAFKIWEGGLGIWGAIALGAVGAWI 113
SgrLgt  VAVWAVPFGLVGGRL-YHVITDYQLYFSD-GEDWVDAFKIWEGGLGIWGAIAFGAVGAWI 113
MtbLgt  IALWAVPFGLIGGRL-YHLATDWRTYFGDGGAGLAAALRIWDGGLGIWGAVTLGVMGAWI 116
MsmLgt  IALWAVPFGLAGGRI-YHVITDWKTYFGPTGKGFGAALQIWEGGLGIWGAVAFGAVGAWI 117
EcoLgt  LLYAGFLGVFLGGRIGYVLFYNFPQFMAD----PLYLFRVWDGGMSFHGGLIGVIVVMII 115
BsuLgt  LVLFAIPIAIICARI-YYVAFEWDYYAAH----PGEIIKIWKGGIAIHGGLIGAILTGYV 109
                
ScoLgt1 GARRRGVPMPAYADAVAPGIALAQAIGRWGNWFNQELYGKAT-DLPWAVEIT-------- 164
ScoLgt2 GCRRHRIPLPAFADAVAPGIVLAQAIGRWGNWFNQELYGRPT-TLPWGLEIDR------- 165
ScabLgt GCRRRGIPLPAYADAVAPGIALAQAIGRWGNWFNQELYGKPT-DLPWAVEIT-------- 164
SavLgt  GCRRRGIPLPAWADAVAPGIAFAQAFGRWGNWFNQELYGRET-HVPWALHIT-------- 164
SgrLgt  ACRRRGIPLPAWADALAPGIAIAQAIGRWGNWFNQELYGKPT-DLPWALEIS-------- 164
MtbLgt  GCRRCGIPLPVLLDAVAPGVVLAQAIGRLGNYFNQELYGRET-TMPWGLEIFYRRDPSGF 175
MsmLgt  ACRLRGIPLPAFGDAIAPGIILAQGIGRLGNYFNQELYGRPT-DVPWGLEIYERLN--KF 174
EcoLgt  FARRTKRSFFQVSDFIAPLIPFGLGAGRLGNFINGELWGRVDPNFPFAMLFPGSRTEDIL 175
BsuLgt  FSRVKNLSFWKLADIAAPSILLGQAIGRWGNFMNQEAHGEAV-SRAFLENLHLP------ 162
                      
ScoLgt1 ---------STADGRVPGTYHPTFLYESLWCIGVALLVIWADRRFKLGHGRAFALYVAAY 215
ScoLgt2 -------AHRPAGTLDIATYHPTFLYESLWNIGVAALILWAAKRFPLGHGRTFALYVAAY 218
ScabLgt ---------SSTDGRLPGTYHPTFLYESLWCIGVALLVIWADRRFTLGHGRAFALYVASY 215
SavLgt  ---------SSTDGRVPGYYHPTFLYESLWCVGVGFLVIWADRRFKLGHGRAFALYVAAY 215
SgrLgt  ---------EGPN-RVAGTYHPTFLYESLWCIGVALLVIWADRRFKLGHGRAFALYVAGY 214
MtbLgt  DVPN--SLDGVSTGQVAFVVQPTFLYELIWNVLVFVALIYIDRRFIIGHGRLFGFYVAFY 233
MsmLgt  GQSD--QLNGVSTGQVTAVVHPTFLYELIWNIAVFGFLIWVDRKFRIGHGRLFALYVASY 232
EcoLgt  LLQTNPQWQSIFDTYGVLPRHPSQLYELLLEGVVLFIILNLYIRKPRPMGAVSGLFLIGY 235
BsuLgt  ------EFIINQMYINGQYYHPTFLYESLWSF-VGVIVLLLLRRANLRRGEMFLIYIIWY 215
ScoLgt1 CAGRFWIEYMRVDDAHHILG----LRLNNWTALFVFLLAVLYIVLSARKR---------- 261
ScoLgt2 TVGRFGTEYLRIDEAHTFLG----LRLNNWTSVLVFLGAVACLVVSAHRH---------- 264
ScabLgt CTGRFWIEYMRVDEAHHILG----LRLNNWTALFVFVLAVIYMVLSARKR---------- 261
SavLgt  CVGRAWIEYMRVDDAHHILG----VRLNDWTAIAVFLLAVLYIVLSSRKR---------- 261
SgrLgt  CAGRGWIEYMRVDEAHHILG----LRLNVWTAIVVFILAVVYIVISAKIR---------- 260
MtbLgt  CAGRFCVELLRDDPATLIAG----IRINSFTSTFVFIGAVVYIILAPKGREAPGALRG-- 287
MsmLgt  CVGRFWVELMRSDTATEFAG----IRVNTFTSTFVFIGAVVYIMLAPKGREEPESLRGKA 288
EcoLgt  GAFRIIVEFFRQPDAQFTGAWVQYISMGQILSIPMIVAGVIMMVWAYRRS---------- 285
BsuLgt  SIGRYFIEGMRTDSLMLTDS----LRIAQVISIVLIVLAVAAIIFRRVKG---------- 261
ScoLgt1 --------------------------------------------------------PGR- 264
ScoLgt2 --------------------------------------------------------PGI- 267
ScabLgt --------------------------------------------------------PGR- 264
SavLgt  --------------------------------------------------------PGR- 264
SgrLgt  --------------------------------------------------------PGR- 263
MtbLgt  --------SEYVVDEALEREPAELAAAAVASAASAVG----------------PVGPGEP 323
MsmLgt  ADETEEGDEESLVDEAGKELVAAAAGTGVVAAATAAAREDTDDTDGTTDPAAASDEPGDE 348
EcoLgt  ------------------------------------------------------------
BsuLgt  ------------------------------------------------------------            
ScoLgt1 ---------------------------------------------EAVVEPGAETAAGDS 279
ScoLgt2 ---------------------------------------------ENVAR--------LQ 274
ScabLgt ---------------------------------------------EEVVEPGVSDGDGDE 279
SavLgt  ---------------------------------------------EEIVEPGAS----DT 275
SgrLgt  ---------------------------------------------EEIVEPDRD------ 272
MtbLgt  NQPD----------------------DVAEAVKAEVAEVTDEVAAESVVQVADRDGESTP 361
MsmLgt  AEPETEAATAVLTADGAEAMSVDEQPDDDEAVDEEAGQEAEEPADELVELADEPEGEPEP 408
EcoLgt  ------------------------------------------------------------
BsuLgt  ------------------------------------------------------------  
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ScoLgt1 GSAADKDVKGTKDAE-------DAEGAEDGAEKTDASGATEAPEDTSGADEADAAKDAEG 332
ScoLgt2 GAGADGRTD---------------DPRPADASVGLASGPPGNSTPRRATESWNVRNRS-- 317
ScabLgt GAGAAAPVE-------------DSETKSESKAKPGES-EAKAEGDAGASGGGGEKKEPE- 324
SavLgt  GTGADDPVDLGKD---------EDKATTDKATATDTSTTTDKSTDRGKNEDENEGEDAEP 326
SgrLgt  ATPAEKDGSG------------EDGSGEKGVAKADAAAKDPLTKDEPGKDATAENAGAAG 320
MtbLgt  AVEETSEADIERE---------QPGDLAGQAPAAHQVDAEAASAAPEEPAALASEAHDET 412
MsmLgt  AAAEEAEPAETIEPDEDEIFDAELAEALAEAAEDFAVVPESAGSDEAEVAAAESAADAED 468
EcoLgt  ---PQQHVS--------------------------------------------------- 291
BsuLgt  -YSKERYAE--------------------------------------------------- 269        
ScoLgt1 ---VTNGADSAKKG---------------------------------------------- 343
ScoLgt2 ------------------------------------------------------------
ScabLgt ---------SAKKS---------------------------------------------- 329
SavLgt  SEKTESAAESAKKV---------------------------------------------- 340
SgrLgt  ---------AAEKA---------------------------------------------- 325
MtbLgt  EP------EVPEKAAP----IPDPAK---------------------------------- 428
MsmLgt  GPSDAESAEVPAEAAADDAVVSEPAGTVDETEVAEEAAAEAADLEFESYDAELAEALAEA 528
EcoLgt  ------------------------------------------------------------
BsuLgt  ------------------------------------------------------------            
ScoLgt1 ------------------------------------------------------------
ScoLgt2 ------------------------------------------------------------
ScabLgt ------------------------------------------------------------
SavLgt  ------------------------------------------------------------
SgrLgt  ------------------------------------------------------------
MtbLgt  ---------PDELAVAGPGDDPAEPDGIRRQDD--------------------------- 452
MsmLgt  AEDMAVVVAPAETAESDEAREPVETDATESEEPSEPEEPDAPEAVEAPEALDENADETRA 588
EcoLgt  ------------------------------------------------------------
BsuLgt  ------------------------------------------------------------            
ScoLgt1 ----------------------------
ScoLgt2 ----------------------------
ScabLgt ----------------------------
SavLgt  ----------------------------
SgrLgt  ----------------------------
MtbLgt  ------------FSSRRRRWWRLRRRRQ 468
MsmLgt  EPAAPAAVATAPVEPEKGRLRRWLRRNR 616
EcoLgt  ----------------------------
BsuLgt  ----------------------------
Figure 3.1  Amino acid sequence alignment of the Lgt enzymes. Potential 
transmembrane domains are underlined.  The essential E. coli H103 is highlighted in 
red whilst the H196 and Y235, important for function in E. coli are highlighted in blue. 
Sequences compared using ClustalW (http://www.ebi.ac.uk/Tools/clustalw2/
index.html).
What is immediately obvious when comparing the actinomycetes to E. coli and 
B. subtilis is that Lgt proteins from the actinomycetes contain elongated, 
cytoplasmic, C-termini which are not present in E. coli and B. subtilis. 
Interestingly, these elongated sequences contain very  little similarity to each 
other, with the Mycobacterium proteins being substantially  longer than those 
from Streptomyces.  When compared from amino acid 292 onwards (EcoLgt 
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terminates at amino acid 291), the two S. coelicolor enzymes only  share 15% 
similarity, whilst the 30% similarity  shared between ScoLgt2 and MtbLgt is the 
highest similarity found between any two actinomycete Lgt proteins.  The amino 
acid comparison can be seen in figure 3.2.
ScoLgt1 ------------------------------------------------------------
ScoLgt2 ------------------------------------------------------------
ScabLgt ------------------------------------------------------------
SavLgt  ------------------------------------------------------------
SgrLgt  ------------------------------------------------------------
MtbLgt  ---------VDEALEREPAELAAAAVASAASAVGPVGPGEPN------------------ 33
MsmLgt  TEEGDEESLVDEAGKELVAAAAGTGVVAAATAAAREDTDDTDGTTDPAAASDEPGDEAEP 60  
                                                                         
ScoLgt1 ------------------------------------------------------------
ScoLgt2 ------------------------------------------------------------
ScabLgt ------------------------------------------------------------
SavLgt  ------------------------------------------------------------
SgrLgt  ------------------------------------------------------------
MtbLgt  --------------------QPDDVAEAVKAEVAEVTDEVAAESVVQVADRDGESTPAVE 73
MsmLgt  ETEAATAVLTADGAEAMSVDEQPDDDEAVDEEAGQEAEEPADELVELADEPEGEPEPAAA 120
                                                                            
ScoLgt1 --------------------------------------------------DAEDAEGAED 10
ScoLgt2 ------------------------------------------------------------
ScabLgt ------------------------------------------------------------
SavLgt  --------------------------------------------------ATTDKATATD 10
SgrLgt  ------------------------------------------------------------
MtbLgt  ETSE---------ADIEREQPGDLAGQAPAAHQVDAEAASAAPEEPAALASEAHDETEPE 124
MsmLgt  EEAEPAETIEPDEDEIFDAELAEALAEAAEDFAVVPESAGSDEAEVAAAESAADAEDGPS 180
                                                                            
ScoLgt1 GAEKTDASGATEAPEDTSGADEADAAKDAEGVTNGADS---------AKKG--------- 52
ScoLgt2 --------------VGLASGPPGN--STP---RRATES-------WNVRNRS-------- 26
ScabLgt --TKSESKAKPGESEAKAEGDAGA--SGGGGEKKEPES---------AKKS--------- 38
SavLgt  TSTTTDKSTDRGKNEDENEGEDAE---PSEKTESAAES---------AKKV--------- 49
SgrLgt  ------AKADAAAKDPLTKDEPGK---DATAENAGAAG--------AAEKA--------- 34
MtbLgt  VPEKAAPIPDPAKPDELAVAGPGDDPAEPDGIRRQDDFSSRRRRWWRLRRRRQ------- 177
MsmLgt  DAESAEVPAEAAADDAVVSEPAGTVDETEVAEEAAAEAADLEFESYDAELAEALAEAAED 240
   
ScoLgt1 ------------------------------------------------------------
ScoLgt2 ------------------------------------------------------------
ScabLgt ------------------------------------------------------------
SavLgt  ------------------------------------------------------------
SgrLgt  ------------------------------------------------------------
MtbLgt  ------------------------------------------------------------
MsmLgt  MAVVVAPAETAESDEAREPVETDATESEEPSEPEEPDAPEAVEAPEALDENADETRAEPA 300        
ScoLgt1 -------------------------
ScoLgt2 -------------------------
ScabLgt -------------------------
SavLgt  -------------------------
SgrLgt  -------------------------
MtbLgt  -------------------------
MsmLgt  APAAVATAPVEPEKGRLRRWLRRNR 325
Figure 3.2  Amino acid sequence alignment of the C-termini of the Actinomycete Lgt 
enzymes.  Sequences compared using ClustalW (http://www.ebi.ac.uk/Tools/clustalw2/
index.html).
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3.3.1.2 Lipoprotein signal peptidase (Lsp).
Of the species tested, the Lsp  proteins from the Streptomyces species share 
the highest identity (≥75%).  ScoLsp showed relatively weak identity with the 
Lsp  from Mycobacterium species (~41%) and even lower to both EcoLsp  (36%) 
and BsuLsp  (34%).  Currently it is believed that there are five regions of the Lsp 
protein necessary for protein function (fig. 3.3).
Figure 3.3. The predicted membrane topology of L. pneumophila Lsp showing the five 
essential regions I->V.  From [19].
Within these conserved regions, the amino acid residues that are critical for 
function can be found in domains I, where an aspartic acid (D) is necessary for 
enzyme stability  [26], as are the residues NXXD in region III and FNXAD in 
region V.  It is thought that the aspartic acid residues in III and V may form a 
catalytic dyad which is the active site of the protease [19, 28].  Whilst the amino 
acid sequences of regions I->V are inconsistent between species, all the 
residues needed for stability  or catalysis in B. subtilis [26] are conserved in all 
species (fig. 3.4).
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ScoLsp   MAEAERIIGTPDIPDAAGEGQERPDADPEREQQEQEQAPERTRGKRRVAVLFAVALFAYL 60
ScabLsp  MAEAERIIGTPDIPDATGAGPEQSDDGAGAATAEPADAAARPRGRRRIAVLFGVAALAYA 60
SavLsp   MAEAERIIGTPDIPEAAGAEPEQADGESGGAGAG----TERPKGRRRIAVLFAVAALAYA 56
SgrLsp   MAEAERIIGMPENPDVDGTDEGGSTAADAAVNAG--------RGKRKILALLSVAVVAYL 52
MtbLsp   MPDEP--TG-SADPLTSTEEAGGAGEPNA------------PAPPRRLRMLLSVAVVVLT 45
MsmLsp   MTDET--SG-PAEPVT--DAPGDAESP--------------AQPKRRLRLLLTVAAVVLF 41
EcoLsp   --------------------------------MSQSICSTG-------LRWLWLVVVVLI 21
BsuLsp   ------------------------------------------------MLYYMIALLIIA 12
ScoLsp  LDLGSKMLVVAKLEHHEPIEIIGDWLRFAAIRNAGAAFGFGEA----FTIIFTVIAAAVI 116
ScabLsp LDLVSKMIVVARLEHHEPIEIIGEWLKFEAIRNAGAAFGFGEA----FTIIFTVIATIVI 116
SavLsp  FDLVSKLIVVAKLEHHAPIEIIGDWLRFEAIRNAGAAFGFGEA----FTVIFTVIAAAVI 112
SgrLsp  LDLGSKMLVVAKLEHQPPIDIIGDWLQFRAIRNPGAAFGIGEA----FTVIFTIIATGVI 108
MtbLsp  LDIVTKVVAVQLLPPGQPVSIIGDTVTWTLVRNSGAAFSMATG----YTWVLTLIATGVV 101
MsmLsp  LDVVTKVLAVRLLTPGQPVSIIGDTVTWTLVRNSGAAFSMATG----YTWVLTLVATGVV 97
EcoLsp  IDLGSKYLILQNFALGDTVPLFP-SLNLHYARNYGAAFSFLADSGGWQRWFFAGIAIGIS 80
BsuLsp  ADQLTKWLVVKNMELGQSIPIIDQVFYITSHRNTGAAWGILAG----QMWFFYLITTAVI 68
ScoLsp  VVIARLARKLHS--LPWAIALGLLLGGALGNLTDRIFRAPGVFEGAVVDFIAPKHFAVFN 174
ScabLsp VVIARLARKLYS--LPWAIALGLLLGGALGNLTDRIFRAPGVFEGAVVDFIAPKGFAVFN 174
SavLsp  VVIARLARKLYS--LPWAIALGLLLGGALGNLTDRIFRSPGVFEGAVVDFIAPKHFAVFN 170
SgrLsp  VVIFRIARKLYS--LPWAIALGLLLGGALGNLTDRIFRAPGVFEGAVVDFIAPKNSAVFN 166
MtbLsp  VGIFWMGRRLVS--PWWALGLGMILGGAMGNLVDRFFRAPGPLRGHVVDFLSVGWWPVFN 159
MsmLsp  IGIIWMGRRLVS--PWWALGLGLILGGATGNLVDRFFRSPGPLRGHVVDFFSVGWWPVFN 155
EcoLsp  VILAVMMYRSKATQKLNNIAYALIIGGALGNLFDRLWH--GFVVDMIDFYVGDWHFATFN 138
BsuLsp  IGIVYYIQRYTKGQRLLGVALGLMLGGAIGNFIDRAVR--QEVVDFIHVIIVNYNYPIFN 126
ScoLsp  LADSAIVCGGILIVILSFRGLD----------------------------PDG------- 199
ScabLsp LADSAIVCGGILIVLLSFRGLD----------------------------PDG------- 199
SavLsp  LADSAIVCGGILIVLLSFRGLD----------------------------PDG------- 195
SgrLsp  LADSAIVCGGILIVILSFKGLD----------------------------PDG------- 191
MtbLsp  VADPSVVGGAILLVILSIFGFDFDTVGRR--------------------HADG------- 192
MsmLsp  VADPSVVGGAILLVALSLFGFDFDTVGRRRPGEDAEPSAGASDSTPEAPAADGPDKPAGP 215
EcoLsp  LADTAICVGAALIVLEGFLPSR-------------------------------------- 160
BsuLsp  IADSSLCVGVMLLFIQMLLDSG-------------------------------------- 148
ScoLsp  -----------TVHKD---- 204
ScabLsp -----------TVHKG---- 204
SavLsp  -----------TVHKD---- 200
SgrLsp  -----------TVHKD---- 196
MtbLsp  ----------DTVGRRKADG 202
MsmLsp  VGPEDAAEESKTVGHQAEPS 235
EcoLsp  ------------AKKQ---- 164
BsuLsp  -----------KKKKEQ--- 154
Figure 3.4.  Amino acid sequence alignment of the Lsp enzymes.  Potential 
transmembrane domains are underlined, highlighted in yellow are regions believed to 
be important in B. subtilis Lsp.  Amino Acids in blue are to be necessary  for enzyme 
stability  in B. subtilis whilst those in red are necessary  for catalysis.  Sequences 
compared using ClustalW (http://www.ebi.ac.uk/Tools/clustalw2/index.html).
As with the Lgt enzymes, there is a marked protein elongation between the Lsp 
enzymes from the actinomycetes and those from E. coli and B. subtilis.  This 
time however the elongated sections are found in the N-termini.  Like the C-
terminal tails of Lgt these extensions are predicted to be cytoplasmic, however 
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unlike the Lgt tails they  show a higher level of similarity.  Between the 
Streptomyces species the similarity ranges from 45-68%, whilst between the 
Mycobacterium species the similarity is 35%.  However, there is low similarity 
between the two groups.  There are two predicted amino acids that are 
conserved between the species. (fig. 3.5).
ScoLsp  MAEAERIIGTPDIPDAAGEGQERPDADPEREQQEQEQAP 39
ScabLsp MAEAERIIGTPDIPDATGAGPEQSDDGAGAATAEPADAA 39
SavLsp  MAEAERIIGTPDIPEAAGAEPEQADGESGGAGAGT---- 35
SgrLsp  MAEAERIIGMPENPDVDGTD----EGGSTAADAAV---- 31
MtbLsp  MPDEP--TG-SADPLTS------TEEAGGAGEP------ 24
MsmLsp  MTDET--SG-PAEPVT---------DAPGDAE------- 20
Figure 3.5.  Amino acid sequence alignment of the N-terminal extensions of the Lsp 
enzymes from the actinomycetes tested.  Predicted conserved residues are highlighted 
in red.
3.3.1.3 Lipoprotein N-acyl transferase (Lnt).
As has been discussed, S. coelicolor is unusual as it contains two potential 
copies of the lnt gene.  The ScoLnt1 protein shares a high degree of identity 
with ScabLnt1 (86%) and a lower level with the Mycobacterium Lnt enzymes 
(~42%).  It only shares 29% identity with ScoLnt2, which is itself more similar to 
the remaining Streptomyces Lnt enzymes.  There is no BsuLnt homologue, as 
discussed in Chapter 1.
Currently, the only experimentally confirmed Gram-positive Lnt enzymes are 
found in M. smegmatis, and M. tuberculosis [38].  MsmLnt, ScoLnt1 and 
ScoLnt2 all conserve the three residues (E267, K355, C387) which form the 
enzymeʼs catalytic triad in E. coli [30], as do all the other species tested (fig. 
3.6).  However, of the four remaining essential amino acids found in E. coli Lnt, 
only E343 and E389 are conserved between all species.  In both MsmLnt and 
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ScoLnt1, a valine is present in place of E. coli W237 whilst in ScoLnt2 a serine 
is present.  Y388 is conserved between EcoLnt and ScoLnt1, with a 
phenylalanine located here in ScoLnt2 or a tryptophan in MsmLnt.  As can be 
seen in figure 3.6, MtbLnt has an extended C-terminus.  As described in chapter 
1, this is as a result of a fusion between lnt and the ppm1 genes [37], which has 
lead to a multi domain protein.
ScoLnt1  ---------------------------------------------------------MTA 3
ScoLnt2  ------------------------------------------------------------
ScabLnt1 ---------------------------------------------------------MTV 3
ScabLnt2 ------------------------------------------------------------
SavLnt   ------------------------------------------------------------
SgrLnt   ------------------------------MRIRGARLPARRHAAGTAAAGGSGGRAGDD 30
MtbLnt   ------------------------------------------------------------
MsmLnt   MADDRARRFDRFRVRPEEITEVIPAVTDDDPLEDPLDDDVAPGLDDAEPEPEPRDEHDEP 60
EcoLnt   ------------------------------------------------------------           
ScoLnt1  TATTVGEPDRTQPQTTPASRAVSRLARLLPAAAAALSGVLLYISFPPRTLWWLALPAFAV 63
ScoLnt2  ----------------MKTLDRRLASPWRRSGLAVLAGALPVLAFPGPALWWWAW--FAL 42
ScabLnt1 TATPVDEPEQLEPQAAPVSRVSRWAARLLPAAAAALSGVLLYVSFPPRTLWWLALPAFAV 63
ScabLnt2 ----------------MRTP-DWIASPWRRRSAVVVAGALPVLAFPAPGLWWSAY--GAL 41
SavLnt   ----------------MRMPEDWLGSRWWRGAAAVLAGALPMLAFPAPSWWWFAY--VAL 42
SgrLnt   ASGDGPPDDGPGPRGRGSAREGALSSAWARGAAALLAGALPALAFPAPGLWWFAY--VAL 88
MtbLnt   ------MKLGAWVAAQLPTTRTAVRTRLTRLVVSIVAGLLLYASFPPRNCWWAAVVALAL 54
MsmLnt   SRPATGSRIGGWVARRGSRFGKGVLDRCAPLSAAIGGGLALWLSFPPIGWWFTAFPGLAL 120
EcoLnt   -----------------MAFASLIERQRIRLLLALLFGACGTLAFSPYDVWPAAIISLMG 43
ScoLnt1  FGWVLRGR----GWK--AGLGLG-YLFGLGFLLPLLVWTGVEVGPGPWLALAAIEALFVA 116
ScoLnt2  VPWILLAR----TAPGGKRAAYDGWCGGFGFVLAMHHWLLPNLHVFTFVIAALLGALWVP 98
ScabLnt1 LGWVLRGR----GWK--AGLGLG-YLFGLGFLLPLLVWTGVEVGPGPWLALAVIEAVFVA 116
ScabLnt2 VPWILLLR----AAPTGRRAAYDGWLGGFAFMLAMHHWLLPNLHVFTFLIAGLLGALWAP 97
SavLnt   VPWILLAR----TAPTGGRAAYDGWLGGLGFMLAVHHWLLPSLHVFTVLIAALLGALWAP 98
SgrLnt   VPWLLLIR----GARSPRRAALDGWIGGIGFVVAVHHWLMPSLHVFIVLLAALLGLLWAP 144
MtbLnt   LAWVLTHR----ATTPVGGLGYG-LLFGLVFYVSLLPWIGELVGPGPWLALATTCALFPG 109
MsmLnt   LGWVLTRT----ATTKAGGFGYG-VLFGLAFYVPLLPWISGLVGAVPWLALAFAESLFCG 175
EcoLnt   LQALTFNRRPLQSAAIGFCWGFGLFGSGINWVYVSIATFGGMPGPVNIFLVVLLAAYLSL 103
ScoLnt1  AVGAGVAAVSKLPGSP------VWAAAVWIAGEAARARAPFEGFPWGKIAFG-QADGVFL 169
ScoLnt2  WGWLVHRTLGGTPSSRRVAAALVVLPSGWLLAELVRSWQGLGG-PWGMLGASQWQVAPAL 157
ScabLnt1 LVGAGVAVVSKLPGWP------VWAAALWVAGEAARARAPFHGFPWGKIAFG-QADGVFL 169
ScabLnt2 WAWLAHRFLAGSPSSGRVAAALLVVPSGWLMIELVRSWQGLGG-PWGLLGSSQWEVEAAL 156
SavLnt   WGWLVRRFLAGVPSPGRVAAAMLVLPSGWLMVELVRSWQGLGG-PWGLLGSSQWQVEPAL 157
SgrLnt   WGLLVARLLGGSPSAGRAVAAVVVVPSGWLMIELVRSWEGLGG-PWGLLGASQWDVAPAL 203
MtbLnt   IFGLFAVVVRLLPGWP------IWFAVGWAAQEWLKSILPFGGFPWGSVAFG-QAEGPLL 162
MsmLnt   LFGLGAVVVVRLPGWP------LWFATLWVAAEWAKSTFPFGGFPWGASSYG-QTNGPLL 228
EcoLnt   YTGLFAGVLSRLWPKTTWLRVAIAAPALWQVTEFLRGWV-LTGFPWLQFGYS-QIDGPLK 161
ScoLnt1  PLAAVGGTPVLGFAVVLCGFALHEAVRLAVRARR-GDEVRRGAAAVALLGVAVPVVGAVA 228
ScoLnt2  RLASVGGVWLLSFLVVAVNAALAVLVAVRRARVP-------ALAGLVATAAATSAAWVWS 210
ScabLnt1 PLAALGGTPVLGFAVVLCGFGLCEAVRLLVANRRTGEAVRRGTAAVAALSVAVPLAGAFA 229
ScabLnt2 RLASVGGVWLLSFLVVAVNVAVTVLVSVRASRAP-------ALAGLVVVAVATSAVWLWS 209
SavLnt   RLASVGGVWLLSFLVVTVNIAVAVLVSVRASRMP-------ALAGLVATAAATSAAWAWS 210
SgrLnt   RVASVGGVWLVSLLVLAVNTGVALLVADRAARRT-------GGVLLAVCALSVAAVWAWA 256
MtbLnt   PLVQLGGVALLSTGVALVGCGLTAIALEIEKWWRTGGQ-GDAPPAVVLPAACICLVLFAA 221
MsmLnt   ALARIGGAPLVSFAVALIGFSLTLLTAQIVWWWRHGHKPGVPAPAVMLPGVAIAASLLVT 288
EcoLnt   GLAPIMGVEAINFLLMMVS-GLLALALVKRNWRP-------LVVAVVLFALPFPLRYIQW 213
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ScoLnt1  A------RPLVSDTAEDGTATVAVIQGNVPRAGLGFNAQRRAVLDYHARETQRLADEVKA 282
ScoLnt2  P-----------RPDTDERAAIAVVQPGV--------VAGADSADRRFDREEQLTRRLAD 251
ScabLnt1 S------RALVSDTAEDGTATVAVIQGNVPRLGLDFNAQRRAVLDYHAKETERLAAQVKA 283
ScabLnt2 P-----------RPDVRGEVRIAVVQPGV--------TDGP---DARFAREEALTRRLAG 247
SavLnt   P-----------RPDHDGDMRIAIVQPGV--------IDGTGSADRRFDREEQLTRELAG 251
SgrLnt   P-----------RPTETGAVRIAVVQPGV--------VEGPGSVARRFDRGEELTRALRG 297
MtbLnt   IVVWPQVRHAGSGSGGEPTVTVAVVQGNVPRLGLDFNAQRRAVLDNHVEETLRLAADVHA 281
MsmLnt   ALVWPQVRQSGTGAGDDTAVTVAAVQGNVPRLGLEFNAQRRAVLDNHVKETLRLADDVKA 348
EcoLnt   F-----------TPQPEKTIQVSMVQGDIP--------QSLKWDEGQLLNTLKIYYNATA 254
ScoLnt1  GKVARPDFVLWPENSSDIDPFANADARLVIDRAAKAVGAPISVGGVVERDGK------LL 336
ScoLnt2  ---RDLDLIVWGESSVGFDLDDRPDLARRLAALSRETGADILVN-VDARRSD---KPGIY 304
ScabLnt1 GKVARPDFVLWPENSSDIDPFANADARAVIDRAATAIGAPISVGGVVERDGK------LY 337
ScabLnt2 ---QDVDLIVWGESSVGHDLADRPDLSDRIAALARAADSDILVN-VDARRSD---RPGIY 300
SavLnt   ---QNVDLVVWGESSVGFDLADRPDLARRIAGLSERVGADILVN-VDARRSD---RPGIY 304
SgrLnt   ---RGVDLVVWGESSIGAGAWERPETARRLAGLSRLVGADLLVN-VDARQTDGSGRSGIF 353
MtbLnt   GLAQQPQFVIWPENSSDIDPFVNPDAGQRISAAAEAIGAPILIGTLMDVPGRPRENPEWT 341
MsmLnt   GRAAQPMFVIWPENSSDIDPLLNADASAQITTAAEAIDAPILVGGVVRADGYTPDNPVAN 408
EcoLnt   PLMGKSSLIIWPESAITDLEINQQPFLKALDGELRDKGSSLVTGIVDARLNK-QNRYDTY 313
ScoLnt1  NEQILWDPDKG----PVDTYDKRQIQPFGEYLPLRSLIGAINDEWTSMVSRDFSRGTEPG 392
ScoLnt2  KSSVLVGPQGP----TGDRYDKMRLVPFGEYVPFRSLLGWATSVGKAAG-EDRRQGTEQV 359
ScabLnt1 NEQILWDPAKG----PVDTYDKRQIQPFGEYLPLRSLIGAINGEWTSMVRKDFSRGTEPG 393
ScabLnt2 KSSVLVGPDGP----TGDRYDKMRLVPFGEYIPMRSLLGWATSVGEAAG-EDRRRGTEQV 355
SavLnt   KSSVLVGPHGP----TGDRYDKMRLVPFGEYIPARSLLGWATSVGKAAG-EDRRRGSEQV 359
SgrLnt   KSAVLVGPDGP----TGDRYDKMRLVPFGEYVPARSLLGWATSVGKAAG-EDRLRGDRQV 408
MtbLnt   NTAIVWNPGTG----PADRHDKAIVQPFGEYLPMPWLFRHLSGYADRAG--HFVPGNGTG 395
MsmLnt   NTVIVWEPTDG----PGERHDKQIVQPFGEYLPWRGFFKHLSSYADRAG--YFVPGTGTG 462
EcoLnt   NTIITLGKGAPYSYESADRYNKNHLVPFGEFVPLESILRPLAPFFDLPMSSFSRGPYIQP 373
ScoLnt1  VFT----MAGTKVGLVTCYEAAFDWAVRSEVTDGAQMISVPSNNATFDRSEMTYQQLAMS 448
ScoLnt2  VM---DVGDGLRIGPMVCFESAFPDMSRSLVADGAQVLVAQSSTSTFQHTWAPEQHASLA 416
ScabLnt1 VFT----MHGAKIGLVTCYEAAFDWAVRSEVTDGAQLISVPSNNATFDRSEMTYQQLAMS 449
ScabLnt2 VF---DAGKGLRIGPMVCFESAFPDMSRQLALDGAELLLAQSATSSFQQSWAPEQHATLA 412
SavLnt   VM---NAGHGLRIGPMVCFETAFPDMSRHLAEDGAEVLLAQSSTSTFQQSWAPEQHASLA 416
SgrLnt   VMTLPDGARGLRIGPLVCFETAFPDMSRRLVRDGAQVIVAQSATSTFQHSWAPAQHASLG 468
MtbLnt   VVR----IAGVPVGVATCWEVIFDRAPRKSILGGAQLLTVPSNNATFNKT-MSEQQLAFA 450
MsmLnt   VVH----AAGVPIGITTCWEVIFDRAARESVLNGAQVLAVPSNNATFDEA-MSAQQLAFG 517
EcoLnt   PLS----ANGIELTAAICYEIILGEQVRDNFRPDTDYLLTISNDAWFGKSIGPWQHFQMA 429
ScoLnt1  RIRAVEHSRTVTVPVTSGVSAIIMPDG-RITQKTGMFVADSLVQEVPLRSSETPATRLGI 507
ScoLnt2  ALRAAETGRPMVHATLTGVSAVYDANGARIGSWLGTDASASRVYEVPVTHGTTPYVRYGD 476
ScabLnt1 RVRAVEHSRTVTVPVTSGVSAIIMPDG-RIAQKTGMFVPDSLVQKVPLRSSQTPATRYGI 508
ScabLnt2 ALRAAETGRPMVHATLTGVSAVYGPSGERVGPWLGTDASEAAVYRVPMAGGTTPYVRFGE 472
SavLnt   ALRAAETGRPMVHATLTGVSAVYGPSGERVGSWLGTGKSTSAVYDVPLARGVTPYVRFGD 476
SgrLnt   ALRAAENGRPMVHATLTGISAAYGPRGERVGRPLGTDASAAEVFDLPLAGGSTLYNRLGD 528
MtbLnt   KVRAVEHDRYVVVAGTTGISAVIAPDG-GELIRTDFFQPAYLDSQVRLKTRLTPATRWGP 509
MsmLnt   KLRAVEHDRYVVVAGTTGISAVIAPDG-HEISRTEWFQPAYLDNQIRLKTDLTPATKWGP 576
EcoLnt   RMRALELARPLLRSTNNGITAVIGPQG-EIQAMIPQFTREVLTTNVTPTTGLTPYARTGN 488
ScoLnt1  APEIALVLVAAGGLGWAVGAG--------------------------------------- 528
ScoLnt2  WTVYAALGILAAWGAAEGVRTVRLRRNRPARPGPP------------------------- 511
ScabLnt1 APEMLLVLVAAGGLGWAIGAG--------------------------------------- 529
ScabLnt2 WPVQAALLVLVAWGAVEGVRALRLRRQAG-PRPPA------------------------- 506
SavLnt   WPVHAALLILAALCTAEGVREFRLRRTVPSPRVPP------------------------- 511
SgrLnt   WPVYGALAALAVLCAVEGLR--ALRRPAPGPPGPP------------------------- 561
MtbLnt   ILQWILVGAAAAVVLVAMRQNGWFPRPRRSEPKGENDDSDAPPGRSEASGPPALSESDDE 569
MsmLnt   IVQAVLVIAGVAVLLIAILHNGRFAP---------------------------------- 602
EcoLnt   WPLWVLTALFGFAAVLMSLRQRRK------------------------------------ 512
ScoLnt1  ------------------VRGRRARDV--------------------------------- 537
ScoLnt2  ------------------ARTAH-GSPARPGH---------------------------- 524
ScabLnt1 ------------------VRGRRAGGV--------------------------------- 538
ScabLnt2 ------------------AQSADPSSTARTTRSHSS------------------------ 524
SavLnt   ------------------ARTVR-ESPARPGR---------------------------- 524
SgrLnt   ------------------ARTAH-GSPGSPGH---------------------------- 574
MtbLnt   LIQPEQGGRHSSGFGRHRATSRSYMTTGQPAPPAPGNRPSQRVLVIIPTFNERENLPVIH 629
MsmLnt   -----------------RMLRRRSATTVKR------------------------------ 615
EcoLnt   ------------------------------------------------------------
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ScoLnt1  ------------------------------------------------------------
ScoLnt2  ------------------------------------------------------------
ScabLnt1 ------------------------------------------------------------
ScabLnt2 ------------------------------------------------------------
SavLnt   ------------------------------------------------------------
SgrLnt   ------------------------------------------------------------
MtbLnt   RRLTQACPAVHVLVVDDSSPDGTGQLADELAQADPGRTHVMHRTAKNGLGAAYLAGFAWG 689
MsmLnt   ------------------------------------------------------------
EcoLnt   ------------------------------------------------------------ 
ScoLnt1  ------------------------------------------------------------
ScoLnt2  ------------------------------------------------------------
ScabLnt1 ------------------------------------------------------------
ScabLnt2 ------------------------------------------------------------
SavLnt   ------------------------------------------------------------
SgrLnt   ------------------------------------------------------------
MtbLnt   LSREYSVLVEMDADGSHAPEQLQRLLDAVDAGADLAIGSRYVAGGTVRNWPWRRLVLSKT 749
MsmLnt   ------------------------------------------------------------
EcoLnt   ------------------------------------------------------------
ScoLnt1  ------------------------------------------------------------
ScoLnt2  ------------------------------------------------------------
ScabLnt1 ------------------------------------------------------------
ScabLnt2 ------------------------------------------------------------
SavLnt   ------------------------------------------------------------
SgrLnt   ------------------------------------------------------------
MtbLnt   ANTYSRLALGIGIHDITAGYRAYRREALEAIDLDGVDSKGYCFQIDLTWRTVSNGFVVTE 809
MsmLnt   ------------------------------------------------------------
EcoLnt   ------------------------------------------------------------
ScoLnt1  ------------------------------------------------------------
ScoLnt2  ------------------------------------------------------------
ScabLnt1 ------------------------------------------------------------
ScabLnt2 ------------------------------------------------------------
SavLnt   ------------------------------------------------------------
SgrLnt   ------------------------------------------------------------
MtbLnt   VPITFTERELGVSKMSGSNIREALVKVARWGIEGRLSRSDHARARPDIARPGAGGSRVSR 869
MsmLnt   ------------------------------------------------------------
EcoLnt   ------------------------------------------------------------
ScoLnt1  -----
ScoLnt2  -----
ScabLnt1 -----
ScabLnt2 -----
SavLnt   -----
SgrLnt   -----
MtbLnt   ADVTE 874
MsmLnt   -----
EcoLnt   -----
Figure 3.6.  Amino acid sequence alignment of the Lnt enzymes.  Potential 
transmembrane domains are underlined.  Amino Acids in blue are to be necessary  for 
enzyme stability  in E. coli whilst those in red are necessary  for catalysis.  Sequences 
compared using ClustalW (http://www.ebi.ac.uk/Tools/clustalw2/index.html).
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3.3.2 Bioinformatic analysis of lipoproteins in S. coelicolor. 
3.3.2.1 Identification of Lipoproteins.
Analysis of the S. coelicolor genome sequence by Professor Iain Sutcliffe 
(University  of Northumbria, Newcastle), Dr Matt Hutchings (UEA) and Dr. 
Govind Chandra (John Innes Centre, Norwich) led to the identification of up  to 
223 putative lipoproteins (appendix 1).  All S. coelicolor proteins (http://
strepdb.streptomyces.org.uk/) were assessed, and only those with a cysteine 
within the first 50 amino acids (representing a potential lipobox C+1, 
characteristic of a lipoprotein) were accepted for further analysis.  These 
proteins were matched against the G+LPP pattern, used for the identification of 
Gram positive lipoprotein sequences [64], and the revision G+LPPv2 [11, 85]. 
These patterns are used to filter out any proteins that do not contain a potential 
lipobox (see chapter 1).  In tandem with this, potential lipoproteins were also 
tested against the prosite pattern PS51257 (http://www.expasy.ch/tools/
scanprosite/).  Those which passed both tests were submitted to the following 
tests: SignalP v3.0 [86], Phobius [87], LipoP [88] and Predlipo [89].  The 
combined use of these tests is useful for accurate identification of lipoproteins. 
In addition lipoproteins secreted by the Tat pathway (Chapter 1), were identified 
using TatFind [90] and TatP [91].
3.3.2.2 Functional analysis of lipoproteins.
The 223 potential lipoproteins identified in the S. coelicolor genome using the 
methods described above represent ~2.7% of the S. coelicolor proteome. 
Surprisingly, fifty of the putative lipoproteins passed one or other of the Tat tests 
mentioned above, with 38 passing both, which would represent 17% of the total 
S. coelicolor lipoproteins.  Even when taking into account the genome size of S. 
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coelicolor, this is a large amount.  M. tuberculosis  is estimated to have 10-15% 
Tat secreted lipoproteins [11].  In comparison,  E.coli is predicted to have 28 Tat 
secreted proteins in total, and B. subtilis is predicted to only  secrete ≤7 proteins 
via Tat [2].
Of the putative S. coelicolor lipoproteins, it is unsurprising that 35% are of 
unknown function and several have no homologues outside of the genus 
Streptomyces.  ABC transporters make up a further 41% of the lipoproteome. 
Of these, more than half are needed for carbohydrate transport, and given the 
complex nature of the soil, and the saprophytic nature of S. coelicolor cannot be 
surprising.
Function Numbers %
Solute binding proteins 92 41%
Putative enzymes 34 15%
Redox processes 6 3%
Signal transduction (ʻthree componentʼ systems) 6 3%
Cell envelope processes 7 3%
Function unknown 78 35%
Table  3.1.  Overview of lipoprotein functions in S. coelicolor.  Number of proteins and % of total 
lipoproteins are shown.
3.3.3 Disrupting the S. coelicolor biosynthetic genes.
Cosmids containing the S. coelicolor genes lgt1 (Sco2034), lgt2 (Sco7822) and 
lsp (Sco2074), were obtained from the Streptomyces group at the John Innes 
Centre.    Genes were identified, by homology searches against the proteomes 
of E. coli, B. subtilis and M. tuberculosis (see section 3.3.1 above).  The 
cosmids were checked by restriction digest, to ensure their fidelity.  Digestion 
patterns were obtained from http://streptomyces.org.uk/.
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Apramycin marked cassettes for each of the genes were generated using ʻKOʼ 
primers specific to each gene (table 2.4) and introduced into their respective 
cosmids as explained in chapter 2.  The disrupted cosmids were checked by 
PCR, and the correct position of the antibiotic disruption cassette was ensured 
by using several combinations of primers.  Firstly, short test primers annealing 
to flanking regions of the gene were used to confirm that there was a size 
difference between the wild type and the disrupted gene, with a band at ~1400 
bp  representing the apr cassette.  Secondly primers specific to the apr cassette 
were used to show that it did indeed exist somewhere in the cosmid, and finally 
combinations of the two were used to show that it was in the right place.  PCR 
primers are listed in table 2.4 and results for each of the genes can be seen in 
figures 3.7 and 3.8.
Figure 3.7.  Confirmation of the disrupted lgt1::apr (Lanes 1. -> 4.) and lgt2::apr (Lanes 
4->8) in cosmids 4G6 and 8E7 respectively.  Primer combinations in each lane 
(expected band sizes shown in brackets): 1. = P1/P2 (1423 bp), 2. = P1/Sco Lgt1 Test 
Rev  (1424 bp), 3. = P2/Sco Lgt1 Test For (1423 bp), 4. = Sco Lgt1 Test For/Sco Lgt1 
Test Rev (1424 bp), 5. = P1/P2 (1423 bp), 6 = P1/Sco Lgt2 Test Rev (1424 bp), 7. = 
P2/Sco Lgt1 Test Rev  (1423 bp), 8. = Sco Lgt2 Test For/Sco Lgt2 Test Rev  (1423 bp). 
Lanes 9 and 10 are positive controls of the lgt1::apr and lgt2::apr PCR products using 
the P1 + P2 primers (1423 bp).
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Figure 3.8.  Confirmation of the disrupted lsp::apr in cosmid 4A10.  Primer 
combinations in each lane (expected band sizes shown in brackets): 1. = Sco LspTest 
For/Sco Lsp Test Rev  (1424 bp), 2. = P1/P2 (1423 bp), 3. = P2/Sco Lsp Test For (1423 
bp), 4. = P1/Sco Lsp Test Rev (1424 bp).
When the mutagenised cosmids were transferred into S. coelicolor by 
conjugation to give in-frame gene disruptions (section 2.3.5), genomic DNA was 
isolated from the exconjugants selected on apramycin and checked by PCR as 
before (Figs. 3.9 and 3.18).
Figure  3.9. PCR of S. coelicolor genomic DNA, to confirm apramycin disruption of lgt1. 
Primer combinations in each lane (expected band sizes shown in brackets): 1. = Sco 
Lgt1 Comp For/Rev (1736 bp), 2. = P1/Sco Lgt1 Comp Rev  (1611 bp), 3. = P1/P2 
(1423 bp).
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A marker-less deletion of lsp was also made, using the FLP recombinase 
method described in Chapter 2.  Removing the apr cassette, left a signature 
81bp  ʻ scarʼ, which was detectable by PCR, as can be seen in figure 3.10.  This 
strain was used throughout the experiments described below.
Figure 3.10.  PCR of S. coelicolor genomic DNA using the Sco LspTest For/Sco Lsp 
Test Rev  primers (expected band sizes shown in brackets).  Lane 1. = wild-type  M145 
(654 bp).  Lane 2. = Δlsp::apr (1424 bp).  Lane 3. = ΔlspFLP (81 bp).
Initial attempts to isolate a deletion of lgt2 proved fruitless.  The mutation was 
successfully  made in the cosmid 8E7 but could not be conjugated into S. 
coelicolor M145, probably due to the presence of three transposons in the 
cosmid carrying the lgt2 gene.  Instead, the lgt2 gene deletion was carried out 
by Dr David Widdick (UEA). A suicide vector containing the apr disrupted lgt2 
gene was used to make the mutant S. coelicolor strain, which was thoroughly 
tested to ensure it was correct [82].  A hygromycin cassette was also used to 
make an lgt2::hyg disruption strain. Creation of the S. coelicolor lgt double 
mutant using lgt1::apr and lgt2::hyg proved impossible despite repeated 
attempts.  The deletion of lsp also proved difficult, and resulted in numerous 
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growth phenotypes that are described below.
3.3.3.1 Development and colony morphology.
Of all the null mutants obtained, only the Δlsp strain (BJT1001) showed a 
marked phenotype.  This strain is slower growing, and sporulates poorly.  This 
strain frequently overproduces the blue-pigmented antibiotic actinorhodin (act) 
when grown on a variety of growth media, which is often a sign of stress [92]. 
The macroscopic phenotype of the lgt1::apr and lgt2::apr strains appear similar 
to the wild-type.
1. 1.
2.
3.
2.
3.
4. 4.
5. 5.
6. 6.
Figure 3.11.  Unmagnified phenotypes of each of the S. coelicolor strains grown on 
SFM media.  The sections are as follows: 1. = WT (M145), 2. = M145 Δlgt1::apr 
(BJT1002), 3. = M145 Δlgt2::apr (BJT1027), 4. = M145 ΔlspFlp (BJT1001), 5. =  M145 
Δlsp + lsp in trans complementation (BJT1007), 6. = M145 Δlsp + lsp cis 
complementation (BJT1006). The growth retardation of the Δlsp strain is clearly  visible, 
whilst the complemented strains look more closer to wild-type.  Neither Δlgt1, nor Δlgt2 
display any obvious phenotype.
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All strains were visualised by both light and scanning electron microscopy.  Both 
of these techniques confirmed that the Δlsp mutant (BJT1001) had a drastic 
phenotype in comparison to the other strains.  Individual colonies viewed under 
the light microscope can be seen in figure 3.12.  After 5 nights growth on SFM 
growth media (table 2.3), the wild-type, Δlgt1 (BJT1002) and Δlgt2 (BJT1027) 
mutants were typically between 3 and 4 mm in diameter, whilst the diameter of 
the Δlsp mutant was between 1 and 2 mm.  The Δlsp mutant also lacks depth 
when compared to the other strains, appearing very flat against the growth 
media.  As this mutant sporulates very poorly it is unsurprising to see a larger 
proportion of white areas around the colony, representing undifferentiated 
substrate hyphae, than grey areas, representing mature spore chains.   The 
bisections shown in the WT and Δlgt1 colonies below are unexplained, and 
appears to occur at random in these strains as well as in the Δlgt2 mutant.  A 
colony divided into four was also seen regularly.  These crenellations were not 
seen in the Δlsp mutant and could potentially be caused by the colony 
collapsing in upon itself, due to its increased height and mass.
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Colonies dissected bilaterally can be seen in figure 3.13.  As with the top-down 
images, the difference between the Δlsp mutant and the other strains is 
conspicuous.  These results again highlight the lack of depth in this strain, and 
its overall reduced size.  Also apparent, is the reduction in the layer of 
undecylprodigiosin, the red pigmented antibiotic, in the Δlsp mutant.  Whether 
or not this is down to the delayed development in the strain is unknown.
Viewing colonies grown for 5 nights under SEM (fig. 3.14) shows some 
differences between the samples.  As with the light microscopy results above, 
the wild-type sample appears very similar to both the Δlgt1 and Δlgt2 mutants. 
At first glance, this appears to be the case for the Δlsp mutant as well. 
However, on closer inspection there are very few spiral spore chains in 
comparison to the other strains.  The overall lack of these structures would 
explain the reduction of sporulation in the Δlsp mutant, in comparison to the 
wild-type.  The spore chains in S. coelicolor begin as undifferentiated aerial 
hyphae (see chapter 1), which grow vertically in comparison to the substrate 
mycelium. The lack of this vertical growth may also be a contributing factor to 
the overall lack of depth in the Δlsp mutant.
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3.3.4 Effect of gene disruption on lipoprotein processing.
3.3.4.1 Western blots.
Spores of each strain were grown for 15 hours in 50% TSB/YEME growth 
media (table 2.3) and the resultant cell extract was fractionated by 
ultracentrifugation to obtain separate cytoplasmic and cell membrane fractions. 
Each group of proteins was run on a separate 15% SDS PAGE gel, with the 
amount protein loaded in each lane normalised.  The results for each of the 
fractions can be seen in figures 3.15 and 3.16.
3.3.4.2 CseA.
The first lipoprotein assayed was CseA (SCO3357), a Sec translocated, 
experimentally  confirmed lipoprotein from S. coelicolor, with no known 
homologues outside of the streptomycetes [93].  CseA is part of the CseABC-σE 
regulatory system which is involved in sensing of cell envelope stress in S. 
coelicolor.  Good polyclonal antibodies exist against this lipoprotein [93].  The 
CseA protein runs as a band at 21 kDa on a protein gel.  This band was absent 
from all the cytoplasmic fractions (fig. 3.15).  The band was also undetectable in 
the precipitated growth medium (not shown).  Being a membrane bound protein, 
CseA was present as expected in the membrane fractions of wild-type S. 
coelicolor.  It is absent from the ΔcseA null mutant (J2172 - see table 2.2).  In 
the membrane fractions of both the Δlgt1 (BJT1002) and Δlgt2 (BJT1027) 
strains CseA is present, with no detectable size shift in comparison to the wild-
type.  However, in the ΔlspFLP mutant (BJT1001), CseA was undetectable.
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Membrane
Cytoplasm
ΔlspFLPΔlgt2::aprΔlgt1::aprWTΔcseA
J2172 M145 BJT1002 BJT1027 BJT1001
Figure 3.15.  Western blot analysis of the cytoplasm and membrane fractions of the 
various S. coelicolor  strains.  CseA can be seen in the WT, Δlgt1 and Δlgt2 membrane 
samples.  The fractions were incubated against an anti-CseA antibody.  Strain names 
are as labelled.
3.3.4.3 SCO3484
The second lipoprotein assayed was SCO3484, a Tat translocated, confirmed 
lipoprotein [2, 82], and a substrate binding protein of unknown function.  An 
effective antibody against this lipoprotein is unavailable at the current time, so a 
fusion was created whereby the gene was cloned with six histidine codons at its 
3′ end (pTDW188 - see table 2.2).  Constructs carrying this altered gene were 
conjugated into each S. coelicolor strain in single copy, integrating using the 
ϕC31 attP-int locus, and membrane fractions of each of the strains were 
prepared, as discussed previously.  These fractions were immunoblotted with a 
commercially available, monoclonal anti-His antibody  (Qiagen).  This antibody is 
highly sensitive and is able to detect proteins at a very low level.  The results 
(fig 3.16), show that as with CseA, the processing of SCO3484 in both the Δlgt1 
and Δlgt2 mutants appears to be the same as the wild-type.  However, the 
processing in the Δlsp strain is different.  In this case the protein, whilst present 
at a low level, is detectable although it is larger than the protein from the wild-
type.  This suggests that it retains its signal peptide due to the lack of Lsp and 
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that the majority of the protein is proteolysed to remove it from the membrane. 
The size of the protein in an in trans complemented Δlsp mutant is returned to 
normal.  This will be discussed in section 3.3.5.2 below.
Membrane
in transΔlspFLPΔlgt2::aprΔlgt1::aprWT
M145 BJT1002 BJT1027 BJT1001 BJT1007
Figure 3.16.  Western blot analysis of His-tagged SCO3484 using an anti-His antibody 
in the membranes of each of the strains listed.  The protein in the Δlsp mutant has 
shifted in comparison to the other strains, suggesting it is improperly  processed.  It has 
reverted to its fully  processed size in the complemented strain.  Strain names are as 
labelled.
3.3.5 Complementation of the Δlsp mutant.
Of the three gene disruptions made, only the Δlsp mutant displays a severe 
phenotype, as described above.  In an attempt to reverse these mutations, a full 
length copy of the lsp gene was replaced into the Δlsp strain in order to see if 
could restore the mutant back to a wild-type phenotype.  This was done in two 
ways, with a full length copy of the gene and its promoter being reintroduced 
into the mutant on an integrative plasmid, or by reversing the REDIRECT 
mediated apramycin gene disruption (section 2.4), to reintroduce a full length 
lsp gene back into the bacterial chromosome, thus reconstructing the wild-type 
strain.  A copy  of the full length lsp was synthesised by Genscript USA inc. with 
an additional 300 bp of upstream DNA incorporating the lsp promoter (see 
Chapter 2).  
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The in trans complementation of the Δlsp mutant involved subcloning the full 
length lsp gene, under the control of its own promoter, into the vector pSET152 
to form vector pBT100 (see table 2.2) and transforming it into the unmarked 
Δlsp deletion strain to create the strain BJT1007.
 
Replacing the lsp gene into the chromosome of the mutant to make a cis 
complemented strain (section 2.4.2) involved replacing the ampicillin resistance 
gene (bla) found on the backbone of the cosmid 4A10 (which contains full 
length lsp) with the hygromycin resistance cassette (hyg) containing the origin 
of transfer (fig. 3.17).  This altered cosmid, pBT110, was conjugated into M145 
lsp::apr (BJT1000) and double exconjugants were selected by choosing 
colonies that were hygromycin sensitive and apramycin sensitive (BJT1006). 
Genomic DNA was tested by PCR (fig. 3.18), as described earlier, to ensure 
that the full length lsp was present.
Figure 3.17  PCR confirmation of the replacement of the bla gene in the backbone of 
cosmid 4A10 with the hyg cassette. Lane 1. = cosmid 4A10, lane 2. = cosmid 4A10 
bla->hyg.  The bla Test forward and reverse primers were used.   The band in lane 1 
(~1 Kb) is the bla gene and flanking DNA, absent in the altered cosmid and replaced by 
the hyg cassette (~1.5 Kb).
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Figure 3.18.  PCR of genomic DNA to confirm the replacement of full length lsp into 
the Δlsp::apr mutant. Lanes 1-3 = cis complementation, 4-6 = M145 wild-type, 7-9 = 
M145 lsp::apr.  Primer combinations in lane 1,4,7 = hyg test forward/reverse.  Lanes 
2,5,8 = P1 and P2. Lanes 3,6,9 = lsp Test forward/reverse.  A band representing full 
length lsp (614 bp) is present in the wild-type and cis complementation.  This band is 
absent in the Δlsp::apr mutant, where the apr gene is present (1424 bp), replacing the 
lsp gene.
3.3.5.1 Development and colony morphology.
When plated as a confluent lawn, as in figure 3.11 the complementations both 
look closer to the wild-type than the ΔlspFLP mutant (BJT1001).  They appear 
to have grown more than the mutant, and are sporulating to a greater extent. 
When individual colonies were viewed under the light microscope however, the 
similarities between the wild-type and complemented strains end.  The results 
for colonies grown for 5 nights can be seen in figure 3.19.  As before the Δlsp 
mutant colony is dwarfed by  the wild-type.  Neither of the complemented strains 
have returned to the size of the wild-type, and appear to approximately the 
same size as the deletion mutant.  The cis complemented strain (BJT1006) is 
markedly  more grey than the in trans complemented strain (BJT1007) (fig. 3.19) 
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and is producing a higher number of spores, which is confirmed in the SEM 
images (fig. 3.22).  Both complemented colonies retain the large proportion of 
white areas seen in the Δlsp mutant but absent in the wild-type.  The cross-
sections of each of the colonies (fig. 3.20) confirms the drastic difference with 
both complemented strains show the same lack of depth observed in the Δlsp 
mutant.
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Whilst light microscopy shows very  little difference between the Δlsp and the 
complemented strains, the use of SEM revealed some variations unseen at a 
low magnification.  Colonies viewed after both 2 and 5 nights can be seen in 
figures 3.21 and 3.22.
After 2 nights, the cis complementation (BJT1006) resembles the wild-type, with 
a large amount of aerial hyphae present.  As with the wild-type, there are no 
spore chains visible.  The in trans complemented strain (BJT1007) however 
closely  resembles Δlsp strain and shares the distinctive lack of aerial hyphae. 
High magnification of these strains show there is no vertical growth of aerial 
hyphae and any depth of the colony appears to be a result of substrate hyphae 
aggregating on top of each other.  After 5 nights, all the strains look broadly 
similar, but closer inspection reveals that whilst both the wild-type and cis 
complemented strains share an abundant number of curly aerial hyphae, they 
are not present in either the Δlsp mutant or the in trans complemented strain. 
The highest magnification does reveal though that mature spores are present in 
all four of the strains.  If you were to base the analysis of the complemented 
strains solely on these SEM data it would appear that the cis complementation 
closely  resembles the wild-type, whilst the in trans complementation is closer to 
the Δlsp mutant.
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3.3.5.2 Effect of gene disruption on lipoprotein processing.
As can be seen in figure 3.16, in trans complementation of the Δlsp mutant 
(BJT1007) is able to restore the processing of SCO3484 (the cis 
complementation could not be tested at the time due to a clash of antibiotic 
resistance cassettes in the integrative vectors).  In order to confirm this, 
membrane fractions from the wild-type, Δlsp mutant and complemented strains 
were collected as before and tested against an unaltered native lipoprotein, in 
this case CseA.  The results can be seen in figure 3.24 below.  As before, the 
band representing CseA in the wild-type membrane is absent from the Δlsp 
membrane.  It is however, detectable in both of the complemented strains at the 
same size as the wild-type band.
3.3.6 Phenotype tests.
Many lipoproteins are involved in maintaining cell envelope integrity.  In E. coli, 
the murein lipoprotein (Lpp) is needed to covalently  attach the peptidoglycan 
cell wall to the inner membrane.  It seems feasible that disruption of the 
lipoprotein biosynthetic pathway may lead to a weakened cell envelope due to 
the incomplete processing, or absence of lipoproteins.  To test this hypothesis 
the wild type and mutant strains were tested for sensitivity to a variety of 
stresses.  Identical numbers of spores were plated into each well of a 12 well 
cell-culture plate containing 3ml of minimal growth media (+1% glucose).  Each 
well contained a decreasing concentration of the compound to be tested, with 
the highest concentration being well A1 and the control well being C4 (fig. 3.23). 
Growth was scored as 2 if the growth was confluent, 1 if individual colonies 
were sparse enough to be counted by eye, or 0 for the absence of growth (for 
full results see appendix 2).
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Name/Strain WT Δlgt1::apr Δlgt2::apr ΔlspFLP cis comp in trans 
comp
M145 BJT1002 BJT1027 BJT1001 BJT1006 BJT1007
Bacitracin
Confluent Growth (2) up to 50 μg/ml 30 μg/ml 100 μg/ml 20 μg/ml 35 μg/ml 35 μg/ml
Weak Growth (1) up to N/A 40 μg/ml 500 μg/ml 30 μg/ml 40 μg/ml 50 μg/ml
+15 Hour SDS
Confluent Growth (2) up to 0.2% 0.2% 0.2% 0.05% 0.06% 0.04%
Weak Growth (1) up to N/A N/A N/A 0.1% 0.1% 0.1%
0 hour lysozyme
Confluent Growth (2) up to 0.5 μg/ml 0.5 μg/ml 0.5 μg/ml 0.3 μg/ml 0.75 μg/ml 0.75 μg/ml
Weak Growth (1) up to 1.25 μg/ml 2.5 μg/ml 2.5 μg/ml 0.75 μg/ml 1 μg/ml 1.25 μg/ml
+15 Hour Lysozyme
Confluent Growth (2) up to 1 μg/ml 0.5 μg/ml 0.3 μg/ml 0.4 μg/ml 0.3 μg/ml 0.4 μg/ml
Weak Growth (1) up to 1.25 μg/ml 1.25 μg/ml 1.25 μg/ml 1.25 μg/ml 2.5 μg/ml 1.25 μg/ml
Table 3.2. Abbreviated results of the stress test carried out on each of the S. coelicolor 
strains.  As described, confluent growth was scores as a 2, whilst weak growth was 
scored as a 1. N/A represents confluent growth to the highest level tested.
3.3.6.1 Cell envelope specific antibiotics.
Of the antibiotics tested, bacitracin, carbenicillin and vancomycin, the most 
obvious effect was observed with bacitracin.  Bacitracin is a cyclic 
dodecapeptide produced by Bacillus species, and an unusual antibiotic 
because it requires a divalent metal ion (for example Zn2+) in order to function 
[94].  Bacitracin inhibits cell wall biosynthesis in Gram-positive bacteria by 
interfering with the transport of peptidoglycan precursors, leading to the 
cessation of cell wall synthesis and eventually cell lysis (fig. 3.27) [95].  Wild-
type S. coelicolor exhibited growth at ≤50 μg ml-1 bacitracin but higher 
concentrations were lethal.  The Δlgt1 mutant (strain BJT1002 - see table 2.2) 
showed slightly lower resistance, with strong growth at ≤30 μg ml-1 and weak 
growth up  to 40 μg ml-1.  The Δlgt2 mutant (BJT1027) showed a higher level of 
resistance than the wild-type, growing strongly  at ≤100 μg ml-1 and growing 
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weakly  at 500 μg ml-1.  In contrast, Δlsp (BJT1001) showed decreased 
resistance compared to the wild-type, only showing strong growth at ≤20 μg ml-1 
and weak growth up to 30 μg ml-1.
3.3.6.2 SDS Sensitivity.
The detergent Sodium Dodecyl Sulphate (SDS) is an anionic surfactant.  It is 
used frequently  in experiments to denature proteins by disrupting their non-
covalent bonds.  As a detergent, SDS also affects lipid-lipid interaction in the 
cell membrane phospholipid-bilayer [96], potentially leading to a weakened cell 
membrane.  Of the three SDS experiments carried out, neither incubating the 
spores for 1 hour in SDS nor overlaying the spores with SDS after 0 hours lead 
to any discernible effect on the strains.  Overlaying the plates after 15 hours 
growth (newly germinated spores) had no effect on the wild-type, Δlgt1 
(BJT1002) or Δlgt2 (BJT1027) strains, each of which was resistant to ≤0.2% 
SDS.  The Δlsp strain (BJT1001) showed strong growth at ≤0.05% SDS and 
weak growth up to 0.1% SDS.  There was no growth at 0.2% SDS.  These 
results suggest that S. coelicolor spores are very resistant to SDS as are newly 
germinated spores under normal conditions but deletion of lsp increases SDS 
sensitivity.
3.3.6.3 Lysozyme sensitivity.
Lysozyme belongs to a family of enzymes known as the 1,4-β-N-
acetylmuramidases which damage Gram-positive bacterial cell walls [97].  This 
enzyme attacks peptidoglycan by hydrolysing a glycosidic bond between N-
acetylmuramic acid and N-acetylglucosamine [98].  The weakening of the cell 
wall means that an affected bacterium is more susceptible to lysis caused by 
turgor pressure.  Lysozyme had an effect on the strains both when overlain after 
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0 hours and 15 hours.  After 0 hours, the wild-type showed confluent growth on 
≤0.5 μg ml-1 and weak growth up to 1.25 μg ml-1.  The Δlgt1 (BJT1002) and 
Δlgt2 (BJT1027) mutants were broadly  similar.  The Δlsp mutant (BJT1001) was 
the most sensitive, showing confluent growth up  to ≤0.3 μg ml-1 and weak 
growth up to 0.75 μg ml-1.  This pattern is changed in the +15 hour overlay 
experiment.  In this case, the wild-type and Δlsp mutant both show higher levels 
of resistance than at 0 hours, with confluent growth at ≤1.0 μg ml-1 and ≤0.4 μg 
ml-1 respectively.  The Δlgt1 mutant shows a similar level of resistance to the 0 
hour overlay, but the Δlgt2 mutant shows considerably lower resistance, with 
confluent growth at ≤0.3 μg ml-1 and weak growth up to 0.75 μg ml-1.
3.3.6.4 Complemented Δlsp strain phenotypes.
As the Δlsp mutant typically displayed enhanced sensitivity to stresses 
compared to the wild-type, the same phenotype assays were carried out using 
the cis and in trans complemented lsp strains (BJT1006 and BJT1007 
respectively).  The resistance of both complemented strains to bacitracin 
increased.  Both showed a similar level of resistance, with confluent growth 
seen at ≤35 μg ml-1 compared to ≤20 μg ml-1 for the Δlsp mutant (BJT1001) and 
≤100 μg ml-1 for the wild-type (M145).  
The Δlsp mutant showed confluent growth on 0.05% SDS when overlain after 
15 hours.  The complemented strains both showed approximately  the same 
level of resistance, with the cis complementation slightly higher at 0.06% and 
the in trans complementation slightly lower at 0.04%.  These results are still far 
lower than the wild-type, which showed confluent growth at the highest level of 
SDS tested, 0.2%.
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The pattern of resistance for the complemented Δlsp strains when stressed by 
lysozyme differed between the 0 hour and 15 hour experiments.  When overlain 
after 0 hours these strains showed levels of resistance closer to the wild-type 
whilst after 15 hours the levels were closer to the Δlsp mutant.  After 0 hours, 
the wild-type showed confluent growth at  ≤0.5 μg ml-1.  This was increased to 
≤0.75 μg ml-1 in both the cis and in trans complementations, the Δlsp mutant 
grew confluently ≤0.3 μg ml-1.  When overlain after 15 hours, the wild-type grew 
confluently to ≤1.25 μg ml-1, whilst both the Δlsp mutant and in trans 
complementation grew to  ≤0.4 μg ml-1.  The cis complementation was even 
lower, only growing confluently to ≤0.3 μg ml-1.
3.3.7 Truncating the N-terminus of Lsp.
As has been shown in figure 3.5, the Lsp protein from S. coelicolor contains an 
elongated N-terminus, when compared to both E. coli and B. subtilis.  Similar 
elongations are also present in the Lsp enzymes of the other actinomycetes, as 
described above.  In order to find out whether this extension is needed for the 
enzyme to function, deletions were made in the coding sequence of lsp in order 
to produce truncated enzymes.  These truncated genes were synthesised by 
Genscript, sub-cloned into pSET152 to form vectors pBT101-105 (table 2.2), 
and introduced into the unmarked Δlsp deletion mutant (BJT1001) in single 
copy, integrating using the ϕC31 attP-int locus, to make strains which were 
identical to the in trans complemented strain (BJT1007), except for the loss of 
some, or all of the N-terminal extension.  In total, four truncations were made, 
with enzymes starting at amino acid 10 (N10), 20 (N20), 30 (N30) and 40 (N40) 
(strains BJT1008-1011).  The first amino acid of the N40 truncation aligns to the 
first amino acid of the E. coli Lsp  (fig. 3.23).  In addition to these truncations, a 
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double point mutant was constructed, where two active site aspartate residues, 
D148 and D177, were change to alanine (D148A/D177A), in order to create an 
inactive enzyme (BJT1012).  These residues are conserved in all genomes 
checked and thought to make up a catalytic dyad forming the active site of the 
protein in B. subtilis (section 3.3.1.2).
BsLsp  ------------------------------------------------MLYYMIALLIIA 12
EcLsp  ---------------------------------------MSQSICSTGLRWLWLVVVVLI 21
ScLsp  VAEAERIIGTPDIPDAAGEGQERPDADPEREQQEQEQAPERTRGKRRVAVLFAVALFAYL 60
                N10       N20       N30       N40 
Figure 3.23.  The N-terminal extensions of Lsp from B. subtilis, E. coli and S. 
coelicolor.  The four truncations are shown, with the amino acid which becomes the 
start of the protein highlighted in red.  The codons for each of these amino acids were 
changed to encode methionine in the truncated forms.
To test if the truncations or the point mutant were able to complement the Δlsp 
mutant, membrane fractions were prepared and immunoblotted with the CseA 
antibody as described in section 3.3.4.2.  The results can be seen in figure 3.24. 
As before, mature CseA is present in the wild-type and complemented strains 
and absent in the Δlsp strain.  The fully processed protein is also present in the 
N10 truncation.  There is a band in the N30 lane, but it is slightly larger than 
those seen in the other lanes.  This would be consistent with an unprocessed 
form of CseA which retains its signal peptide.  The protein is undetectable in the 
N20, N40 and D148A/D177A complementations.  As before, CseA was 
undetectable in cytoplasmic fractions or precipitated supernatant (not shown).
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WT ΔlspFLP N10 N20 N30 N40 DD in trans cis
M145 BJT1001 BJT1008 BJT1009 BJT1010 BJT1011 BJT1012 BJT1007 BJT1006
Figure 3.24.  Membrane fractions from Wild-type, Δlsp, N-truncated Lsps, point mutant 
(DD), cis and in trans complementations.  The band visible represents CseA.  Strain 
names are as indicated.
3.3.8 Lsp specific antibody.
Whilst the results shown in section 3.3.7 demonstrated whether the CseA 
protein was processed correctly or not by the N-truncated Lsp enzymes, the 
absence of detectable lipoprotein neither confirms nor denies the presence of 
the Lsp enzyme itself.  In order to see whether the absence of the model 
lipoprotein CseA was down to the absence of Lsp, an antibody was raised 
against the synthesised peptide KLEHHEPIEIIGDWLRFA, which corresponds to 
residues 72 to 89 in an extracytoplasmic loop of Lsp.  Disappointingly this 
antibody was unable to detect the Lsp protein in S. coelicolor cell extracts of 
membrane fractions.  This also thwarted a plan to visualise potential direct 
interactions between Lgt1/Lgt2 and Lsp using membrane crosslinking.
3.3.9 Complementing an E. coli lsp disruption.
The Lsp  protein is encoded in only  single copy in the majority of bacterial 
species studied, such as B. subtilis [20].  The protein is essential in E. coli, as 
has been shown when the protein is inhibited by the antibiotic globomycin.  As 
has been discussed above, the S. coelicolor lsp gene has been correctly 
identified, and disrupting this gene leads to altered lipoprotein processing.  It 
has also been shown that the N40 truncated Lsp protein is unable to rescue a 
S. coelicolor Δlsp mutant (section 3.3.7).  To further investigate the role the N-
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terminal extension plays in S. coelicolor Lsp, both the full length (FL) protein 
and N40 truncation were tested to see whether they could rescue an E. coli 
Δlsp strain.   Typically, to test whether a potential protein is a true Lsp 
homologue, it is expressed in E. coli to see whether the excess of the enzyme 
leads to an increase in resistance to globomycin.  This approach was not 
chosen here as globomycin is in very short supply worldwide and is not 
commercially available.  Instead, the full length E. coli lsp, FL S. coelicolor lsp 
and the N40 truncation gene were subcloned into the cosmid pBAD24-NdeI 
containing an arabinose inducible promotor, to create vectors pBT107-109 
(table 2.2) and introduced into E. coli strain BW25113 / pIJ790 (see section 
2.4.3).  The E. coli chromosomal copy was disrupted with an apramycin 
cassette whilst the in trans alleles were expressed by the addition of arabinose.
Despite repeated attempts, a knockout of the E. coli lsp gene was not obtained. 
However, apramycin resistant colonies of the strains complemented with the 
N40 or FL S. coelicolor lsp gene were obtained, and an initial PCR using 
primers specific for the apramycin cassette confirmed it was present, as can be 
seen in figure 3.25 below.
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Figure 3.25.  PCR showing the presence of the apr cassette in six potential E. coli 
Δlsp colonies. Lanes 1->3 were complemented with full length S. coelicolor lsp and 
lanes 4->6 were complemented with N40 lsp.  Bands at ~1400 bp represent the apr 
cassette.
Although these results showed that the apramycin cassette was present in both 
the FL and N40 complemented strains, it did not confirm that the E. coli 
chromosomal lsp gene had been disrupted.  Using primers specific to the E. coli 
lsp gene as well as those specific for the apramycin cassette, showed that 
whilst the apramycin cassette is present in each (as before), a band 
representing the E. coli lsp gene is also present, suggesting that the antibiotic 
cassette has gone in to the chromosome in an incorrect location.  Repeated 
attempts produced the same result suggesting that the E. coli lsp gene is very 
difficult to disrupt (fig. 3.26).
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Figure 3.26.  PCR of E. coli genomic DNA showing our inability  to disrupt the E. coli 
lsp gene, despite the presence of the apr cassette.  FL = full length S. coelicolor lsp 
complementation (Lanes 1 + 2).  N40 = truncated S. coelicolor lsp complementation 
(lanes 3 + 4).  Lanes 1 + 3 use the E. coli lsp Test forward/reverse primers.  Lanes 2 + 
4 use apr cassette P1 + P2 primers.  Lane 5 shows the size of the lsp gene in E. coli 
DH5α using the E. coli lsp Test forward/reverse primers.
3.4 Discussion
The data presented in this chapter shows that disrupting the lipoprotein 
biosynthetic pathway in S. coelicolor has a deleterious effect on the overall 
fitness, and phenotype, of the bacterium.  From a macroscopic perspective it is 
obvious that the Δlsp mutant (BJT1001 - see table 2.2) has a number of severe 
growth phenotypes, whilst the Δlgt1 (BJT1002) and Δlgt2 (BJT1027) mutants 
appear quite normal.  This observation is backed up by  both the light and 
scanning electron microscopy, both of which show that Δlsp is retarded in every 
aspect of its growth and development.  This strain frequently overproduced the 
antibiotic actinorhodin, which is often seen as a response to cellular stress [92]. 
At this point it is timely to note that S. coelicolor has a tendency to show random 
growth phenotypes, however time was taken to ensure that the microscopic 
phenotypes described within this chapter were characteristic for the majority  of 
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colonies/cells and for multiple, independently isolated, Δlsp colonies.
Bioinformatic analysis of each of the proteins making up  the S. coelicolor 
lipoprotein biosynthetic pathway reveal that there are a number of differences 
compared to the published and studied enzymes from other bacterial species. 
Typically, once an immature lipoprotein has been exported out of the cell by Sec 
or Tat and is anchored into the cell membrane by its signal sequence, the first 
enzyme to act upon it is Lgt, which adds the diacylglyceryl moiety  to the 
proprotein.  S. coelicolor is unusual in that it contains two homologues of the Lgt 
protein, whereas E. coli, B. subtilis and the selection of actinomycetes chosen 
(fig. 3.2) only have one.  Both of the S. coelicolor Lgt enzymes share a good 
level of similarity (~58%) and both share the His-196 and Tyr-235 residues that 
have been shown to be important for function in E. coli Lgt [17] which suggests 
that they are true Lgt enzymes.  However His-103, which is essential for 
function in E. coli Lgt, is present in B. subtilis, yet absent from S. coelicolor Lgt1 
and Lgt2 (as well as the other actinomycete Lgt enzymes) where it is a 
tryptophan.  The reasons for this are unknown.  Lgt in E. coli is used to transfer 
the lipid moiety  from phosphatidyl glycerol (PG) to the sulphydryl group of the 
immature lipoprotein [12].  Perhaps, given the difference in membrane 
composition between the actinomycetes and E. coli, a different phosholipid is 
used as a substrate by their respective Lgt enzymes, and therefore the amino 
acid substitution is needed. 
In contrast to Lgt, the S. coelicolor Lsp enzyme, which removes the signal 
peptide from the immature lipoprotein contains all the experimentally  verified 
essential residues from another organism, in this case B. subtilis, as do all the 
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other species tested (fig. 3.4).  The S. coelicolor Lsp  shows a low similarity to 
both E. coli and B. subtilis Lsp  (~30%), and the conserved regions I->V 
probably account for a large proportion of this similarity.
The essential amino acids of the final enzyme in the lipoprotein pathway, Lnt, 
have been experimentally verified in E. coli [30].  This enzyme was thought not 
to exist in Gram-positive bacteria, but has recently  been identified in M. 
smegmatis and M. tuberculosis [38].  The M. smegmatis enzyme contains the 
three essential amino acids thought to form the catalytic region in E. coli [30], 
but only contains two of the other four essential E. coli residues (fig. 3.6).  Given 
the lack of an outer membrane, the reason S. coelicolor contains two potential 
Lnt homologues is unclear, especially  as at they  appear, at first glance, to be 
functionally redundant.  However, whilst S. coelicolor Lnt1 and Lnt2 share a low 
level of similarity (26%) to each other, the catalytic triad found in E. coli and M. 
smegmatis Lnt enzymes is present in both S. coelicolor homologues.  Lnt1 
shares three out of the other four essential E. coli residues, whist Lnt2 has two. 
Sadly, it was not possible to see whether either, or both of these proteins are 
able to N-acylate a lipoprotein, or whether their deletion alters the way 
lipoproteins are processed in S. coelicolor as the genes could not be disrupted 
in S. coelicolor (D. Widdick, unpublished). 
One of the more striking aspects of the S. coelicolor proteins, is that both the 
Lgt enzymes, and Lsp  contain extended C, or N-termini respectively, which are 
absent from E. coli.  The functions of these extensions is unclear and will be 
discussed below.
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As mentioned above, disrupting the lgt genes in S. coelicolor had very little 
effect on the bacterium, whilst disrupting lsp led to a highly  pleiotropic 
phenotype.  In order to try to explain why this might be the case, it is necessary 
to again consider the pathway by which lipoproteins are created.  The loss of 
Lgt1 or Lgt2 had no effect on the processing of either of the model lipoproteins 
tested (CseA, SCO3484), both of which were detected in membrane fractions. 
Neither mutant had a detectable growth phenotype, with each strain looking 
comparable to the wild-type under both light and electron microscopy.  Given 
that both of the lipoproteins tested are the same size as the wild-type protein it 
seems likely  that they  are correctly  lipidated (fig. 3.15 and 3.16).  In B. subtilis it 
has been shown that the signal sequence of an unlipidated lipoprotein is 
enough to anchor it to the cytoplasmic membrane [99].  If this were the case in 
either of the Δlgt mutants however, you would expect a size shift in the band 
representing the immature lipoprotein as it would have an increased mass due 
to the presence of the signal sequence.  This is clearly not the case in either of 
the mutants tested.
A likely explanation for this lack of phenotype and the correct lipoprotein 
processing observed in both single mutants is that the the two Lgt homologues 
in S. coelicolor are complementing each other.  In the absence of Lgt1 the 
lipoproteins are lipidated by Lgt2, and vice versa.  Both Lgt enzymes are able to 
partially complement a S. scabies Δlgt mutant (BJT1040) (Chapter 4), which is 
good evidence that both are true Lgt homologues.  However, these results raise 
several questions.  Firstly, is the lipidation of of proteins so important to the 
viability of a S. coelicolor cell that it needs two copies of the lgt gene, in case 
one is lost?  The lgt2 (SCO7822) gene is found in one of the arms of the 
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chromosome, which typically contain non-essential genes most likely acquired 
through HGT [66].  Conversely, lgt1 is found in the core-region of the 
chromosome, which contains the essential genes.  Regardless of the position of 
the genes, it appears that both are retained by S. coelicolor suggesting that the 
lipidation step  of the lipoprotein biosynthetic pathway is of great importance to 
the bacterium.  The second question that is unanswered, is whether or not each 
Lgt enzyme has a specific ʻsub-setʼ of lipoproteins to lipidate.  S. coelicolor has 
an estimated 223 lipoproteins, and to test the processing of each one in both 
the Δlgt1 and Δlgt2 mutants (BJT1002 and BJT1027 repectively) would be an 
arduous task.  Again though, this scenario seems unlikely, given that of the two 
lipoproteins tested neither showed a difference in either the Δlgt1 or the Δlgt2 
mutant.  If both were from the Lgt1 subset, you would expect a difference in the 
Lgt2 membrane and vice versa.  Also, 2 dimensional gel electrophoresis carried 
out by D. Widdick shows that there is little difference between the proteomes of 
the membranes of wild-type and Δlgt1/Δlgt2 mutants implying that the single 
mutants are complementing one another [82].  Our hypothesis that one enzyme 
caters to Sec translocated lipoproteins and the other caters to Tat translocated 
lipoproteins seems unlikely.  CseA is Sec dependent, whilst SCO3484 is Tat 
dependent and both were were processed correctly in the Δlgt1 and Δlgt2 
mutant.  Given these results, it appears that, for reasons unknown, S. coelicolor 
has two functioning copies of the Lgt protein.
What is also unknown based upon these results, is whether lipidation by Lgt is a 
prerequisite for the action of Lsp, as it is in the majority of bacteria tested to 
date [14], with the exception of L. monocytogenes [24].  In order to find out if this 
is the case in S. coelicolor a double Lgt mutant is needed.  Despite numerous 
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attempts, the construction of this mutant proved impossible.  If the order of 
enzyme activity is tightly controlled, then the loss of lipidation will mean that Lsp 
is unable to function, leaving the immature lipoprotein bound to the membrane 
by its signal sequence with a detectable shift in size in the lipoproteins tested, 
as mentioned above.  If the processing pathway is not tightly controlled then it 
might be expected that the lipoproteins tested would be undetectable in the 
membrane fraction of a Δlgt1 lgt2 mutant as Lsp  would act on the proprotein to 
cleave its signal sequence leading to its release into the extracellular medium 
as has been shown in L. monocytogenes [24].  Alternatively, the loss of 
lipidation may be fatal, which would explain the inability  to construct the double 
mutant.  An inability to construct a double lgt mutant in S. coelicolor suggests 
that Lgt function is essential in this bacterium.
The loss of Lsp  had a large effect on the growth of S. coelicolor presumably due 
to the loss of lipoprotein processing.  This is immediately obvious simply looking 
at the colonies by eye, without the need for magnification.  Compared to the 
wild-type (M145) the ΔlspFLP (BJT1001) colonies are small, and overproduce 
actinorhodin.  Under the light microscope the severity  of the growth retardation 
is even clearer.  The colonies are a fraction of the size of the wild-type, and are 
lacking any depth, appearing to grow almost flush to the surface of the growth 
media (figs. 3.12 and 3.13).  They also sporulate poorly, and the shortage of 
aerial hyphae and spore chains can be observed when a colony is viewed 
under SEM (fig. 3.14).
The two lipoproteins tested were processed in different ways in the Δlsp mutant. 
SCO3484 was present in the cell membrane fraction (fig. 3.16) but was seen at 
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a larger size than in the wild-type, suggesting that it still contained an uncleaved 
signal peptide.  CseA on the other hand, was completely undetectable in both 
the cytoplasmic and membrane fractions as well as the precipitated 
supernatant.  The reasons for this difference are unknown, but it has been 
noted that the same lipoprotein can be processed in different ways, even in the 
same mutant [11].  Why there is this difference in processing is difficult to 
explain.  A large amount of unprocessed lipoproteins anchored in the cell 
membrane by both their signal sequence and lipid moiety is likely to a 
detrimental effect on the integrity of the membrane.  These accumulated 
proteins are likely to be broken down by extra-cellular proteases.  If this were 
happening in the S. coelicolor Δlsp mutant (BJT1001) it could explain why no 
CseA was detectable.  However as SCO3484 is present, then not all incorrectly 
anchored lipoproteins are proteolysed, or at least not all at the same rate.
Even though the lipoprotein biosynthetic pathway  is non-essential in the Gram-
positive bacteria tested to date, a number of essential lipoproteins do exist, 
such as PrsA in B. subtilis, required for the correct folding of translocated 
proteins [49], or PrtM and OppA from Lactococcus lactis [52].  The retention of 
one lipoprotein (SCO3484) and the loss of another (CseA) may indicate that 
there are a subset of lipoproteins that are essential or more important to the 
viability of the bacterium.  For example, the S. coelicolor lipoprotein SCO1639 is 
involved in the correct folding of translocated proteins and its homologue found 
in Streptomyces anulatus (formerly S. chrysomallus) could not be deleted [100], 
suggesting that essential lipoproteins probably do exist in Streptomyces, 
although SCO1639 can be disrupted in S. coelicolor [82].
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If the absence of CseA is representative of a number of lipoproteins in the Δlsp 
mutant (BJT1001) it might explain the dramatic phenotypes seen. 
Complementing the mutant both cis and in trans (BJT1006 and BJT1007 
respectively) restored the correct processing of CseA and it was detectable in 
the membrane fractions of each at the same size as in the wild-type (fig. 3.24). 
The in trans complementation also lead to the correct processing of SCO3484, 
which was detectable at the same size as in the wild-type, not the increased 
size seen in the Δlsp mutant, suggesting that the signal sequence is again 
being cleaved (fig. 3.16).  Two dimensional electrophoresis of lipoproteins from 
the wild-type, Δlsp and complemented strains performed by  D. Widdick 
confirms that whilst there is a large subset of lipoproteins lost from the Δlsp 
membrane when compared to the wild-type, they are restored in both the 
complemented strains [82]. 
Whilst the processing of lipoproteins was restored by complementing the loss of 
Lsp, the retarded growth phenotype remained [82].  The cis complementation 
(BJT1006) seems to produce a higher number of spores than the in trans 
complementation (BJT1007) although both show no increase in colony size 
compared to the Δlsp mutant, and colonies of both complemented strains 
remain much smaller than the wild-type (fig. 3.19).  Both complemented strains 
also retain the characteristic flat colony phenotype shown by the Δlsp mutant 
(fig. 3.20).  Surprising differences between the two types of complementations 
were seen when viewed under SEM (figs. 3.21 and 3.22).  After 5 nights of 
growth, the wild-type, Δlsp (BJT1001) and complemented strains (BJT1006 and 
BJT1007) looked quite similar, but after only 2 nights, the cis strain closely 
resembled the wild-type, whilst the in trans strain was much closer to the Δlsp 
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mutant, showing that replacing Lsp  in different ways has lead to different 
results.  This, and the inability to restore a wild-type phenotype in a 
complemented strain, suggests that the growth defects seen in the Δlsp mutant 
are not solely  down to the loss of Lsp. Deletion of lsp appears to result in 
spontaneous secondary mutations that may suppress an otherwise lethal 
phenotype.  If lipoprotein processing is essential in S. coelicolor this might also 
explain why it encodes two copies of Lgt and why a double lgt mutant could not 
be isolated in this study.
This idea is further backed up by the stress tests carried out.  Figure 3.27 below 
shows the actions of several antibiotics that effect the cell envelope in various 
ways.  The majority of the antibiotics tested had no effect on any of the S. 
coelicolor strains (data not shown).  For example, S. coelicolor has a natural 
resistance to the β-lactam group  of antibiotics due to its constitutive expression 
of β-lactamases [101].  S. coelicolor also contains a gene cluster which confers 
resistance to the glycopeptide antibiotic vancomycin, likely transferred by HGT 
from other members of the actinomycetes [93].
The most drastic effect was seen with bacitracin.  Whilst the wild-type and Δlgt2 
mutant showed good growth at high concentrations of bacitracin (100 and 200 
μg/ml respectively), the Δlsp mutant is much more sensitive, only showing 
strong growth at 20 μg/ml.  The Δlgt1 strain was in between showing strong 
growth up to 30 μg/ml.  As has been mentioned, bacitracin, a cyclic 
dodecapeptide produced by Bacillus species, inhibits cell wall biosynthesis in 
Gram-Positive bacteria by binding to the lipid carrier undecaprenyl 
pyrophospate (UP), preventing it from being dephosphoylated by membrane 
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associated pyrophosphatases [94, 95].  Preventing this dephosphorylation 
means that the UP cannot be recycled, reducing the amount available for 
transport of the newly synthesised peptidoglycan precursors, leading to the 
cessation of cell wall synthesis and eventually  cell lysis (fig. 3.27) [103]. 
Currently, there are four known resistance mechanisms to bacitracin: removal of 
the antibiotic by an ABC transporter, overexpression of UP, expression of 
alternative UP phosphatase or exopolysaccaride production [95].
Figure 3.27. Diagram showing the effects of a variety of antibiotics on cell wall 
biosynthesis.  From [102].
Both the detergent SDS, and the muramidase lysozyme, had a severe effect on 
the Δlsp mutant.  When overlain after 15 hours with SDS the wild-type and Δlgt 
mutants all survived the highest % tested (0.2%), whilst the Δlsp mutant grew 
confluently at a quarter of this.  The spores of all of the strains were impervious 
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to SDS and the results show that the Δlsp mutant has a compromised cell 
membrane. 
The lysozyme results are curious.  When overlain after 0 hours, the Δlsp mutant 
(BJT1001) is more susceptible than the other strains which are all resistant to 
the same concentration.  When overlain over 15 hours however, the results are 
different, with all the mutants more susceptible than the wild-type.  The 
lysozyme in the 0 hour overlay affects the germinating spores, and as we have 
seen the growth of the Δlsp strain is much more feeble than the others, 
suggesting that the newly emerging germling cell walls may be more 
susceptible to cell wall damage than the other strains.  When the strains are 
overlain after 15 hours the resistance in the Δlsp strain increases relative to the 
0 hour overlay, either because; there is a higher density  of cells, and therefore 
there is a much larger amount of cell wall present raising the resistance to the 
lysozyme or the mycelial cell walls are simply  more resistant than the germling 
cell walls.  Quite why the resistance of the Δlgt2 mutant drops is unknown, 
although reproducible.
As has been discussed, complementing the Δlsp strain leads to the resumption 
of correct lipoprotein processing, but shows mixed results in the phenotype 
assay tests.  Both the cis and in trans complementations have a higher 
resistance to bacitracin than the Δlsp mutant, although they do not match the 
wild-type levels.   This is also true of the 0 hour Lysozyme overlay. Conversely 
neither complementation shows an increased resistance to SDS, nor 15 hour 
lysozyme overlay.
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Recent work has uncovered a new type of enzyme that may shed some light on 
why the Δlsp mutant is so damaged, and why complementing the mutant 
restores lipoprotein processing, but only  some of its ability to resist cell 
envelope stress. 
Typically, in the final stage of cell wall synthesis, glycan chains are polymerised 
by transglycosylation and transpeptidation, in which peptide side chains are 
cross-linked to form the rigid cell wall peptidoglycan (fig. 3.28) [104].  The 
enzymes that facilitate this reaction are transglycosylases/transpeptidases, also 
know as Penicillin Binding Proteins (PBPs).  The peptidoglycan is crosslinked 
by transpeptidases between Ala4 and Lys3 leading to a D,D (also known as 3,4) 
transpeptidation.  PBPs are targets for the β-lactam antibiotics which inhibit cell 
wall synthesis by acting as analogues of the D-Ala-D-Ala portion of 
peptidoglycan, covalently altering the transpeptidase active site [95] and 
preventing peptidoglycan cross-linking, leading to a mechanically weakened cell 
wall.
Figure 3.28. The transpeptidation reaction.  From [105].
An enzyme domain known as the YkuD  domain (formerly  known as the ErfK/
YbiS/YcfS/YhnG domain) is ubiquitous amongst prokaryotes and appears to be 
involved in alternative cross-linking of peptidoglycan and in attachment of 
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proteins to the cell wall.  The YkuD family can be recognised by the conserved 
amino acid sequence ΦGΦHGTX10(S/T)XGCΦR(M/L) (where Φ is a 
hydrophobic amino acid and X is any amino acid) [106].  The first protein 
containing this domain whose function was elucidated is L,D transpeptidase 
(Ldtfm) from Enterococcus faecium [107].  This enzyme catalyses the 
modification of the bacterial peptidoglycan, acting as an alternate 
transpeptidase cross-linking peptidoglycan between Lys3 and Lys3.  This leads 
to L,D  (also known as 3,3) cross-links, rather than the D,D links created by 
PBPs (fig. 3.29).
Figure 3.29. Comparison of the two different forms of transpeptidation:  D,D-
transpeptidation, facilitated by PBPs, and L,D-transpeptidation, as carried out by Ldt 
enzymes containing a YkuD domain.  From [108].
In E. faecium Ldt was shown to confer resistance to β-lactam antibiotics as the 
protein has no affinity  for these compounds. Ldt-catalysed remodelling of the 
peptidoglycan is an alternative pathway that negates the use of PBPs which are 
often sensitive to β-lactam antibiotics.  Further studies have revealed that Ldt 
proteins exist in other bacterial species, including E. coli [109] and B. subtilis 
[108].  During stationary phase, M. tuberculosis contains up to 80% L,D cross-
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links in its peptidoglycan [110] and recent work has identified the protein LdtMt2. 
Deleting the gene encoding this protein lead to mutants which were small and 
smooth and had stunted aerial growth, despite the lack of difference in the cell 
wall constituents [111].  Streptomyces albus G has been shown to contain L,D 
cross-links, but only as a minor percentage of the overall cross-linking in the cell 
wall [112].
These findings are important to this work as homology searching has shown 
that S. coelicolor possesses six lipoproteins containing the YkuD domain 
(appendix 1).  All are of unknown function, although one of the proteins 
(SCO4868) also contains a peptidoglycan binding domain.  Assuming they are 
Ldt enzymes, the potential disruption of the processing of these lipoproteins in 
the Δlsp mutant, as seen with CseA, is likely to have a detrimental effect on the 
cell wall and could explain the extreme sensitivity of the Δlsp mutant to 
bacitracin.  As discussed above, bacitracin stops the recycling of UP and 
therefore prevents any new peptidoglycan precursors being transported out of 
the cell, ceasing the formation of any new D,D cross-linked peptidoglycan.  The 
L,D transpeptidases are the only group of enzymes capable of modifying the 
cell wall in the absence of new peptidoglycan precursors [110], and the absence 
of these lipoproteins in the Δlsp mutant would suggest that, in the presence of 
bacitracin, no peptidoglycan cross-links of any kind are being made, leading to 
substantial weakening of the cell wall.  The small flat growth phenotype seen in 
the Δlsp mutant is also analogous to the growth phenotype seen in the M. 
tuberculosis strain lacking LdtMt2.  As has been shown, complementing the Δlsp 
mutant restores the correct processing of CseA and SCO3484.  It also raises 
the resistance of the complemented strains to bacitracin, suggesting that the 
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YkuD domain containing lipoproteins have also been restored and that L,D 
peptidoglycan cross-linking has resumed, although these lipoproteins were not 
identified in the membrane proteome of wild-type or complemented Δlsp 
mutants, and the colonies retain their flat phenotype.
Whilst the Ldt homologues in Gram-positive bacteria are involved in remodelling 
the cell wall, a homologue in the Gram-negative E. coli has been shown to have 
a separate function, catalysing the cross-linking of Braunʼs Lipoprotein (Lpp) to 
the periplasmic peptidoglycan. The Ldt enzyme anchors the C-terminus of the 
Lpp to the peptidoglycan [109], while the N-terminus is secured in the outer 
membrane by the lipid moiety.  If any of the S. coelicolor YkuD containing 
lipoproteins are involved with linking lipoproteins anchored in the cytoplasmic 
membrane to the cell wall peptidoglycan, then the loss of anchoring may also 
contribute to the weakened cell wall of the Δlsp strain.
Restoring the Lsp enzyme restores resistance to bacitracin, as well as 
resistance to  lysozyme overlay after 0 hours, but not resistance to 15 hour SDS 
or lysozyme overlay.  This suggests that the mycelia immediately post-
germination are as healthy as the wild-type, but later develop  flaws in their cell 
envelope.  
The inability  of the complemented strains to restore both the growth phenotype 
of the wild-type and the integrity of the cell envelope, but to restore the correct 
processing of lipoproteins, suggests that at least one secondary mutation has 
arisen in the S. coelicolor genome.  If this has occurred spontaneously  to 
compensate for the loss of correct lipoprotein processing it suggests that lsp is 
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an essential gene in S. coelicolor which would prove unique amongst the Gram-
positive bacteria tested to date.  The difficulty  in disrupting the lsp gene 
suggests that it is very  important to S. coelicolor.  The genome of this mutant 
will have to be sequenced, along with that of the wild-type, to ascertain where 
the potential mutations may have arisen.
As has been mentioned previously, the Lgt enzymes in S. coelicolor both 
contain an extended C-terminal whilst the Lsp  protein contains an extended N-
terminus.  These extensions are not present in the Gram-negatives nor the low 
GC Gram-positives.  In order to assess the roles that these extensions perform, 
truncations were made of both the Lsp and the Lgt proteins.  Given that both 
extensions are cytoplasmic, and absent from E. coli, it was thought unlikely that 
they performed an enzymatic function, but more likely a structural one. 
Removing the C-terminal extension from either of the Lgt enzymes had no 
effect on the processing of CseA (data not shown).  This result is not 
unexpected, given that deletion of either protein in its entirety has no effect on 
lipoprotein processing, as discussed.  To ascertain whether the N-terminal 
extension of Lsp  was necessary for enzyme activity  a series of truncation 
mutants were created, and the results are shown in figure 3.24.  The first 10 
amino acids of Lsp appear to be unnecessary  for function as properly 
processed CseA is detectable.  Confusingly, deleting the first 20 amino acids 
renders Lsp inactive, with CseA undetectable, yet removing a further 10 
residues allows CseA to be detected again, albeit at a larger size, presumably 
with its signal sequence still attached. Truncating the N-terminus to the same 
size as E. coli also leads to the loss of CseA. 
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These results suggest that the N-terminal extension of Lsp is required for 
enzyme function.  What cannot be proved however, is whether or not the 
extension is required for enzyme stability.  The inactivity of the anti-Lsp antibody 
means we were unable to show whether the enzyme is present in situ but 
functionally inactive in the N20 and N40 truncation mutants or whether it is not 
expressed. The lack of an anti-Lsp antibody also meant that the planned 
experiment to directly  visualise Lgt1/Lgt2-Lsp  interaction was not possible.  The 
plan was to chemically link proteins in the cell membrane fraction, then probe 
the fraction with the anti-Lsp antibody.  If there was a direct Lgt-Lsp  interaction, 
the band present would be larger than the size of the Lsp protein.  This could 
have been carried out in both the Δlgt1 and Δlgt2 strain to see whether either, 
or both proteins interacted with Lsp.  This interaction seems plausible, as 
passive diffusion of an immature lipoprotein between processing enzymes 
seems energetically wasteful.  Attempts to fuse Lgt1, Lgt2 and Lsp  to the 
fluorescent reporter protein eGFP, to visualise their position in the bacterial 
hyphae also proved fruitless, presumably  due to the low level of their production 
(data not shown).  It was postulated that these proteins might be localised to the 
hyphal tip, given that this is where the Tat translocation machinery is located (D. 
Widdick and T. Palmer unpublished).
The D148A/D177A (DD) point mutant was created to see whether the loss of 
Lsp  acts as a ʻmaster switchʼ, halting the transcription/translation of non-
essential lipoproteins, to prevent the cell membrane being damaged by having 
too many embedded signal sequences.  The thought was that the presence of 
the inactive DD enzyme in the cell membrane might mean that the switch 
remained ʻonʼ and a higher molecular weight band comprising of CseA with its 
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intact signal peptide would be detectable.  This does not appear to be the case 
as CseA is clearly  not detectable in the membrane although the lack the anti-
Lsp  antibody means we were unable to show whether the enzyme had been 
expressed or not. 
In summary, the work in this chapter describes the lipoprotein biosynthetic 
pathway in the Gram-positive bacterium S. coelicolor.  This pathway is unusual 
amongst bacteria, as it encodes two Lgt homologues, and two potential Lnt 
homologues.  It appears that the Lgt proteins are functionally redundant 
because both seem capable of lipidating a lipoprotein.  This work suggests, but 
does not definitively prove, that the lsp enzyme is essential in S. coelicolor. 
Deleting lsp does prove seriously  detrimental to the bacterium, altering both the 
processing of lipoproteins and the growth of the cell.  These data suggest that 
Lsp  is an essential enzyme in S. coelicolor but the bacterium has gained one or 
more spontaneous suppressor mutations to rescue the strain.  Also the inability 
to isolate a double lgt mutant suggests that the lipidation step of the lipoprotein 
biosynthetic pathway is essential for survival.  Future work will be aimed at 
mapping these suppressor mutations and this work is ongoing.  Deletion strains 
of each of the six YkuD lipoproteins will also have to be made to see whether 
they contribute to the remodelling of S. coelicolor peptidoglycan and lead to any 
of the growth phenotype seen in the lsp deletion strain.
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Chapter 4 - The lipoprotein biosynthetic pathway of S. scabies.
4.1 Introduction
The previous chapter investigated the lipoprotein biosynthetic pathway in the 
model streptomycete S. coelicolor.  The work showed strong evidence as to the 
essentiality of the enzyme Lsp, but left some unanswered questions, notably  as 
to the phenotype of a mutant lacking Lgt, and the role played by the Lnt 
homologues encoded by  streptomycete genomes.  This chapter attempts to 
rectify this by extending the study of the same pathway to the plant pathogenic 
bacteria S. scabies.  
Whilst the majority  of well studied pathogenic bacteria are Gram-negative, the 
Gram-positive actinomycetes do include a number of animal pathogens (e.g. 
Rhodococcus equi, M. tuberculosis) and plant pathogens (e.g. Leifsonia xyli, 
Clavibacter michiganensis) [113]. S. scabies is a plant pathogen, predominantly 
of potatoes (Solanum tuberosum).  S. scabies is one of only  a few characterised 
pathogenic Streptomyces species and has been identified in Europe, Asia, 
Africa as well as North and South America [74].  The main phenotype of an 
infected potato plant is the presence of lesions or scabs on the surface of the 
potato tuber (fig. 4.1).  These scabs are usually based on the surface of the 
plant and have a round appearance but can overlap to cover a significant 
proportion of the surface of the tuber [67].  These lesions are often only 
identified at the time of harvesting [74] reducing the marketing value of the 
potato.  As a direct result this disease is of great economic importance to 
farmers worldwide.
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Figure 4.1. Typical symptoms of a scabies infected potato [67].
Like S. coelicolor, S. scabies is a soil dwelling saprophytic bacterium, and has a 
very  similar developmental cycle.  However S. scabies has gained a set of 
genes which has enabled it to colonise a variety of plants.  Whilst the bacteria 
usually infects tap root crops such as potato or radish, the bacterium appears to 
be neither host, nor tissue, specific and will infect seedlings of 
monocotyledonous or dicotyledonous plants [67].  Other plant pathogens, such 
as members of the Xanthomonas or the Pseudomonas genera, attack the 
leaves or stems of plants.  There is an advantage in doing this, as these 
structures contain an abundance of natural openings (such as the stomata) 
which the invading pathogen can utilise.  In contrast S. scabies, as a soil 
dwelling bacterium, infects the roots or tubers of plants and causes scabs on 
the latter.  These plant structures have a lower amount of openings [77], and the 
bacterium has developed a specialised way of entering the plant.  The main 
weapons for the pathogenicity of S. scabies are two compounds, thaxtomin A, 
and Nec1.
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4.1.1 The S. scabies pathogenicity island.
Bacterial pathogens have a very specialised niche, and the ability to cause 
disease is a highly evolved phenotype.  The genes responsible for this 
phenotype can be moved between bacteria, either individually  or as a group, 
with the ability  to utilise another source of nutrients potentially conferring extra 
fitness upon the donor strain [114].  Virulence genes are often arranged in a 
bacterial genome in a discrete cluster, known as a pathogenicity island (PAI). 
Pathogenicity islands have been discovered in a wide variety of Gram-positive 
pathogens including Staphylococcus aureus and Bacillus anthracis. Given their 
ability  to move from one species to another, the genetic background of a PAI 
often differs from the species of bacteria it is found in and the G+C content of a 
PAI is frequently different from the genome surrounding it [75].  The movement 
of PAIs from one species to another is often described as ʻHorizontal Gene 
Transferʼ, but in the strictest sense, it should be described as ʻLateral Gene 
Transferʼ as the transfer is intergenetic, rather than interdomain [115].
S. scabies has acquired a set of genes which has allowed it to become a very 
successful plant pathogen. These genes are arranged into a PAI, which at 325 
kb is currently the largest known bacterial PAI.  At 54%, the G+C content of the 
PAI is considerably lower than the rest of the S. scabies genome, which is 
71.45% [76] (www.sanger.ac.uk/projects/S_scabies).  The PAI contains multiple 
genes responsible for pathogenicity, including those needed for the biosynthesis 
of thaxtomin A and the nec1 gene, which has the lowest G+C content of any 
currently sequenced streptomycete gene [113].  The DNA in the areas around 
these genes contains multiple transposons, and insertion elements (IS).  This is 
a typical characteristic of a PAI, as are the presence of truncated ORFs [77], 
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presumably a relic of the transfer of genes from one species to another.
S. scabies is related to the other scab  forming streptomycetes, S. turgidiscabies 
and S. acidscabies but the PAI responsible for the disease phenotype was 
initially passed from S. scabies to the other varieties [76].  These genes offered 
the recipients a selective advantage and were maintained in the newer 
pathogens.  Simply moving the PAI from one species of streptomycete to 
another does not confer the ability to infect plants however.  S. coelicolor cannot 
be made a pathogen simply by artificially introducing the PAI from S. 
turgidiscabies [76].  The reasons for this are unclear, but what is known is that 
the PAI integrates into an 11bp region of the S. coelicolor gene bacA 
(SCO1326), which shows similarity  to an E. coli undecaprenyl pyrophosphate 
phosphatase, a gene involved in resistance to the antibiotic bacitracin.  The 
insertion of the PAI does not affect the resistance of S. coelicolor to bacitracin. 
The DNA flanking bacA, in S. coelicolor has a low G+C content, suggesting that 
this site may have been used for lateral gene transfer previously [67].  Whilst it 
may be impossible to artificially ʻweaponiseʼ S. coelicolor, this is not true of all 
Streptomyces species.  Transfer of the S. turgidiscabies PAI into S. 
diastatochromogenes allowed the recipient to colonise potato tubers [67].  The 
reasons for the selectivity of recipient strains is unclear.  As mentioned earlier, 
there are few pathogenic streptomycetes and it may be that there is some 
underlying genetic background that prevents most species from accepting, or 
retaining, a PAI.  Perhaps another element is needed in order to activate the 
pathogenicity  genes, it has been suggested that perhaps some PAI need 
concomitant ʻmetabolic islandsʼ (MAIs) for optimal pathogen fitness when 
invading a host [115].   These may be absent from one recipient strain, but 
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present in another.
4.1.2. Thaxtomin A.
The most well described virulence factor from S. scabies  is thaxtomin A.  This 
molecule is a nitrated dipeptide phytotoxin, capable of necrosing excised potato 
tissue and causing scabs on immature potatoes [67].  Thaxtomin A is produced 
by S. scabies, S. turgidiscabies and S. acidscabies, with other variations 
produced by other Streptomycetes (e.g. thaxtomin C, produced by S. 
ipomoeae) and is the primary pathogenicity determinant in Streptomyces [116]. 
Thaxtomin A appears to have a novel mechanism of action, whereby it inhibits 
cellulose biosynthesis and induces hypertrophy in plant cells [114] and it can be 
purified from both infected potatoes and growth media, with nanomolar 
concentrations able to induce irregular, binucleate, cells in onion root tips [67]. 
As a virulence factor, thaxtomin A exhibits no antimicrobial activity and is purely 
plant specific [113].  This result suggests that it may be involved in cytokinesis, 
and it is tempting to think that this inhibition of cell wall synthesis would make 
cells weaker, and therefore more susceptible to the invading S. scabies  [77].
The pathway for the production of thaxtomin A requires multiple genes, and is 
summarised in figure 4.2, it requires conserved non-ribosomal peptidase 
synthases, a P450 monooxygenase and Nitric Oxide synthase (NOS) genes 
[113].  Expression of these genes is regulated by TxtR a member of the AraC/
XylS family  of regulators.  TxtR binds a disaccharide, cellubiose, which is a 
component of cellulose.  Disruption of the txtR gene leads to a cessation of 
thaxtomin A production.  However, as well as cellubiose, the  plant polymer 
suberin is also required to induce thaxtomin production [117].  
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Figure  4.2. a) The biosynthetic pathway  for the production of thaxtomin A.  b) The txt 
gene cluster.  From [113].
The conserved non-ribosomal peptidase synthases (TxtA and TxtB) are 
required for production of the N-methylated cyclic peptide backbone of the 
molecule, whilst post-cyclisation  hydroxylation steps are carried out by the 
P450 monooxygenase (TxtC) [113].  Perhaps the most interesting part of the 
pathway is related to the nos gene. Nitric oxide (NO) is an intracellular signalling 
molecule in mammals, involved in a variety of situations, including regulation of 
blood pressure and the immune system [118].  Recently  NOS-like proteins have 
been discovered in several Gram-positive bacteria, including B. subtilis, that 
show homology to the mammalian NOS proteins [119].  The function of these 
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bacterial NOS (bNOS) proteins is unknown, as unlike S. scabies they do not 
produce thaxtomin [113].  In mammals NO is produced by the oxidation of L-
arginine to L-citrulline and NO, via an enzyme bound intermediate, catalysed by 
three isoenzymes [118, 119].  Like the NOS proteins from other bacteria,  S. 
scabies share the same key residues as those found in the mammalian 
enzymes and, typical of bacterial NOS, they lack the mammalian N-terminal 
Zn2+ and carboxy-terminal flavoprotein reductase domains.  However, unlike 
other bacteria the S. scabies bNOS has an elongated N-terminus [118].  The 
nos gene in S. scabies is necessary for thaxtomin A production, as it is in the 
other scab causing Streptomyces species, as they are highly  conserved and 
their deletion results in a drastic drop in thaxtomin A production and a loss of 
virulence [118].
4.1.3 Nec1
Alongside thaxtomin, Nec1 is the other significant virulence factor found in S. 
scabies.  As has been previously mentioned, the nec1 gene has a particularly 
low G+C content, and unusually, although it is conserved amongst scab causing 
bacteria, it shows no homology to any other genes or gene products currently 
sequenced [75].  Thus, it can be thought of as a novel virulence factor [67]. 
Usefully, as nec1 is unique amongst the scab causing streptomycetes, it can be 
used as a marker for the rapid detection of S. scabies and related species by 
conventional or real-time PCR, regardless of whether scab  symptoms are 
present on a potato or not [114].  The Nec1 protein is secreted, typically  during 
the early log phase, after approximately 20 hours [67, 75].  Thaxtomin is 
produced after approximately  48 hours, suggesting that Nec1 is involved with 
early interaction with the plant to be colonised.  Thaxtomin production is 
148
unaffected by Nec1 production [76], but it does appear that a combination of the 
two is required for a pathogen to be truly effective.  Arabidopsis thaliana plants 
infected with a Δnec1 strain of S. turgidiscabies, show mild symptoms of root 
damage, but recover, whilst wild-type infected strains invariably  die [75].  The 
reasons for the need for the combination of the two virulence factors is unclear. 
Certainly the gap between their secretion is likely to be important, and it may be 
that Nec1 has a role in suppressing plant cell defences.  Thaxtomin produces a 
rapid (within one minute of inoculation) Ca2+ influx , followed by a net efflux of 
H+ in root cells, part of the plant cell defence [67], potentially Nec1 suppresses 
the cell defences induced by the acidification of the cell wall.
4.1.4. Mechanisms of S. scabies infection
Whilst the tools used by S. scabies to infect potatoes are known and (at least 
partially) understood, the exact method by which the pathogen interacts with its 
host are not.  As mentioned earlier, root systems in plants offer unique 
challenges for invading pathogens not seen in other plant structures, mainly 
due to their lack of natural openings, such as the multitudinous stomata found in 
leaves [77].  However as a place to live, the soil does offer some distinct 
advantages when compared to a leaf, as it has a relatively stable temperature 
day and night, and young roots are an excellent source of nutrients  [77].
When S. scabies hyphae come into contact with a potato, specialised 
mechanisms must be employed by the bacteria in order to penetrate the tuber. 
S. ipomoea, a pathogen of sweet potato (Ipomoea batatas), appears to grow 
specialised hyphae that branch off directly into the sweet potato.  These lateral 
hyphae are able to both pierce, and grow within, the plant cell wall [78].  More 
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recent work has showed the same structures in S. scabies growing on potato 
tubers (fig. 4.3) [77].  There is some suggestion that there is degradation of the 
cell wall where these hyphae penetrate, which would presumably  be enzymatic 
[78].   It appears that this method of infection differs from that of fungal plant 
pathogens, as there are no appressoria or infection cushions to be seen.
Figure 4.3.  SEM image of S. scabies hyphae growing on a potato tuber.  Infection 
hyphae are shown penetrating the surface of the tubers (white arrows).  Scale bar = 
2μm. From [77].
Whatever the mechanism is for breaching the host cell, it is clear that S. scabies 
does significant damage to the root system of the potato plant.  A  recent paper 
has used Computed Tomograph (CT) scanning to investigate the damage 
caused by scabies to potato plant roots in a non-invasive way, in situ.  The 
results of this study showed that a potato plant growing in S. scabies infected 
sand had a significantly less complex root system than a control plant after four 
weeks of growth, and the growth of the infected plant was reduced after this 
time [74].
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Once the bacterium is growing within the host potato, the next stage in the 
infection process is to secrete the relevant pathogenicity  factors.  In Gram-
negative plant pathogens, such as Pseudomonas syringae, this process has 
been studied in detail, with these bacteria using well characterised methods of 
neutralising plant host defences based around the Type III secretion system 
(T3SS).  This complex of approximately 30 proteins forms a needle like 
structure allows pathogens to directly inject proteins which disrupt the hosts 
defence signalling into a host cell.  These are known as Type III secreted 
effectors [120].  Gram-positive bacteria are completely lacking in T3SS, and the 
exact methods by which pathogenicity factors are exported is unknown, other 
than the Tat or Sec systems, and the specialised ESAT-6 system, also known 
as type VII secretion systems, discovered in M. tuberculosis [121].  Large 
numbers of S. scabies lipoproteins (~20%) are translocated by the Tat system 
[122], and a recent study has shown that the loss of Tat leads to an avirulent 
phenotype in S. scabies [80].  Seven Tat substrate virulence factors were 
identified, and individual mutants in each coding gene showed reduced 
virulence.  One of these proteins, putative spermidine/putrescine transporter 
peptide binding protein (SCAB81041) has been identified as a lipoprotein [122].
4.2 Aims
The aims of this chapter are to analyse the lipoprotein biosynthetic pathway of 
S. scabies.  Unlike S. coelicolor, S. scabies only contains one potential lgt gene 
(SCAB68531)  and, like most bacteria, one potential lsp gene (SCAB68121). 
Like S. coelicolor, S. scabies contains two putative lnt genes, named in this 
study as lnt1 (SCAB83111) and lnt2 (SCAB76621), and the S. scabies cosmids 
containing these genes were provided by Professor Rose Loria (Cornell). 
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Mutants in each of the lipoprotein processing genes will be examined, both 
macro and microscopically, as will the effects these mutations have on the 
processing of lipoproteins.  This work with S. scabies will allow us to confirm 
and extend our findings on lipoprotein biogenesis in Streptomyces gained using 
S. coelicolor as a model (chapter 3).  Additionally, given the lack of research on 
the role of lipoproteins in plant infection, each mutant will be assessed for 
virulence in both potato tubers and whole plants, and compared to a wild-type 
S. scabies infection.  As discussed in chapter 1, disruption of the lipoprotein 
biosynthetic genes can attenuate bacterial animal pathogens, or make them 
hypervirulent.  Given the obvious differences between plant and animal defence 
responses, it will be interesting to see the role lipoproteins play in bacteria-host 
interaction.
4.3 Results
4.3.1 Identification and comparison of the lipoprotein biosynthetic 
enzymes.
The lipoprotein biosynthetic enzymes from S. scabies were initially identified by 
BLASTP analysis, and the primary sequence of each enzyme was aligned with 
the equivalent primary sequences from: S. coelicolor (Sco), S. avermitilis (Sav), 
S. griseus (Sgr), M. tuberculosis (Mtb), M. smegmatis (Msm) B. subtilis (Bsu) 
and E. coli (Eco).
4.3.1.1 Lipoprotein diacyglycerol transferase (Lgt).
The Lgt enzyme from S. scabies shares a high amount of identity (≥74%) to all 
the Streptomyces Lgt enzymes, with the exception of ScoLgt2 (60%).  The 
identity to the M. tuberculosis and M. smegmatis Lgt enzymes is lower at 53% 
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and 57% respectively, whilst the lowest identity is to BsuLgt and EcoLgt (31% 
and 26% respectively) (fig. 3.1 ).
The essential E. coli His-103 is absent from S. scabies where it is a tryptophan, 
although both His-196, and Tyr-235, needed for E. coli function are conserved 
[17], as in the other actinomycetes tested.  Also present is the elongated C-
terminus discussed in chapter 3.
4.3.1.2 Lipoprotein signal peptidase (Lsp).
S. scabies Lsp shares a high level of identity to the enzymes from the other 
Streptomyces species (≥74%), and a low identity  to the other species tested 
(≤44%).  As with S. coelicolor it conserves the NXXD and FNXAD residues 
necessary for catalysis in B. subtilis [19, 28], as well as the Asp-15 needed for 
enzyme stability  [26].  Also present is the extended N-terminus, characteristic of 
the actinomycete enzymes (fig. 3.4).
4.3.1.3 Lipoprotein N-acyl transferase (Lnt).
The S. scabies Lnt1 and Lnt2 enzymes share a low identity  to each other 
(31%), but both also show low levels of identity to E. coli Lnt (22% and 28%). 
Both enzymes conserve the three residues (E267, K355, C387) thought to form 
the enzymeʼs catalytic triad in E. coli [30].  The S. coelicolor Lnt enzymes also 
show a low level of identity  to each other (29%) and E. coli Lnt (~25%), but 
when directly  compared, ScabLnt1 and ScoLnt1 share a high level of identity 
(86%), as do ScabLnt2 and ScoLnt2 (72%).
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4.3.2 Disrupting the S. scabies biosynthetic genes.
Cosmids containing the S. scabies lgt (SCAB68531), lsp (SCAB68121), lnt1 
(SCAB83111) and lnt2 (SCAB76621) were obtained from Cornell University. 
Each gene was replaced with an antibiotic resistance cassette.  Apramycin was 
used to replace each of the genes individually, to form cosmids Scab  139 
lgt::apr, Scab 45 lsp::apr, Scab  351 lnt1::apr and Scab  2255 lnt2::apr.  A 
hygromycin marked lnt2 deletion strain was also made, cosmid Scab 2255 
lnt2::hyg. in order to construct an lnt1::apr, lnt2::hyg double mutant (D. Widdick, 
unpublished). 
The mutagenised cosmids were transferred into S. scabies by conjugation, to 
form strains BJT1040, BJT1044, BJT1047, BJT1048, BJT1049 and BJT1050 
(see table 2.2) as described in chapter 2, and potential mutants were selected 
on apramycin or hygromycin. The genomic DNA from potential mutants was 
checked by PCR.  An important observation was that the isolation of an Δlsp 
mutant was much easier than it was in S. coelicolor (see previous chapter).
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BJT1040 87-22
Figure 4.4.  PCR of S. scabies genomic DNA showing disruption of the lgt gene with 
the apr cassette.  Lanes 1->4 show the mutant, lanes 5->8 are the wild type control. 
Primer combinations in each lane (expected band sizes shown in brackets): 1+5 = 
ScabLgt comp forward/ScabLgt test reverse (1642 bp/1493 bp).  Lanes 2 + 6 = 
ScabLgt comp forward/P2 (1602 bp/no band).  Lanes 3 + 7 = ScabLgt Test reverse/P1 
(1439 bp/no band).  Lanes 4 + 8 = P1/P2 (1423 bp/no band).
BJT1044 87-22
Figure 4.5.  PCR of S. scabies genomic DNA showing disruption of the lsp gene with 
the apr cassette.  Lanes 1->4 show the mutant, lanes 5->8 are the wild type control. 
Primer combinations in each lane (expected band sizes shown in brackets): 1+5 = 
ScabLsp Test forward/reverse (1437 bp/651 bp). Lanes 2 + 6 = ScabLsp test Forward/
P2 (1418 bp / no band). Lane 3 + 7 = ScabLsp Test reverse/P1 (1419 bp /no band). 
Lanes 4 + 8 = P1/P2 (1423 bp/no band).
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BJT1040 87-22
Figure 4.6.  PCR of S. scabies genomic DNA showing disruption of the lnt1 gene with 
the apr cassette.  Lanes 1->3 show the mutant, whilst lanes 4->6 are the wild-type 
control.  Primer combinations in each lane (expected band sizes shown in brackets): 1 
+ 4 = ScabLnt1 Complementation Forward/P2 (1602 bp/no band).  2 + 5 = ScabLnt1 
Test reverse/P1 (1440 bp/no band). 3 + 6 = P1/P2 (1423 bp/no band).
S. scabies lnt2::apr
BJT1048
Figure 4.7.  PCR of S. scabies genomic DNA showing disruption of the lnt2 gene with 
the apr cassette.  Primer combinations in each lane (expected band sizes shown in 
brackets): Lane 1 = ScabLnt2 Test Forward/Reverse (1574 bp).  Lane 2. = can Lnt2 
Test Forward/P1 (1420 bp). Lane 3. = ScabLnt2 Test reverse/P1 (1425 bp).  Lane 4. = 
P1/P2 (1423 bp).
4.3.2.1 Confirmation of nec1.
Before any work was carried out on the strains created, a final check was 
carried out to ensure that all the strains created were S. scabies and not S. 
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coelicolor contamination had occurred.  A simple test using primers specific to 
the nec1 gene [114] (table 2.4) was used.  This gene is present in S. scabies 
and absent in S. coelicolor.  The results shown in figure 4.8 show that a band 
representing both nec1 (666bp) is present in the genomic DNA of each of the S. 
scabies strains, and absent from the negative control, S. coelicolor genomic 
DNA.
Figure  4.8.  PCR of S. scabies genomic DNA to confirm presence of nec1.  Lane 1. = 
Wild-type S. coelicolor (M145). Lane 2. = Wild-type S. scabies (87-22). Lane 3. = S. 
scabies Δlgt::apr (BJT1040). Lane 4 = S. scabies Δlsp::apr (BJT1044).  Lane 5. = S. 
scabies Δlnt1::apr (BJT1047).  Lane 6. = S. scabies Δlnt2::apr (BJT1048).
4.3.2.2 Development and colony morphology.
Once each of the null mutants, and the Δlnt double mutant were created, they 
were viewed under the light microscope (fig. 4.9).  The typical morphology of a 
wild-type colony, is a flat circular disc, about 3-4 mm in diameter, after 5 nights 
growth, with a raised section in the centre.  The shape is akin to that of a fried 
egg.  The colonies were grey, indicating the presence of mature spores, but
typically  contained a white outline, presumably representing areas of 
undifferentiated aerial hyphae. The Δlgt mutant (BJT1040) had a very different 
growth phenotype, growing slower than the wild-type, sporulating poorly, as 
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suggested by a much lighter shade of grey.  Often the size of an Δlgt colony 
was smaller than that of the wild-type, but not consistently.  This strain also 
lacked the raised area in the centre of the colony and the surface was 
frequently  pock marked.  The Δlsp strain (BJT1044) had a similar, although 
more pronounced phenotype than the Δlgt mutant.  The strain sporulated very 
poorly, which lead to an almost entirely  white colony, and was smaller than the 
wild-type, usually between 2-3 mm.  In contrast to the ʻfried eggʼ growth pattern 
seen in the wild-type, the Δlsp mutant grew in a dome structure, frequently 
pock-marked, like the Δlgt mutant.  These holes in the surface of the colony 
were often filled with a clear liquid, which appeared to be covered in a ʻskinʼ of 
come kind (see section 4.3.2.3 below).  The various Δlnt mutants all display a 
more subtle growth phenotype than either the Δlgt or Δlsp mutants, but 
nevertheless they do look different to the wild-type (fig. 4.9).  All sporulate to a 
good level, giving the strains an overall grey appearance, and each retains the 
white border seen in the wild-type.  Although the Δlnt1 (BJT1047) and Δlnt2 
(BJT1048) mutant colonies are of a similar size to the wild-type, the edges are 
much more ragged and the colonies are irregularly shaped.  Frequently  the 
raised section in the centre of the colony is missing from these mutants.  The 
Δlnt double mutant (BJT1050) contains both the raised area from the wild-type, 
and the irregular colony shape of the Δlnt single mutants.  The colony size is 
slightly  larger than the wild-type, although the growth seems more dispersed, 
and there are often patches where no aerial hyphae/spore chains are present.
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Viewing the strains grown for 5 nights under SEM showed that the Δlsp mutant 
(BJT1044) contains fewer hyphae and thus fewer spores than the other strains, 
consistent with the overall whiteness of the colony seen under light microscopy. 
The wide-angle view (fig. 4.10) shows that all of the other strains contain a 
dense mass of hyphae, with the wild-type showing the largest amount of spiral 
spore chains.  Although the Δlgt (BJT1040) and Δlsp mutants share a similar 
growth phenotype, the Δlgt mutant is showing a higher amount of spore chains, 
although not nearly as many as the wild-type.  Time constraints prevented there 
being any images taken of the Δlnt double mutant.  Given its lack of an obvious 
growth phenotype, this was not considered an issue.  Neither of the Δlnt 
mutants (BJT1047, BJT1048) display an obvious phenotype when viewed 
under SEM.
The SEM closeups of the hyphae revealed that S. scabies spores appear to be 
a different shape to those seen in S. coelicolor, with the former being much 
more cylindrical.  This is not overly  surprising given the variety  of spore shapes 
found in the streptomycetes [123].  This highly magnified view confirmed the 
observation that the Δlsp mutant is sporulating poorly.  Finding spore chains 
from each of the other strains to image was relatively  easy, whilst it proved very 
difficult for the Δlsp mutant.  The immature spore chain shown in figure 4.11, 
was the closest identified, and this shows a further phenotype for the Δlsp 
mutant.  As shown, the immature spores are irregularly  sized compared to the 
wild-type.  This was seen frequently  in the Δlsp mutant, but was also seen in 
the Δlgt mutant, although with less regularity.
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4.3.2.3 Liquid on the surface of the Δlsp mutant
As discussed in section 4.3.2.2 above, light microscopy of the Δlsp strain 
revealed the presence of liquid droplets unseen in the wild-type.  These 
appeared to have a ʻskinʼ and were assessed under SEM (fig. 4.12).  The wide 
angle image shows that these droplets do indeed possess a covering of some 
sort, as a number of crenellations can be seen on their surface.  Where this 
liquid has been displaced, a crater is left in the surface of the colony.  A zoomed 
in view of these craters reveals that they are formed by the remains of the 
matrix surrounding the liquid and are frequently punctured by mycelia.  The 
identity of this liquid is unknown, although confluent lawns of both wild-type and 
the Δlsp mutant have been washed with sterile water in order to remove any 
surface associated liquids and consequently discover their identity.  This work is 
currently ongoing.
Wide Zoomed
L
C
Figure 4.12.  Scanning electron microscopy images of the liquid droplets found on the 
surface of the Δlsp mutant (BJT1044), marked L, and the craters they  leave in the 
surface of the colony, marked C.
163
4.3.3 Effect of gene disruption on lipoprotein processing.
4.3.3.1 Western blots.
As with S. coelicolor, each S. scabies mutant was was grown for 15 hours in 
liquid culture, before being fractionated by  ultracentrifugation as described in 
chapter 2.  Both cytoplasmic and membrane fractions were normalised and run 
on a 15% SDS-PAGE gel.  Two model lipoproteins were used and were 
produced in each S. scabies strain with C-terminal His tags to facilitate Western 
blotting with monoclonal anti-His antibodies (Qiagen).
4.3.3.2 SCO3484.
Given the absence of any confirmed S. scabies lipoproteins, and the inability of 
the anti-CseA antibody to detect the S. scabies homologue of CseA, the 
confirmed Tat secreted S. coelicolor lipoprotein, SCO3484 was used as a model 
lipoprotein.  As in chapter 3, this protein was fused to a penta-Histidine peptide 
at its C-terminus and expressed in each of the S. scabies strains.  This allowed 
the monoclonal anti-His antibody (Qiagen) to be used.  Given the sensitivity  of 
this antibody, typically a very short exposure time was used.  This can be seen 
in figure 4.13.  If the band in the membrane of the wild-type fraction represents 
the mature, processed, form of the protein then this mature protein is also 
detectable in the cytoplasm of the wild-type.  The cytoplasm of the Δlgt strain 
(BJT1040 - see table 2.2 ) contains two forms of the lipoprotein, presumably 
with and without signal sequence.  Only the unprocessed form is detectable in 
the membrane of the Δlgt mutant in a 2 second exposure.  The cytoplasm of the 
Δlsp strain (BJT1044) contains the fully  processed protein, whilst the 
unprocessed form is seen in the membrane.  The Δlnt1 (BJT1047) cytoplasm 
contains both forms of SCO3484, whilst only the mature form is seen in the 
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membrane.  The same result is seen in the membranes of the Δlnt2 (BJT1048) 
and Δlnt double (BJT1050) mutants (not shown).
87-22
WT Δlgt Δlsp Δlnt1
C M C M C M C M
BJT1040 BJT1044 BJT1047
Figure 4.13.  Western blot analysis, using anti-his antibody of the cytoplasm (c) 
and membrane (m) fractions of the different S. scabies strains, as listed.
4.3.3.3 PstS-His.
A second S. coelicolor lipoprotein, PstS (phosphate specific transport), was 
used to study  the processing of S. scabies lipoproteins.  This lipoprotein is part 
of the high affinity, low velocity system for the transport of Pi ions across the 
cytoplasmic membrane.  This system has been well characterised in E. coli 
[124], B. subtilis [125] and S. coelicolor [126].  The PstS lipoprotein (SCO4142) 
was produced with a penta-histidine tag at its C-terminus, and expressed in 
each of the S. scabies strains.  The results, shown in figure 4.14 show that the 
fully processed protein can be seen in the membranes of the wild-type, Δlnt1 
(BJT1047), Δlnt2 (BJT1048), and Δlnt double (BJT1050) mutants, although the 
protein is detectable at a lower level in these mutants.  PstS is undetectable in 
the membrane of the Δlgt mutant (BJT1040), but does appear in the 
supernatant of the same strain (M. Hicks, unpublished).  The protein is larger in 
the Δlsp mutant (BJT1044), and presumably retains its signal sequence.
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WT
87-22
Δlgt
BJT1040
Δlsp
BJT1044
Δlnt1
BJT1047
Δlnt2
BJT1048
Δlnt double
BJT1050
Figure 4.14.  Western blot analysis, using an anti-his antibody, of the membrane 
fractions of the different S. scabies strains, as listed.
4.3.4 Plant virulence assays.
As has been mentioned, to date there has been no investigation into the role 
that lipoproteins play in plant pathogenicity although numerous studies have 
been done on animal pathogens (chapter 1).  The aim of this work is to assess 
the role that S. scabies lipoproteins play in the plant infection process.  Two 
approaches were chosen.  The first involved overlaying sterilised discs of potato 
with agar plugs containing a confluent lawn of growth of the wild type, Δlgt, 
Δlsp, Δlnt1, Δlnt2 or Δlnt double mutant strains of S. scabies.  The second 
involved assessing the effect that each of the mutants had on a whole plant, in 
this case newly germinated radish seedlings (Raphanus sativus) (Chapter 2). 
These methods were adapted from previous work on the infection pathway of S. 
scabies [127].  As has been noted, S. scabies is capable of infecting a wide 
number of plants, both monocotyledonous and dicotyledonous [67] and radish 
plants were chosen due to their rapid germination and growth.  The potato 
cultivar Maris Piper was used in the potato disc experiments due to its low 
immunity to S. scabies, as documented by the British Potato Council (http://
varieties.potato.org.uk).
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4.3.4.1 Potato tuber assay.
The effect that each of the S. scabies strains had on potato slices was 
assessed after both 2 and 5 nights. The results can be seen in figures 4.15 and 
4.16 below.  Circular discs were cut from a sterile potato tuber and had an agar 
plug containing a confluent lawn of each S. scabies strain placed upon them 
(section 2.8.1).  After two nights the control, overlain with sterile agar only, 
showed no evidence of necrosis.  It is difficult to see where the agar was 
placed.  In contrast, a brown square is clearly visible in the wild-type infected 
potato disc, and represents an area of necrosis.  This is also visible in each of 
the mutant strains (fig. 4.15), although it does appear to be lighter in colour in 
the Δlnt2 mutant (BJT1048 - see table 2.2) than in the other strains.  Whilst 
these areas of necrosis are present in each strain, there is an absence of any 
obvious breakdown of the tuber surface, which remains a uniform flatness.
After 5 nights growth however, there are large areas of potato tissue 
degradation caused by each of the S. scabies strains (fig. 4.16).  As before, the 
negative control remains totally  clear of any areas of necrosis, and it is still 
difficult to see where the agar plug has been placed.  For each of the infected 
strains, removing the agar square has also removed the top layer of potato, 
either completely  as seen in the wild-type or Δlgt (BJT1040) infected potatoes, 
or partially, as seen in the Δlnt1 (BJT1047) or Δlnt double (BJT1050) mutants. 
The loss of this top  layer is presumably due to the bacteria becoming tightly 
associated with the surface of the potato and potentially growing into the disc, in 
a manner similar to that seen in figure 4.3.  A large covering of bacteria remains 
on each potato, unseen after 2 nights.  There is no obvious difference in the 
rate of growth suggesting that the loss of each respective lipoprotein processing 
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enzyme has had no effect on the ability of the strain to grow on, and necrose, 
the potato tissue.  In the wild-type infected potato, large areas of black are 
seen, corresponding to severe necrosis, likely caused by  thaxtomin A.  These 
areas are beyond the edges of where the agar plug was placed, suggesting that 
either the thaxtomin A is readily diffusible, or that there is a large amount of 
unseen substrate mycelial growth, and it is from here that the toxin is secreted. 
These black areas are also seen in the Δlgt mutant, and the Δlnt1 mutant, 
although to a lesser extent.  They are absent from the remaining mutants, which 
retain the brown areas seen after two nights infection.
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4.3.4.2 Radish seedling assay.
Plant infection assays involved germinating sterile seeds of the Radish cultivar 
Scarlet Globe, and immersing the seedlings in a broth of S. scabies (wild-type 
or mutants), before plating them in sterile containers on Murashige and Skoog 
medium containing 2% sucrose (table 2.3) which had previously been overlaid 
with the same S. scabies strain.  The seedlings were grown for 7 nights in a 
controlled environment chamber, before being assessed (section 2.8.2).  An 
overview of the effect of each of the mutations on virulence in these seedlings 
can be seen in figure 4.17 below.  The negative control plant, overlaid with 
sterile TSB growth medium only, shows healthy growth, with a long primary 
root, and multiple secondary roots.  After 7 days the primary roots were typically 
between 11-12 cm in length.  The leaves are healthy and new leaf growth can 
be seen at the apical meristem.  The stem of the plant was typically between 
1.3 and 1.6 cm.  This growth pattern is also seen in plants treated with the non-
pathogenic S. coelicolor.  However, plants infected with wild-type S. scabies are 
vastly  different.  The growth is stunted, with a primary root of between 4-6 cm. 
There is very little secondary root growth evident, and those that are present 
are much smaller than in the negative control.  Very small leaves were present 
and there was no evidence of further leaf growth.  The stem was shorter than 
the negative control, rarely exceeding 1.5 cm in length.  This phenotype was 
consistent in each of the S. scabies  mutants tested, as can be seen in figure 
4.17.
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WT Δlgt::apr Δlsp::apr Δlnt1::apr Δlnt2::apr Δlnt doubleTSB Sco WT
(BJT1040)(87-22) (BJT1044) (BJT1047)(BJT1048)(M145) (BJT1050)
Figure 4.17.  Overview of Radish seedlings grown for 7 nights and either: mock 
infected (TSB), infected with S. coelicolor wild-type (Sco WT), or the S. scabies strains.  
Strain names are shown in brackets.
4.3.4.3 Analyses of root structures.
As shown above, each of the S. scabies strains has a deleterious effect on the 
root systems of Radish seedlings not seen in mock-inoculated plants or those 
infected with the non-pathogenic S. coelicolor.  The root systems of each plant 
were studied under a light microscope to view any subtle changes not seen in 
the overview above.  The results can be seen in figure 4.18  below.  A complex 
network of root hairs, invisible in the overview photo above can be see in each 
S. scabies strain.  As above however, each of the mutant strains shows a 
severe growth phenotype compared to the negative controls.  Both the TSB 
treated, and S. coelicolor treated negative controls have a complex root system 
consisting of many secondary roots emerging at regular intervals from the 
primary root.  The entire root system grew into the agar making the plants 
difficult to remove without also removing a large amount of agar.  In contrast, 
the root system in each of the S. scabies infected strains was much less 
complex.  In the wild-type infected plant the root system comprises only the 
single, stunted, primary  root, with multiple brown nodules which represent failed 
secondary roots.  The root grows on the surface of the growth medium, and 
lacks the penetration seen in the wild-type.  Only the fragile attachments of the 
root hairs allowed the plant to remained bound.   This weak attachment is seen 
in all of the S. scabies strains.  Whilst the Δlgt strain (BJT1040) does share the 
stunted primary root seen in the wild-type, the overall phenotype does not seem 
as severe.  Multiple secondary roots are present, although they are significantly 
more stunted than in the wild-type.  This phenotype is shared in the Δlsp mutant 
(BJT1044).  The roots of both the Δlnt1 (BJT1047) and Δlnt2 (BJT1048) 
infected plants look like those seen in the wild-type infection, with the presence 
of nodules representing failed secondary  root growth.  The phenotype of the 
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Δlnt double mutant (BJT1050) is similar to that seen in the Δlgt and Δlsp 
mutants.  Multiple secondary roots are seen at regular intervals.  Again 
however, these are consistently shorter than those found in the negative 
controls.
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4.3.5 Complementing the S. scabies Δlgt and Δlsp mutant.
In the previous chapter, we showed that disrupting the lsp gene in S. coelicolor 
caused a severe growth phenotype.  This was not the case with the disruption 
of either of the lgt genes which both appeared as the wild-type, potentially  due 
to the self complementation of the disruption.  S. scabies is unlike S. coelicolor 
as it only contains one copy of the lgt gene (section 4.2).  Disrupting this gene 
causes a growth phenotype similar to that of the Δlsp mutant.  Both of the Δlgt 
and Δlsp strains were only  partially  complemented by replacing a full length 
copy of the disrupted gene back into the mutant in trans.  The S. coelicolor lgt1, 
lgt2 and lsp genes were also used to see if they  were able to complement the 
S. scabies mutants.  Using the lgt genes from S. coelicolor allowed us to further 
investigate whether either, or both genes encoded a true Lgt homologue.  The 
results for colonies grown for  5 nights on IM agar can be seen in figures 4.19 
and 4.20 below.
4.3.5.1 S. scabies Δlgt complementation.
When compared to the wild-type under light microscopy, the Δlgt mutant 
(BJT1040) showed a lower level of sporulation leading to a lighter colony 
appearance, spore chains were observed under SEM however.  Unlike wild-
type colonies which are typically flat with a raised centre, the Δlgt mutant 
appears to have more depth and often contains depressions upon its surface 
similar to those described in the Δlsp strain (section 4.3.2.2).  Complementing 
the mutant with the lgt genes from either S. scabies (BJT1041 - see table 2.2) 
or S. coelicolor (BJT1042 and BJT1043 for Sco lgt1 and Sco lgt2 respectively) 
does go someway to restoring the growth phenotype to wild-type, as can be 
seen below.  When complemented with the S. scabies gene, the colony regains 
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both the flatness, and halo of white substrate mycelium, but fails to regain the 
raised area seen in the middle of a wild-type colony.  This complementation also 
appears to have a more ʻraggedʼ appearance than the uniform shape of the 
wild-type.  This ragged appearance is even more pronounced in the mutant 
complemented with the S. coelicolor lgt1 gene.  This strain lacks both a defined 
edge, and uniform topography, containing many raised areas.  In contrast, the 
S. coelicolor lgt2 complemented strain appears much closer to the wild-type. 
The strain is flat, and a uniform grey with a white halo surrounding it.  However, 
the raised area in the centre of the wild-type colony is again absent from this 
complementation, and it was frequently smaller in size than the wild-type.
4.3.5.2 S. scabies Δlsp complementation.
As discussed in section 4.3.2.2 the S. scabies Δlsp mutant (BJT1044) has a 
severe growth phenotype, with colony sizes much smaller than the wild-type, 
and the presence of an unknown liquid on the colony surface (section 4.3.2.3). 
Substantially less sporulation occurs in the mutant, leading to an overall white 
appearance.  Complementing the mutant with either the S. scabies, or S. 
coelicolor lsp gene (BJT1045 and BJT1046 - respectively) had an effect on the 
mutant, but neither was able to completely  rescue the strain (fig. 4.20).  In both 
cases the complemented strains showed an increase in colony size, with both 
being flat like the wild type, as opposed to the domed shape seen in the Δlsp 
mutant.  However, the shape of the colonies in both complementations was 
different to the wild-type.  Unlike the broadly circular wild-type colony, the S. 
scabies lsp complementation had a misshapen central grey area, surrounded 
by diffuse substrate mycelium.  This area of substrate mycelia was thin enough 
that the growth media could be seen below.  There is no raised area in the 
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middle of the colony, instead holes are seen similar (albeit smaller) to those 
seen in the Δlsp and Δlgt mutants.  The S. coelicolor lsp complemented mutant 
shares the large area of diffuse substrate mycelia, but in this case the centre of 
the colony is more spherical than the S. scabies complementation.  However, 
this is divided into an outer ring and an inner circle.  The outer ring is white, 
presumably consisting of undifferentiated mycelium, whilst the centre is grey, 
indicating mature spore chains are present.  The lower amount of aerial hyphae 
corresponds with the observation that this strain sporulates poorly in 
comparison to the S. scabies lsp complementation. 
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4.4 Discussion
The experiments presented in this chapter were focussed on the plant 
pathogen, S. scabies.  The aim was to investigate the effect that the loss of 
lipoprotein processing had on the bacterium, compare this to results from S. 
coelicolor (chapter 3) and determine whether this had a deleterious effect on its 
ability  to infect plants.  The role of lipoproteins in plant pathogenesis is 
unknown.
The bioinformatic analysis shows that, unlike in S. coelicolor, S. scabies only 
encodes one Lgt homologue which shares a high level of identity with both S. 
coelicolor Lgt1 and Lgt2.  The S. scabies Lsp  enzyme also shows a high level of 
similarity  to the S. coelicolor enzyme.  The S. scabies Lnt enzymes are curious, 
insomuch that although they share the potential catalytic triad from E. coli, they 
share a low level of identity with each other (32%).  The genes encoding both 
Lnt1 and Lnt2 are found in the right arm of the S. scabies genome, suggesting 
that they may have been acquired by HGT and, given their low similarity, could 
have been acquired from different sources.  Both the lgt and lsp genes are 
found more centrally in the chromosome.
Disrupting the lipoprotein processing enzymes in S. scabies was relatively 
simple when compared to S. coelicolor.  However, it should be noted that 
recombination efficiency is much higher in S. scabies compared to S. coelicolor, 
such that single crossover events are rarely seen in S. scabies (R. Seipke, 
personal communication).  However, observing the mutant colony phenotypes 
(fig. 4.9) shows there are several parallels when compared to the S. coelicolor 
mutants.  The Δlsp S. scabies mutant is much smaller than the wild-type, and 
181
sporulates poorly, in a manner similar to the S. coelicolor mutant.  The Δlgt 
mutant (BJT1040) shares many of the growth deformities, although is slightly 
larger than the Δlsp strain (BJT1044).  Both are discernibly  different to the wild-
type.  The same cannot be said for the disruptions in the lnt genes.  Neither of 
the single mutants (BJT1047 and BJT1048), nor the double (BJT1050) show 
any size reduction compared to the wild-type, although both of the single lnt 
mutants lack the raised area in the centre of the colony, characteristic of wild-
type S. scabies.  The edges of each of the lnt mutant colonies does look more 
dispersed than the wild-type, leading to an irregular shape.  A  lack of phenotype 
was observed under SEM, where the Δlnt1 mutant (BJT1047) showed no 
obvious differences to the wild-type.  However, as with the light microscope, the 
Δlsp mutant (BJT1044) sporulated very  poorly, and the spores that were 
observed under SEM were often misshapen.  Surprisingly, given their similarity 
when viewed under light microscope, the Δlgt strain (BJT1040) did not look 
nearly  as damaged when viewed under SEM.  One curious discovery made by 
SEM is the discovery that the liquid on the surface of the Δlsp mutant 
(BJT1044) is sequestered into covered vesicles (fig. 4.12).  The ʻskinʼ forming 
this coating is of unknown consistency, but it is punctured multiple times by the 
mycelia.  S. scabies is known not to produce any antibiotics, so initially this 
liquid was assumed to be water.  The identity  of this liquid remains unknown, 
but is due to be investigated.  Potentially it could represent a cryptic secondary 
metabolic pathway switched on in the absence of lsp or lgt.
The effect that the loss of the lipoprotein biosynthetic enzymes had on the 
processing of the two lipoproteins tested is intriguing.  It is important to note that 
both SCO3484 and PstS (SCO4142) are native S. coelicolor lipoproteins, and 
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therefore may be processed differently in the heterologous host S. scabies than 
they are in their native S. coelicolor.  Looking at the S. scabies membrane 
fractions (fig. 4.13), the mature SCO3484 lipoprotein is present in the wild-type, 
with a larger unprocessed form seen in the membranes of the Δlgt (BJT1040)
and Δlsp mutant (BJT1044).  The protein is properly processed in the Δlnt1 
(BJT1047), Δlnt2 (BJT1048) and Δlnt double (BJT1050) mutants.   This pattern 
would be expected if the lipoprotein biosynthetic pathway is ordered tightly  as it 
is in Gram-negative bacteria.  The unprocessed band seen in the membrane of 
the Δlgt strain shows that lipidation by Lgt is required before Lsp  can cleave the 
signal peptide.  The unprocessed band in the Δlsp strain is also seen in S. 
coelicolor.  However, the presence of processed lipoproteins in the cytoplasms 
of each strain is difficult to explain.  In the wild-type cytoplasm processed 
SCO3484 is detectable, as it is in the Δlsp cytoplasm.  In the cytoplasms of the 
Δlgt and Δlnts both processed and unprocessed forms can be seen.  The 
reasons for these extra bands are unclear, although the result is reproducible. 
Experimental error can be discounted, given that the pattern is different 
between strains, and fractions, and any problem with the fractionating process 
would give a uniform pattern for each lane.  There should be no bands 
detectable in the cytoplasm, as seen in S. coelicolor (fig. 3.16).  
The processing of PstS (fig. 4.14), is different from that seen with SCO3484.  In 
this case, PstS is undetectable in the membrane of the Δlgt mutant (BJT1040). 
However, a band corresponding to the processed form is detectable in the 
supernatant of the Δlgt mutant, showing that it has been cleaved.  This could 
suggest that Lsp is able to act on non-lipidated proteins.   However, mass spec 
analysis of another lipoprotein found in the supernatant of the Δlgt mutant 
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revealed that the signal peptide has been cleaved just downstream of the 
lipobox, removing the C+1 (M. Hicks, unpublished) suggesting that processing is 
not due to Lsp but due to an alternative signal peptidase, potentially a signal 
peptidase I (SpaseI).  In Gram-negative bacteria, one copy of SpaseI exists. 
However in B. subtilis and several Streptomyces species, including S. 
coelicolor, multiple homologues (SCO5596, 5597, 5598, 5599) exist [128]. 
Another possible explanation would be that an alternative, as yet undiscovered 
Lsp, such as the Eep  protein from Streptococcus uberis [53] is cleaving the 
lipoprotein.  The use of alternative processing indicates again that the 
lipoprotein biosynthetic pathway is potentially ordered, given that Lsp  does not 
seem to act on a non-lipidated protein.  The band representing PstS in the Δlsp 
mutant (BJT1044) is larger than seen in the wild-type, suggesting that, as with 
SCO3484, it retains its signal sequence.  The deletion of the lnt genes, either 
individually  or together, appears to have no effect on the processing of PstS, as 
was the case with SCO3484.  As both of these proteins are from S. coelicolor, 
future work will involve using native S. scabies lipoproteins to see whether the 
results are the same as those described here. 
Complementing both the Δlgt and Δlsp mutants only partially  rescues each 
strain.  The similarity of the phenotypes in both the Δlgt and Δlsp mutants 
suggest that they share a defective lipoprotein biosynthesis pathway, which in 
turn suggests that the pathway in S. scabies has a regimented order as found in 
Gram-negative bacteria.  This result is also strong evidence that the two Lgt 
enzymes found in S. coelicolor are complementing each other (chapter 4). 
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Recently  it has been shown that the S. coelicolor lipoprotein SCO3484 is 
triacylated in wild-type S. scabies, whilst in the Δlgt mutant (BJT1040) it is 
unlipidated (M. Hicks unpublished).  This shows that S. scabies contains at 
least one functional Lnt enzyme although what role this N-acylation plays is 
unknown.  Given that the double Δlnt disruption mutant displays no severe 
growth phenotype, the importance of triacylation of lipoproteins in S. scabies 
must be questioned. Perhaps only  a subset of lipoproteins are triacylated in 
Streptomyces.
What is clear from this work is that disrupting lipoprotein processing seems to 
have an effect on plant pathogenicity.  Each of the mutant strains was able to 
infect both potato tubers and radish seedlings to a similar extent to the wild-type 
although the roots of the radish seedlings were less stunted in the Δlgt 
(BJT1040), Δlsp (BJT1044) and Δlnt double (BJT1050) mutants compared to 
wild type S. scabies suggesting a potential reduction in virulence.  Deleting the 
Tat secreted lipoprotein SCAB81041 has been shown to have a moderate effect 
on the virulence of S. scabies [80] in agreement with this work.  That disrupting 
the lipoprotein processing pathway in S. scabies does not have a larger impact 
on virulence is surprising, given that three lipoprotein genes are found on the S. 
scabies PAI island: SCAB77471, encoding a substrate binding protein (SBP) 
also found in S. avermitilis, SCAB77361 and SCAB77271, both encoding SBP, 
although unique to S. scabies.  However, there is no evidence that these 
proteins are virulence factors.  Given that the improper processing of 
lipoproteins does not have a large impact on virulence, it appears that 
lipoproteins are not a determining factor in S. scabies pathogenesis.  Neither of 
the two main pathogenicity factors, thaxtomin A and Nec1, are lipoproteins and 
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it seems that the loss of the lipoprotein processing enzymes does not effect 
their action.  However, Nec1 production seems to be stimulated by glucose [75] 
and thaxtomin A production appears to be induced by xylan and glucan [130], 
so the lack of effect seen through disruption of lipoprotein biosynthetic genes is 
surprising given the large number of lipoproteins are involved in carbohydrate 
transport in the streptomycetes (chapter 3).  There is no evidence of 
hypervirulence in any of the strains, suggesting that lipoproteins are not the 
determining factor for the initiation of the plant defence response, as their loss 
does not allow the bacteria to infect the host plant undetected.  The radish 
assays above had a seven night duration, after which the virulence was 
assessed.  Future work should include a longer term experiment to see whether 
any of the plants are able to recover from infection.  
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Chapter 5. Discussion
The aim of this thesis was to investigate the lipoprotein processing pathway in 
Streptomyces.  Two Streptomyces species were used as models, S. coelicolor, 
a model organism for the high GC Gram-positive actinomycetes and S. scabies, 
one of the causative agents of scab formation on potato tubers, a disease of 
significant economic value worldwide.  Both species are soil dwelling 
saprophytes, with complex multistage lifecycles.  Their genomes are linear and 
considerable larger than most other bacteria, and presumably this linearity 
allows the acquisition of new genes, making the species more successful soil 
saprophytes.  As little is known about the lipoprotein processing pathway in the 
high GC Gram-positive bacteria this work, which involved disrupting the genes 
encoding each of the biosynthetic enzymes in both S. coelicolor and S. scabies, 
allowed us to observe whether the pathway is essential and ordered, as in the 
Gram-negatives, or dispensable, as it is in the low GC Gram-positives.  
S. coelicolor contains two Lgt homologues, and both S. coelicolor and S. 
scabies contain two Lnt homologues.  The reasons for this are unclear.  The 
presence of two Lgt homologues seems unusual amongst Streptomyces 
species, with only S. coelicolor and S. clavuligerus containing the duplicates, 
the latter on a megaplasmid, whilst the presence of two Lnt homologues seems 
ubiquitous throughout the species.  The presence of multiple enzymes made it 
difficult to determine whether Lgt has an essential function in S. coelicolor. 
Disruption of one or other of the S. coelicolor lgt genes had very  little effect on 
the growth of the bacterium, nor did it seem to effect the processing of the two 
model lipoproteins tested or on the lipoproteome, as detected by 2D gel 
analysis [82].  The two lgt genes are therefore self complementing in S. 
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coelicolor.  The double lgt mutant was impossible to isolate in this study, which 
in itself suggests that the lipidation step of the lipoprotein biosynthetic pathway 
may be essential in S. coelicolor and that therefore the entire pathway is also 
essential.  The second lgt gene (SCO7822) is found very close to the end of 
one of the S. coelicolor chromosome arms, and these are the regions of the 
chromosome which typically  contain non-essential genes acquired through 
HGT [66].  Why S. coelicolor has sought to maintain this gene when a second 
homologue is encoded elsewhere on the chromosome does suggest that the 
Lgt function is of great importance to the bacterium.  One hypothesis was that 
each enzyme caters to a different subset of lipoproteins, for example Tat or Sec 
secreted lipoproteins, but this now seems unlikely, given that the two 
lipoproteins tested (one Sec- and one Tat-dependent) were processed correctly 
in both the Δlgt1 and Δlgt2 mutant.
S. scabies only contains a single lgt gene, and it was possible to delete this 
gene, which indicates that Lgt function is not essential in S. scabies.  However, 
the growth phenotype exhibited in this mutant is very  similar to that observed 
upon disrupting the lsp gene, suggesting that they share incorrect lipoprotein 
processing which in turn has an effect on growth and development, as also 
observed in S. coelicolor.  In the Δlgt deletion strain, a band consistent with 
unprocessed SCO3484 still containing its signal peptide was seen in the cell 
membrane, suggesting that the action of Lgt is a required in order for Lsp to 
recognise its substrate and cleave the signal sequence, indicating an ordered 
processing of lipoproteins.  PstS is processed differently in the Δlgt mutant, and 
was undetectable in the cell membrane.  The unlipidated protein was probably 
cleaved by  an alternative signal peptidase, showing that, for this lipoprotein at 
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least, Lsp  is unable to function in the absence of Lgt, again suggesting a strict 
order in the lipoprotein processing pathway.  Why there is a difference in the 
processing of the two lipoproteins is unclear at this time, although there was 
also a difference seen in the processing of CseA and SCO3484 in S. coelicolor.
Disrupting the lsp gene from both S. coelicolor and S. scabies resulted in a 
growth phenotype very different from the wild-type, both growing and 
sporulating poorly.  In S. coelicolor the mutation could not be completely 
rescued by complementation, either cis or in trans with the loss of the gene 
causing the improper processing of the two model lipoproteins tested, with one 
(CseA) becoming undetectable in the cell membrane, and one (SCO3484) 
retaining its signal sequence.  Which of these two outcomes is more prevalent 
is unknown, and more lipoproteins will have to be tested to see which is the 
norm.  Either way, both forms of misprocessing are likely to have a significant 
effect on the bacterium, either leading to the loss of swathes of lipoproteins, or 
having numerous lipoproteins anchored into the cell membrane by both their 
lipid moiety and signal sequence. 
As discussed in chapter 4, recent results have proved the presence of at least 
one true Lnt enzyme in S. scabies.  In the Δlgt deletion mutant the model 
lipoprotein tested is unlipidated and has been non-specifically processed just 
downstream of the lipobox, whilst the same lipoprotein is triacylated in the wild-
type (M. Hicks, unpublished).  Currently, both the Δlnt1 and Δlnt2 deletion 
strains are being tested for N-acylation of lipoproteins to see which, if not both, 
acts as a true Lnt enzyme.  Neither S. scabies lnt mutant exhibited a severe 
growth phenotype probably due to self complementation, as seen in the S. 
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coelicolor Δlgt mutants, although the phenotype of the lnt double mutant is not 
as severe as that of the lgt and lsp mutants.  Now that functional Lnt enzymes 
have been identified in M. smegmatis and S. scabies, with very similar proteins 
present in a variety of actinomycetes including S. coelicolor it must be asked 
ʻWhy does this branch of the Gram-positives need an Lnt enzyme?ʼ.  In Gram-
negative bacteria, this enzyme is a prerequisite for the activity of the Lol 
pathway, needed to transport a lipoprotein to the outer membrane.  In Gram-
positive bacteria the Lol pathway is missing, given the lack of outer membrane, 
and it could therefore be assumed that the Lnt enzyme function is not required. 
However, given the complex nature of the cell envelope in various Gram-
positives, particularly  M. tuberculosis, and the evidence of a potential pseudo-
periplasmic space discovered in others, such as S. aureus [55] and B. subtilis 
[56], it is tempting to think that there may be a targeting system, as yet 
unknown, in the Gram-positive branch of the bacteria in order to shuttle 
lipoproteins to the ʻouterʼ membrane.
Another aspect of lipoprotein processing that this work uncovered is the 
presence of elongated sections of the Streptomyces enzymes.  In both species 
the Lgt and Lsp enzymes contain elongated sections, at the C- and N-terminals 
respectively.  These extensions are absent from both the Gram-negative and 
low GC Gram-positive bacteria assessed.  These areas are both found 
cytoplasmically  suggesting, initially at least, that they serve no enzymatic 
function, given that the active sites of both proteins are on the external face of 
the cell membrane (chapter 1).  The initial theory  was that these extensions 
represent sites of interaction between the Lgt and Lsp enzyme.  This is 
attractive given that the Gram-negative pathway is well ordered (as may be the 
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pathway in S. scabies as described above), and that passive diffusion of 
unprocessed lipoproteins between the processing enzymes seems energetically 
wasteful.  In opposition to this theory is the lack of extensions in the Lnt 
enzymes and the translocation machinery.  The majority of this work was done 
on the S. coelicolor Lsp  protein, as truncating either of the Lgt enzymes 
singularly  has no effect, presumably  due to the self complementation mentioned 
previously.  It was thought that if the Lgt and Lsp  proteins were interacting 
directly,  truncating the N-terminus of the Lsp  enzyme would impede or stop this 
interaction, and the processing of the lipoprotein tested, CseA, would cease in a 
manner similar to the deletion strain.  Removing the first 10 amino acids of the 
protein had no effect on CseA processing, yet removing 20 lead to it being 
undetectable.  Removing 30 amino acids lead to a size shift in CseA, 
suggesting the enzyme was inactive, whilst removing 40 amino acids again 
leads to CseA being undetectable.  With the exception of the N10 truncation, 
removing the N-terminus of Lsp results in the loss of enzyme activity.  It is not 
known however, whether these truncated enzymes are expressed or not. 
Attempts to fuse both of the S. coelicolor Lgt and Lsp proteins to both eGFP 
and mCherry fluorescent markers to visualise them were unsuccessful, given 
their low expression and the natural background fluorescence of S. coelicolor. 
It was thought that the lipoprotein processing machinery may have been 
localised at the growing hyphal tip, given that this is the location of new 
bacterial growth.  The Tat machinery has been found at the hyphal tip (D. 
Widdick, unpublished) and to find the lipoprotein processing enzymes there too 
would lend weight to the theory that the whole pathway is linked.
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Although they  share the same environment, S. scabies differs from S. coelicolor 
as it has gained the ability to infect plants.  Two main compounds, thaxtomin A 
and Nec1 are the main elicitors of necrosis in potato tubers.  Previous to this 
work, no research had been undertaken on the role lipoproteins have on plant 
pathogenesis.  Much has been done on their action in animal pathogenesis, 
and the results of disrupting their biosynthesis range from attenuation to 
hypervirulence.  What is clear though is that the loss of Lgt or Lsp is not lethal in 
the Gram-positive pathogens tested to date.  This is also the case in S. scabies. 
Both the Δlgt and Δlsp deletion strains show a similar growth phenotype as 
described above.  Neither mutation can be fully complemented, similar to the S. 
coelicolor Δlsp mutant, suggesting the strains have also gained secondary 
mutations in order to survive.  The disruption of these enzymes had a clear 
effect on the processing of the two model lipoproteins tested, with examples of 
improper localisation shown in each deletion strain.  It is important to note that 
both SCO3484 and PstS (SCO4142) are native S. coelicolor lipoproteins, and 
therefore may be processed differently in the heterologous host S. scabies than 
they are in their native S. coelicolor.  This is certainly the case for SCO3484 as 
can be seen in figure 3.16 (S. coelicolor) and figure 4.13 (S. scabies).  Future 
work will have to involve native S. scabies lipoproteins.   Despite this incorrect 
processing, none of the mutants showed any avirulence in the two plant assays 
carried out, with each deletion strain able to causes disease in both potatoes 
and radishes.  
The Radish seedlings were also susceptible to each of the S. scabies strains. 
The general pattern of growth seen in the wild-type infected plant: short stem, 
withered leaves and a short primary root is replicated in each infection, although 
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the overall severity  of virulence caused by the Δlgt, Δlsp and Δlnt double 
mutants seemed less than the wild-type, with more secondary roots seen, in 
contrast to the complete failure of secondary root growth in the other strains. 
This growth stunting was clearly  a result of the S. scabies as the non-
pathogenic S. coelicolor produced no evidence of damaged growth.  Given that 
the reduction of secondary  root formation was frequently  seen in each of the 
deletion strains, and the ʻnodulesʼ representing this failed growth are thought to 
be the area where S. scabies gains access to the plant [77], it appears as 
though disrupting the S. scabies lipoprotein machinery  has had no effect on the 
bacteriaʼs ability to colonise root structures.  That disrupting the lipoprotein 
processing pathway does not have a significant effect on virulence is surprising, 
given that three lipoproteins encoding SBP (SCAB77471, SCAB77361, 
SCAB77271) are present in the S. scabies pathogenicity island, although as 
noted above, there is no evidence that these are virulence factors.  The loss of 
the Tat dependent lipoprotein SCAB81041 has been shown to cause a 
moderate decrease in virulence in A. thaliana [80].  A moderate decrease in 
virulence is also seen in the Δlgt, Δlsp and Δlnt double mutants, showing that 
the lipoprotein processing pathway does play a role in plant pathogenesis.  A 
further gene involved in the pathogenicity process SCAB78931 has been 
discovered.  This gene encodes a cutinase, an enzyme used by pathogenic 
fungi to break down the protective layer of cutin found on the aerial organs of 
plants.  The improper processing of this lipoprotein does not seem to impede 
the infection process, and its role is still unclear, given that the target organs for 
the bacterium are found underground.  This gene does offer a potential insight 
into the origins of the pathogenicity genes found in S. scabies given that its 
closest homologue is found in the fungus Phytophthora infestans, the causative 
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agent of potato blight.  The large numbers of potentially  improperly processed 
substrate binding proteins also does not effect the production of pathogenicity 
elicitors.  As has been noted, both Nec1 and thaxtomin A appear to be induced 
by carbohydrates [75, 130], and as we have seen, large numbers of 
lipoproteins, in S. coelicolor at least, are involved with carbohydrate transport. 
Again though, as there is no detriment to virulence it seems likely  that either 
non-lipoprotein transporters are used for carbohydrate uptake, or any 
lipoproteins necessary remain active. 
To conclude, this work has analysed the lipoprotein processing pathways of 
both S. coelicolor and S. scabies and shown strong evidence that the 
lipoprotein biosynthesis pathway is essential in S. coelicolor, and preliminary 
evidence in the latter that the pathway by which lipoproteins are processed 
occurs in a strict, regimented order.  
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Table A2. Stress Phenotype Results.
Name
A B C A B C A B C A B C A B C A B C
Bacitracin μg/ml 0 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2
2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2
4 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2
5 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2
10 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2
15 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2
20 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2
25 2 2 2 2 2 2 2 2 2 1 1 1 2 2 2 2 2 2
30 2 2 2 2 2 2 2 2 2 1 1 1 2 2 2 2 2 2
35 2 1 2 1 1 1 2 2 2 0 0 0 1 2 2 2 2 2
40 2 1 2 1 1 1 2 2 2 0 0 0 1 2 1 2 1 1
50 2 0 2 1 0 0 2 2 2 0 0 0 1 1 0 1 1 0
100 0 0 0 0 0 0 2 2 2 0 0 0 0 0 0 0 0 0
200 0 0 0 0 0 0 1 1 2 0 0 0 0 0 0 0 0 0
300 0 0 0 0 0 0 1 1 1 0 0 0 0 0 0 0 0 0
400 0 0 0 0 0 0 1 1 1 0 0 0 0 0 0 0 0 0
500 0 0 0 0 0 0 1 1 1 0 0 0 0 0 0 0 0 0
1000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
+15 Hour SDS % 0 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2
0.01 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2
0.02 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2
0.03 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2
0.04 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2
0.05 2 2 2 2 2 2 2 2 2 2 1 2 2 2 2 1 1 1
0.06 2 2 2 2 2 2 2 2 2 1 1 1 2 2 1 1 1 1
0.07 2 2 2 2 2 2 2 2 2 1 1 1 1 1 0 1 1 1
0.08 2 2 2 2 2 2 2 2 2 1 1 1 1 1 0 1 1 1
0.09 2 2 2 2 2 2 2 2 2 1 1 1 1 1 0 1 1 1
0.1 2 2 2 2 2 2 2 2 2 1 0 1 1 1 0 1 1 1
0.2 2 1 2 2 2 2 2 2 2 0 0 0 0 0 0 0 0 0
0 hour lysozyme μg/ml 0 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2
0.1 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2
0.2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2
0.3 2 2 2 2 2 2 2 2 2 2 1 2 2 2 2 2 2 2
0.4 2 2 2 2 2 2 2 1 2 1 1 1 2 2 2 2 2 2
0.5 2 2 2 2 2 2 2 1 2 1 1 1 2 2 2 2 2 2
0.75 1 1 1 1 1 1 1 1 2 1 1 1 1 2 2 2 2 2
1 1 1 1 1 1 1 1 1 1 0 0 0 1 1 1 1 1 1
1.25 1 1 1 1 1 1 1 1 1 0 0 0 0 0 0 1 1 1
2.5 0 0 0 1 1 1 1 0 1 0 0 0 0 0 0 0 0 0
5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
10 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
+15 Hour Lysozyme μg/ml 0 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2
0.1 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2
0.2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2
0.3 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2
0.4 2 2 2 2 2 2 1 1 1 2 2 1 1 2 1 1 2 2
0.5 2 2 2 2 2 2 1 1 1 1 1 1 1 1 1 1 1 1
0.75 2 2 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
1 2 2 1 1 1 1 1 0 0 1 1 1 1 1 1 1 1 1
1.25 1 1 1 1 0 1 1 0 0 1 1 1 1 1 1 1 1 1
2.5 0 1 0 0 0 1 0 0 0 0 0 0 1 0 0 0 0 0
5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
10 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
*cis = Δlsp cis complementation
in trans = Δlsp in trans complementation
ΔlspFLP cis* in trans*Conc/Amount WT Δlgt1::apr Δlgt2::apr
